Product Name | CAS | MF | MW | Synonyms |
---|---|---|---|---|
Forskolin | 66428-89-5 | C22H34O7 | 410.5 | |
Forosamine | 18423-27-3 | |||
Forodesine hydrochloride | 284490-13-7 | C11H15ClN4O4 | 302.715 | 7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,5-dihydropyrrolo[3,2-d]pyrimidin-4-one;hydrochloride 1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-iminoribitol BCX-1777 BCX1777 forodesine ImmH cpd immucillin H immucillin-H |
Forodesine | 209799-67-7 | C11H14N4O4 | 266.25 | BCX-1777; Fodosine; Immucillin H; Immucillin-H; Fodosine. |
Formoterol tartrate | 200815-49-2 | C23H30N2O10 | 494.497 | N-[2-Hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-formamide, (2R,3R)-2,3-dihydroxybutane-dioate; Arformoterol Tartrate |
Formoterol-D6 (mixture of diastereomers) | 1020719-45-2 | C19H18D6N2O6 | 350.44 | N-[2-Hydroxy-5-[1-hydroxy-2-[[1-[(4-methoxyphenyl)methyl-d2]ethyl-1,2,2,2-d4]amino]ethyl] phenyl]formamide |
Formoterol Impurity E (Mixture of Diastereomers) | 1616967-26-0 | C20H26N2O4 | 358.44 | |
Formoterol Impurity D (Mixture of Diastereomers) | 1795133-96-8 | C20H26N2O4 | 358.44 | |
Formoterol Impurity B | 1224588-66-2 | C18H22N2O4 | 330.39 | N-[2-hydroxy-5-[(1RS)-1-hydroxy-2-[[2-(4- methoxyphenyl)ethyl]amino]ethyl]phenyl]formamide |
Formoterol Impurity A (Mixture of Diastereomers) | 150513-24-9 | C18H24N2O3 | 316.40 | |
Formoterol Hemifumarate | 43229-80-7 | C19H24N2O4.1/2C4H4O4 | 402.40 | Eformoterol, CGP 25827A, NSC 299587, YM 08316; CGP25827A, NSC299587, YM08316; CGP-25827A, NSC-299587, YM-08316 |
Formoterol Fumarate Dihydrate EP Impurity I (S,R-isomer) | 67346-50-3 | C19H24N2O4 | 344.41 | (S,R)-Formoterol; Formamide, N-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, [S-(R*,S*)]- |
Formoterol Fumarate Dihydrate EP Impurity I (R,S-isomer) ((R,S)-Formoterol) | 67346-51-4 | C19H24N2O4 | 344.41 | Formamide, N-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, [R-(R*,S*)]- |
Fmoc-Tyr(SO3H)-OH | 181952-24-9 | C24H21NO8S | 483.50 | Fmoc-Tyr(SO3H)-OH; N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-O-(hydroxysulfonyl)-L-tyrosine |
Fluvastatin t-Butyl Ester | 194934-96-8 | C28H34FNO4 | 467.59 | tert-Butyl (E)-3,5-Dihydroxy-7-[3'-(4''-fluorophenyl)-1'-methylethylindol-2'-yl)hept-6-enoate; 7-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid 1,1-dimethylethyl ester; (3R,5S)-Fluvastatin tert-Butyl Ester; (3R,5S,6E)- |
Fluticasone 17beta-Carboxylic Acid | 28416-82-2 | C21H26F2O5 | 396.42 | (6a,11b,16a,17a)-6,9-Difluoro-11,17-dihydroxy-16-methyl-3-oxoandrosta-1,4-diene-17-carboxylic acid; (6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carboxy |
Fluthiacet-methyl | 117337-19-6 | C15H15ClFN3O3S2 | 403.88 | FLUTHIACET-METHYL; fluthiacet-methyl (bsi, pa iso); kih-9201; Methyl 2-[2-chloro-4-fluoro-5-[(3-oxo-5,6,7,8-tetrahydro-[1,3,4]thiadiazolo[3,4-a]pyridazin-1-ylidene)amino]phenyl]sulfanylacetate; Eluthiacet-methyl; [[2-Chloro-4-fluoro-5-[(tetrahydro-3-oxo-1 |
Flutax 1 | 191930-58-2 | C71H66N2O21 | 1283.3 | (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-Bis(acetyloxy)-9-[(2R,3S)-3-(benzoylamino)-2-hydroxy-1-oxo-3-phenylpropoxy]-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[ |
Flutamide-d7 | 223143-72-3 | C11H4F3N2O3D7 | 283.26 | 2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide-d7; 4'-Nitro-3'-trifluoromethylisobutyranilide-d7; Drognil-d7; Euflex-d7; Eulexin-d7; Flutamide-d7; N-[(Isopropyl-d7)carbonyl]-4-nitro-3-trifluoromethylaniline; Sch 13521-d7 |
Flutamide | 13311-84-7 | C11H11F3N2O3 | 276.21 | SCH13521; SCH-13521; SCH 13521; Flucinom; Flugerel; Niftolid; Eulexin; Apimid; Chimax; Drogenil; Euflex; Eulexine; Flucinome; Fluken; Flulem; Flutabene; Flutacan; FlutaGry; Flutamex; Flutamin; Flutan; Flutaplex; Fugerel; Grisetin; Oncosal; Profamid; Prost |
Fluspirilene | 1841-19-6 | C29H31F2N3O | 475.57 | FLUSPIRILENE;8-(4,4-BIS[P-FLUOROPHENYL]BUTYL)-1-PHENYL-1,3,8-TRIAZINO(4,5)DECAN-4-ONE;R 6218;1-phenyl-4-oxo-8-(4,4-bis(4-fluorophenyl)butyl)-1,3,8-triazaspiro(4,5)decane;8-(4,4-bis(p-fluorophenyl)butyl)-1-phenyl-1,3,8-triazaspiro(4,5)decan-4-one;8-triaza |
Flurossene | 406-90-6 | C4H5F3O | 126.08 | 2-ethenoxy-1,1,1-trifluoroethane; 2,2,2-Trifluoroethyl vinyl ether; |
Flurofamide | 70788-28-2 | C7H9FN3O2P | 217.14 | N-(Diaminophosphinyl)-4-fluorobenzamide |
Flurbiprofen Sodium | 56767-76-1 | C15H12FNaO2 | 266.24 | |
Flurbiprofen Related Compound A (Biprofen) | 6341-72-6 | C15H14O2 | 226.28 | Biprofen; alpha-Methyl-4-biphenylacetic acid; 2-(Biphenyl-4-yl)propanoic acid; LY-71130; p-Phenylhydroatropic acid; (2RS)-2-(Biphenyl-4-yl)propanoic acid; 2-(4-Phenylphenyl)Propionic Acid; (1,1'-Biphenyl)-4-Acetic Acid, Alpha-Methyl-; 2-(P-Biphenyl)Propio |
Flurbiprofen Impurity D | 42771-79-9 | C14H11FO | 214.24 | 1-(2-fluoro[1,1'-biphenyl]-4-yl)ethan-1-one; 3-Fluoro-4-phenyl acetophenone; 2-Fluoro-4-acetylbiphenyl; 4-acetyl 2-fluorobiphenyl |
Flurbiprofen Impurity 4 | 55258-76-9 | C14H13F | 200.26 | 1,1'-Biphenyl, 4-ethyl-2-fluoro- |
Flurbiprofen Impurity 2 | 42771-82-4 | C16H13FO4 | 288.28 | |
Flurbiprofen Impurity 1 | 42771-81-3 | C20H21FO4 | 344.39 | |
Flurbiprofen Axetil (Mixture of Diastereomers) | 91503-79-6 | C19H19FO4 | 330.35 | 1-Acetoxyethyl 2-(2-fluoro-4-biphenylyl)propionate; 2-Fluoro-alpha-methyl-[1,1'-biphenyl]-4-acetic acid 1-(acetyloxy)ethyl ester; [1,1'-Biphenyl]-4-acetic acid, 2-fluoro-a-methyl-, 1-(acetyloxy)ethyl ester; LFP 83; FP 83; Hurbiprofen Axetil; Lipfen; Ropio |
Flurbiprofen | 5104-49-4 | C15H13FO2 | 244.27 | Ansaid; Froben; Antadys; 2-(3-fluoro-4-phenylphenyl)propanoic acid |
Fluralaner | 864731-61-3 | C22H17Cl2F6N3O3 | 556.29 | 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-2-methyl-N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]benzamide |
Fluprostenol methyl ester | 73275-76-0 | C24H31F3O6 | 472.5 | 7-[(1R,2R,3R5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-(5Z)-heptenoic acid, methyl ester |
Fluprostenol | 40666-16-8 | C23H29F3O6 | 458.47 | (+/-)-16-(3-TRIFLUOROMETHYLPHENOXY)TETRANORPROSTAGLANDIN F2ALPHA; (+/-)16-(M-TRIFLUOROMETHYLPHENOXY)-TETRANOR-PROSTAGLANDIN F2ALPHA; (+/-)-9ALPHA,11ALPHA,15R-TRIHYDROXY-16-(3-(TRIFLUOROMETHYL)PHENOXY)-17,18,19, 20-TETRANORPROSTA 5Z,13E-DIEN-1-OIC ACID; FL |
Fluproquazone | 40507-23-1 | C18H17FN2O | 296.343 | Fluproquazone; 4-(4-Fluorophenyl)-1-isopropyl-7-methyl-1H-quinazolin-2-one; 46-790; RF-46-790; Tormosyl |
Flupirtine-d4 Hydrochloride | 1324717-75-0 | C15H14FN4O2D4Cl | 344.81 | N-[2-Amino-6-[[4-fluorophenyl-d4)methyl]amino]-3-pyridinyl]carbamic acid ethyl ester hydrochloride; 2-Amino-6-[(p-fluorobenzyl)amino]-3-pyridinecarbamic Acid Ethyl Ester Hydrochlorite |
Flupirtine Maleate Impurity E | 1506942-35-3 | C12H11FN4O2 | 262.25 | 6-Amino-2-(4-fluorobenzyl)amino-3-nitro-pyridine |
Flupirtine Maleate | 75507-68-5 | C15H17FN4O2·C4H4O4 | 420.39 | ARC029, FR34235; ARC 029, FR 34235; ARC-029, FR-34235 |
Flupirtine Impurity A (Impurity I) | 951624-49-0 | C13H11FN4O | 258.26 | 5-[[(4-Fluorophenyl)Methyl]aMino]-1,3-dihydro-2H-iMidazo[4,5-b]pyridin-2-one; 5-(4-fluorobenzylaMino)-1H-iMidazo[4,5-b]pyridin-2-ol |
Flupirtine Hydrochloride | 33400-45-2 | C15H18ClFN4O2 | 340.78 | ethyl N-[2-amino-6-[(4-fluorophenyl)methylamino]pyridin-3-yl]carbamate;hydrochloride; |
Flupirtine | 56995-20-1 | C15H17FN4O2 | 304.32 | D 9998; Katadolon; ethyl N-[2-amino-6-[(4-fluorophenyl)methylamino]pyridin-3-yl]carbamate; |
Fluphenazine-N-2-chloroethane hydrochloride | 3892-78-2 | C22H25ClF3N3S·2HCl | 528.9 | Fluphenazine-N-mustard; FNM; FPCE; SKF-7171A; 10-[3-[4-(2-chloroethyl)-1-piperazinyl]propyl]-2-(trifluoromethyl)-10H-phenothiazine dihydrochloride |
Fluphenazine Enantate | 2746-81-8 | C29H38F3N3O2S | 549.70 | Fluphenazine O-enantate; Heptanoic acid, 2-4-3-2-(trifluoromethyl)-10H-phenothiazin-10-ylpropyl-1-piperazinylethyl ester; 2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethyl heptanoate; enanthic acid 2-[4-[3-[2-(trifluoromethyl)phen |
Fluphenazine DiHCl | 146-56-5 | C22H28F3N3OSCl2 | 510.45 | 4-[3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl]-1-piperazineethanol Dihydrochloride;Anatensol;Dapotum;Flufenazin;Tensofin;Permitil hydrochloride;Prolinate;Prolixin;Siqualone;Squibb 4918;Trancin;Valamina;Fluphenazine Decanoate EP Impurity B DiHCl |
Fluphenazine Decanoate N-Oxide | 76005-64-6 | C32H44F3N3O3S | 607.78 | 2-[1-Oxido-4-[3-[2-(Trifluoromethyl)Phenothiazin-10-Yl]Propyl]Piperazin-1-Ium-1-Yl]Ethyl Decanoate; Decanoic Acid 2-[1-Oxido-4-[3-[2-(Trifluoromethyl)-10-Phenothiazinyl]Propyl]-1-Piperazin-1-Iumyl]Ethyl Ester; Capric Acid 2-[1-Oxido-4-[3-[2-(Trifluorometh |
Fluphenazine Decanoate Impurity 3 | 76013-31-5 | C32H44F3N3O3S | 607.77 | Fluphenazine decanoate N-1-oxide; Decanoic acid, 2-(4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazinyl)ethyl ester, N-1-oxide; 2-(4-Oxo-4-{3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl}-4lambda 5-piperazin-1-yl)ethyl decanoate; |
Fluphenazine Decanoate EP Impurity G | 61555-18-8 | C34H48F3N3O2S | 619.84 | |
Fluphenazine Decanoate EP Impurity F | 13220-06-9 | C33H46F3N3O2S | 605.81 | 2-(4-{3-[2-(trifluoromethyl)-10H-phenothiazin-10- yl]propyl}piperazin-1-yl)ethyl undecanoate |
Fluphenazine Decanoate EP Impurity A | 1674-76-6 | C22H26F3N3O2S | 453.53 | Fluphenazine Sulfoxide ; 4-[3-[5-Oxido-2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl]-1-piperazineethanol; 4-[3-[2-(Trifluoromethyl)phenothiazin-10-yl]propyl]-1-piperazineethanol 5-Oxide |
Fluphenazine decanoate dihydrochloride | 2376-65-0 | C32H44F3N3O2S.2HCl | 664.69 | 2-[4-[3-[2-(Trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethyl decanoate dihydrochloride |
Fluphenazine Decanoate | 5002-47-1 | C32H44F3N3O2S | 591.79 | Fluphenazine O-decanoate; 2-[4-[3-[2-(Trifluoromethyl)phenothiazin-10-yl]propyl]-1-piperazinyl]ethyl Ester Decanoic Acid; 4-[3-[2-(Trifluoromethyl)phenothiazin-10-yl]propyl]-1-piperazineethanol Decanoate; Dapotum D; Depot; Fluorophenazine Decanoate; Lyoge |
Fluphenazine | 69-23-8 | C22H26F3N3OS | 437.52 | 4-[3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl]-1-piperazineethanol; 1-(2-Hydroxyethyl)-4-[3-(trifluoromethyl-10-phenothiazinyl)propyl]piperazine; 10-[3-(2-Hydroxyethyl)piperazinopropyl]-2-(trifluoromethyl)phenothiazine; 4-[3-(2-Trifluoromethyl-1 |
Fluperlapine | 67121-76-0 | C19H20FN3 | 309.38 | FLUPERLAPINE; 3-Fluoro-6-(4-methyl-1-piperazinyl)-11H-dibenz[b,e]azepine; NB-106-689 |
Fluperamide | 53179-10-5 | C30H32ClF3N2O2 | 545.042 | Fluperamide; CHEMBL421665; UNII-6H13T09362; 53179-10-5; R-18910; 4-[4-[4-chloro-3-(trifluoromethyl)phenyl]-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide |
Fluoxetine USP Related Compound C | 1026723-45-4 | C21H22F3NO4 | 409.41 | 4-(methyl{3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl}amino)-4-oxobutanoic acid |
Fluoxetine Impurity B HCl | 30684-07-2 | C10H16NCl | 185.70 | N-Methyl-3-phenylpropylammonium chloride; N-methyl-3-phenyl-propan-1-amine hydrochloride |
fluoxetine hydrochloride | 59333-67-4 | 345.79 | ||
fluoxetine hydrochloride | 59333-67-4;56296-78-7 | C17H18F3NO·HCl | 345.79 | |
Fluoxetine hydrochloride | 56296-78-7 | C17H19ClF3NO | 345.79 | Prozac; Fluoxetine HCl; N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine hydrochloride |
Fluoxetine D-glucuronide (mixture of isomers) | 96735-71-6 | |||
Fluoxetine | 54910-89-3 | C17H18F3NO | 309.33 | Prozac; LY110140 |
Fluoxastrobin | 193740-76-0 | C21H16ClFN4O5 | 458.8314 | {2-[6-(2-chlorophenoxy)-5-fluoropyrimidin-4-yloxy]phenyl} (5,6-dihydro-1,4,2-dioxazin-3-yl) methanone O-methyloxime; BAY HEC 5725; Fandango; Fluoxastrobin; Fluoxastrobin (E,Z isomer); Fluoxastrobin [iso] |
Fluorouracil Impurity C | 66-22-8 | C4H4N2O2 | 112.09 | Uracil; 2,4-Dioxopyrimidine; 2,4-Pyrimidinedione; Pirod; Pyrod. |
Fluorotripentylstannane | 20153-49-5 | C15H33FSn | 351.131 g/mol | Fluorotripentylstannane; fluoro(tripentyl)stannane; 20153-49-5; AC1L3FM0; AC1Q4HK8; FLUORO-TRIPENTYL-STANNANE |
Fluorotrimethylsilane | 420-56-4 | C3H9FSi | 92.19 | (CH3)3SiF; fluorotrimethyl-silan; Trimethylsilicon fluoride; FLUOROTRIMETHYLSILANE; TRIMETHYLFLUOROSILANE; TRIMETHYLSILYL FLUORIDE |
Fluorotrihexylstannane | 20153-50-8 | C18H39FSn | 393.211 g/mol | Fluorotrihexylstannane; fluoro(trihexyl)stannane; 20153-50-8; AC1L3FM3; AC1Q4HK9; CTK4E3426 |
Fluorotriethylsilane | 358-43-0 | C6H15FSi | 134.27 | |
Fluorometholone acetate | 3801-06-7 | C24H31FO5 | 418.5 | NSC 47438 |
Fluorometholone | 426-13-1 | C22H29FO4 | 376.468 | FML; Flarex; Oxylone acetate; Fluorometholone 17-acetate; UNII-9I50C3I3OK; NSC47438; NSC-47438; NSC 47438 |
Fluorol Yellow 088 | 81-37-8 | C22H16O | 296.369 | 2,8-Dimethylnaphtho[3,2,1-kl]xanthene |
Fluorogestone acetate | 2529-45-5 | C23H31FO5 | 406.494 | Flurogestone Acetate, Flugestone Acetate, Fluorogesterone Acetate, SC-9880. |
Fluorescent brightener 71 | 16090-02-1 | C40H38N12Na2O8S2 | 924.91 | disodium 4,4'-bis[(4-anilino-6-morpholino-1,3,5-triazin-2-yl)amino]stilbene-2,2'-disulphonate; fluorescent brightener 71; Fluorescent brightener 260; 2,2'-(1,2-ethenediyl)bis[5-[[4-(4-morpholinyl)-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-benzenesulfonic |
Fluorescent Brightener 61 | 8066-05-5 | |||
Fluorescent Brightener 54 | 12768-89-7 | 0 | Fluorescent Brightener 54; Fluorescent brightening agent 54 | |
Fluorescent Brightener 54 | 40691-09-6 | C21H17ClN2O3SNa | 434.871109;g/mol | Fluorescent Brightener 54; Sodium 4-[3-(4-chlorophenyl)-4,5-dihydro-5-phenyl-1H-pyrazol-1-yl]benzenesulfonate |
Fluorescein-5-maleimide | 75350-46-8 | C24H13NO7 | 427.4 | 5-Maleimido-fluorescein; 5-MF; 1-(3',6'-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-5-yl)-1H-pyrrole-2,5-dione |
Fluorescein-5-isothiocyanate diacetate | 118378-76-0 | C25H15NO7S | 473.45 | FITCDA; (6'-acetyloxy-5-isothiocyanato-3-oxospiro[2-benzofuran-1,9'-xanthene]-3'-yl) acetate |
Fluorescein-5-EX succinimidyl ester | 123761-26-2 | C29H22N2O10S | 590.56 | 5-FEX, SE; (2,5-dioxopyrrolidin-1-yl) 3-[2-[(3',6'-dihydroxy-3-oxospiro[2-benzofuran-1,9'-xanthene]-5-yl)amino]-2-oxoethyl]sulfanylpropanoate |
Fluorescein-5-carbonyl azide diacetate | 223743-67-7 | C25H15N3O8 | 485.41 | |
Fluorescein-5(6)-sulfonic acid trisodium salt | 445289-99-6 | C20H9Na3O8S | 478.32 | |
Fluorescein-4',5'-bis(methyliminodiacetic acid) | 207124-64-9 | C30H26N2O13 | 622.5364 | 4',5'-Bis(N',N'-di-(carboxymethyl)aminomethyl)fluorescein, DCAF |
Fluorescein phalloidin | 84313-38-2 | C56H60N10O15S2 | 1177.27 | |
Fluorescein mono-b-D-galactopyranoside | 102286-67-9 | C26H22O10 | 494.45 | FMGal |
Fluorescein isothiocyanate-dextran - Average MW 3,000-5,000 | 60842-46-8 | |||
Fluorescein diphosphate triammonium salt | 134869-03-7 | C20H14O11P2 | 492.266084;g/mol | Fluorescein 3,6-diphosphate triammonium salt |
Fluorescein diphosphate tetraammonium salt | 217305-49-2 | C20H26N4O11P2 | 560.39 | FDP |
Fluorescein dibutyrate | 7298-65-9 | C28H24O7 | 472.49 | |
Fluorescein Cadaverine | 786705-84-8 | C26H27Br2N3O5S | 653.38 | 5-((5-Aminopentyl)thioureidyl)fluorescein dihydrobromide |
Fluorescein Biotin | 134759-22-1 | C42H50N6O8S2 | 831.0 | FITC Biotin; (3aS,4S,6aR)-N-[6-[[5-[[[(3',6'-dihydroxy-3-oxospiro[isobenzofuran-1(3H),9'-[9H]xanthen]-5-yl)amino]thioxomethyl]amino]pentyl]amino]-6-oxohexyl]hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide |
Fluorescamine | 38183-12-9 | C17H10O4 | 278.30 | |
Fluorapatite (Ca5F(PO4)3) | 1306-05-4 | Ca10F2O4P | 0 | Fluorapatite (Ca5F(PO4)3); fluorapatite |
Fluorapacin | 869811-23-4 | C14H12F2S3 | 314.427 | Fluorapacin. bis(4-fluorobenzyl)trisulfide |
Fluocinonide | 356-12-7 | C26H32F2O7 | 494.52 | Fluocinonide, Lidex, Fluocinolide, Lyderm, Metosyn, Topsyn, Vanos, Lonide |
Fluocinolone acetonide | 67-73-2 | C24H30F2O6 | 452.488 | Isepamicine (Isepamycin, sch21420) Sulphate |
Fluocinolone | 807-38-5 | C21H26F2O6 | 412.43 | Fluocinolone Acetonide EP Impurity C; 6-alpha-Fluorotriamcinolone; 6-alpha,9-alpha-Difluoro-11-beta,16-alpha,17-alpha,21-tetrahydroxypregna-1,4-diene-3,20-dione |
Flunixin-D3 | 1015856-60-6 | 2-(2-Methyl-D3-3-trifluoro-methyl-phenylamino)-nicotinic acid | ||
Flunixin Meglunine | 42461-84-7 | C14H11F3N2O2.C7H17NO5 | 491.46 | Flunixin meglumine; Banamine; Flumeglumine; Flunixin-S; |
FLUNIXIN | 38677-85-9 | C14H11F3N2O2 | 296.25 | Flunixine; 38677-85-9; Flunixino; Flunixinum; Sch 14714; 2-[2-methyl-3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid |
Flunarizine Impurity C | 90830-31-2 | C26H26F2N2 | 404.51 | 4-Defluoro 2-Fluoro Flunarizine; (E)-1-[(4-Fluoroohenyl)(2-fluorophenyl)methyl]-4-(cinnamyl)piperazine |
Flunarizine DiHCl | 30484-77-6 | C26H26F2N2.2HCl | 477.42 | KW-3149, R-14950; KW 3149, R 14950; KW3149, R14950 |
Flunarizine | 52468-60-7 | C26H26F2N2 | 404.50 | Sibelium;Flunarizinum;Flunarizina;(E)-1-[Bis-(p-fluorophenyl)methyl]-4-cinnamylpiperazine;1-[Bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenyl-2-propenyl]piperazine;Piperazine, 1-[bis(4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl)-, (E)- |
Flumorph | 211867-47-9 | C21H22FNO4 | 371.4 | SYP-L190 |
Flumizole | 36740-73-5 | C18H15F3N2O2 | 348.32 | 4,5-bis(4-methoxyphenyl)-2-(trifluoromethyl)-1H-imidazole; |
Flumioxazin | 103361-09-7 | C19H15FN2O4 | 354.336 | S-53482; PLEDGE; V-53482; VALOR; FLUMIOXAZIN; 4,5,6,7-tetrahydro-2-(7-fluoro-3,4-dihydro-3-oxo-4-1h-isoindole-3(2h)-dione |
FLUMICLORAC-PENTYL | 87546-18-7 | C21H23ClFNO5 | 423.86 | SUMIVERDE; RESOURCE; FLUMICLORAC-PENTYL; flumiclorac-pentyl (bsi,pa iso,ansi); PENTYL2-CHLORO-4-FLUORO-5-(3,4,5,6-TETRAHYDROPHTHALIMIDO)PHENOXYACETATE; PENTYL2-CHLORO-4-FLUORO-5-(3,4,5,6-TETRAHYDROPHTHALIMIDO).; pentyl-[2-chloro-5-(cyclohex-1-ene-1,2-dica |
Flumethrin (Mixture of Diastereomers) | 69770-45-2 | C28H22Cl2FNO3 | 510.40 | 3-[2-Chloro-2-(4-chlorophenyl)ethenyl]-2,2-dimethylcyclopropanecarboxylic Acid Cyano(4-fluoro-3-phenoxyphenyl)methyl Ester; Bayticol; Bayvarol; FCR 2769; Cyano(4-fluoro-3-phenoxyphenyl)methyl 3-[2-chloro-2-(4-chlorophenyl)ethenyl]-2,2-dimethylcyclopropane |
Flumethasone pivalate | 2002-29-1 | C27H36F2O6 | 494.57 | Locorten; Flumetasone pivalate; Lorinden; Locacorten; [2-[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 2,2-dimethylpropanoate |
Flumethasone | 2135-17-3 | C22H28F2O5 | 410.45 | RS 2177; RS-2177; RS2177; NSC 54702; U-10,974; U-10974; Anaprime; Aniprime; Fluvet; Methagon; BRN 5645455; Flumethasone; Cortexilar; Flucort; Flucorticin;Locacorten; Locorten |
Flumequine-13C3 | 1185049-09-5 | 9-Fluoro-5-methyl-1-oxo- 6,7-dihydro-1H,5H-pyri- do[3,2,1-ij] quinoline-2- carboxylic acid-13C 3 |
||
Flumequine | 42835-25-6 | C14H12FNO3 | 261.25 | 9-Fluoro-6,7-dihydro-5-methyl-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid; Fluoromethylquinoline; Fluoromethyl; Apurone; Fantacin; R 802 |
flumecinol | 56430-99-0 | C16H15F3O | 280.288 | |
Flumazenil Related Compound B | 131666-45-0 | C15H15N3O4 | 301.30 | 4H-Imidazo[1,5-a][1,4]benzodiazepine-3-carboxylicacid, 5,6-dihydro-8-hydroxy-5-methyl-6-oxo-, ethyl ester; Ethyl 8-hydroxy-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate; Defluoro 8-Hydroxy Flumazenil (Impurity) ; 5,6-Dihydr |
Flumazenil Related Compound A | 84378-44-9 | C13H10FN3O3 | 275.24 | 8-Fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid; Flumazenil acid; 4H-Imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid, 8-fluoro-5,6-dihydro-5-methyl-6-oxo-; O-Desethylflumazenil; 3-Desethyl-FMZ; Ro 15-3890 |
Flumazenil Impurity D | 78755-80-3 | C10H9FN2O2 | 208.19 | 7-Fluoro-3,4-dihydro-4-methyl-1H-1,4-benzodiazepine-2,5-dione; 7-Fluoro-4-methyl-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione; 1H-1,4-Benzodiazepine-2,5-dione, 7-fluoro-3,4-dihydro-4- Methyl- |
Flumazenil | 78755-81-4 | C15H14FN3O3 | 303.29 | Flumazenil, Flumazepil, Anexate, Romazicon, Lanexat, Ro 15-1788, Ro 15 1788, Ro 151788 |
Flumatinib Mesylate Impurity 1 | 859027-02-4 | C14H17F3N2O2 | 302.30 | 4-((4-Methylpiperazin-1-yl)Methyl)-3-(trifluoroMethyl)benzoic acid |
Flumatinib Mesylate | 895519-91-2 | C30H33F3N8O4S | 658.69 | HH-GV-678 mesylate |
Flumatinib | 895519-90-1 | C29H29F3N8O | 562.59 | BenzaMide, 4-[(4-Methyl-1-piperazinyl)Methyl]-N-[6-Methyl-5-[[4-(3-pyridinyl)-2-pyriMidinyl]aMino]-3-pyridinyl]-3-(trifluoroMethyl)-;4-[(4-Methyl-1-piperazinyl)methyl]-N-[6-methyl-5-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-3-pyridinyl]-3-(trifluoromethyl)be |
Fluindione-d4 | 1246820-41-6 | C15H5FO2D4 | 244.26 | 2-(4-Fluorophenyl)-1H-indene-1,3(2H)-dione-d4; 2-(p-Fluorophenyl)-1,3-indandione-d4; LM 123-d4; Previscan-d4; 2-(4-fluorophenyl-2,3,5,6-d4)-1H-indene-1,3(2H)-dione |
Fluindione | 957-56-2 | C15H9FO2 | 240.24 | Fluorindione; 2-(4-fluorophenyl)indane-1,3-quinone; 2-(4-fluorophenyl)indene-1,3-dione; 2-(p-Fluorophenyl)-1,3-indandione; LM 123; Previscan |
Fluifort | 49673-81-6 | C11H23N3O6S | 325.38 | S-(Carboxymethyl)-L-cysteine compd. with L-lysine |
Flufylline | 82190-91-8 | C21H24FN5O3 | 413.445 g/mol | |
Flufenpyr-ethyl | 188489-07-8 | C16H13ClF4N2O4 | 408.73200 | |
Flufenamic acid-13C6 | 1325559-30-5 | 2-(3-Trifluoromethyl- phenylamino)-13C - benzoic acid | ||
Flufenamic acid | 530-78-9 | C14H10F3NO2 | 281.23 | |
Flufenacet | 142459-58-3 | C14H13F4N3O2S | 363.33 | N-(4-FLUOROPHENYL)-N-ISOPROPYL-2-[5-(TRIFLUOROMETHYL)-1,3,4-THIADIAZOL-2-YLOXY]ACETAMIDE; acetamide,n-(4-fluorophenyl)-n-(1-methylethyl)-2-((5-(trifluoromethyl)-1,3,4-t; hiadiazol-2-yl)oxy)-; n-(4-fluorophenyl)-n-(1-methylethyl)-2-((5-(trifluoromethyl)-1, |
Fluensulfone | 318290-98-1 | C7H5ClF3NO2S2 | 291.687 | 5-chloro-2-(3,4,4-trifluorobut-3-ene-1-sulfonyl)-1,3-thiazole; 5-Chloro-2-[(3,4,4-trifluoro-3-buten-1-yl)sulfonyl]thiazole |
Fludroxycortide | 1524-88-5 | C24H33FO6 | 436.52 | (6alpha,11beta,16alpha)-(oxy));20-dione,6-alpha-fluoro-11-beta,16-alpha,17,21-tetrahydroxy-pregn-4-ene-cy;20-dione,6alpha-fluoro-11beta,16alpha,17,21-tetrahydroxy-pregn-4-ene-cycli;33379;6alpha-fluoro-11beta,16alpha,17,21-tetrahydroxyprogesteronecyclic16 |
Fludarabine Phosphate Impurity F | 159002-28-5 | C12H18N5O8P | 391.28 | [(2R,3S,4S,5R)-5-(6-amino-2-ethoxypurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate |
Fludarabine phosphate impurity B | 149297-79-0 | C5H5N5O | 151.13 | |
Fludarabine Phosphate | 75607-67-9 | C10H13FN5O7P | 365.21 | PN 200-110 |
2-Fluoroadenosine | 146-78-1 | C10H12FN5O4 | 285.235 | 2-Fluoroadenosine; Fludarabine; 2-Fluoro Adenosine; |
Fludalanine | 35523-45-6 | C3H6FNO2 | 108.09 | 3-Fluoro-D-(2-2H)alanine;(S)-2-amino-3-fluoropropanoic-2-d acid; |
Fluconazole mesylate | 159532-41-9 | C14H16F2N6O4S | 402.38 | UK 49858 mesylate; UK49858 mesylate; UK-49858 mesylate |
Fluconazole Impurity I | 150168-54-0 | C13H14F2N7O. Br | 402.2 | Fluconazole Amino Impurity ; 4-Amino-1-[(2RS)-2-(2,4-difluorophenyl)-2-hydroxy-3(1H-1,2,4-triazol-1-yl)propyl]-4H-1,2,4-triazolium bromide ; |
Flucloxacillin Impurity G | 150194-52-8 | C32H27Cl2F2N5O9S | 766.55 | (5R)-Flucloxacillin N4-[N-[[3-(2-Chloro-6-fluoro-phenyl)-5-methyl-4-isoxazolyl]carbonyl]-glycinyl] Penilloic Acid |
Fluconazole Impurity G | 86386-76-7 | C12H11F2N3O4S | 331.30 | Fluconazole Epoxide Impurity ; 1-[[(2RS)-2-(2,4-Difluorophenyl)oxiran-2-yl]methyl]-1H-1,2,4-triazole ; |
Fluconazole Impurity C | 514222-44-7 | C10H8N6 | 212.22 | 1,1'-(1,3-Phenylene)bis-1H-1,2,4-triazole; 1,1'-(1,3-Phenylene)di-1H-1,2,4-triazole; |
Fluconazole Impurity 1 | 173837-65-5 | C9H10F2O3 | 204.18 | 2-(2,4-Difluorophenyl)-1,2,3-propanetriol; |
Fluconazole Impurity (1-(2,4-Difluorophenyl)-1-(1H-1,2,4-Triazol-1-yl)-2,3-Epoxy Propane Methanesulfonate Salt) | 86386-77-8 | C11H9F2N3O CH4O3S | 237.21 96.11 | 2-[[(2,4-Difluorophenyl)-2-oxiranyl]methyl]-1H-1,2,4-triazole methanesulfonate |
Fluconazole hydrate | 155347-36-7 | C13H14F2N6O2 | 324.29 | UK 49858 hydrate; UK49858 hydrate; UK-49858 hydrate |
Fluconazole EP Impurity F | 118689-07-9 | C11H11F2N3O2 | 255.23 | Fluconazole Diol Impurity; 2-(2,4-Difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)-1,2-propanediol; |
Fluconazole | 86386-73-4 | C13H12F2N6O | 306.27 | UK 49858; UK49858; UK-49858 |
Flucloxacillin Sodium Impurity B | 1276016-89-7 | C18H19ClFN3O4S | 427.89 | 2-[[[[3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl]carbonyl]amino]methyl]-5,5-dimethyl-4-thiazolidinecarboxylic Acid; |
Florfenicol amine | 76639-93-5 | C10H14FNO3S | 247.3 | Sch 40458 |
Florfenicol | 73231-34-2 | C12H14Cl2FNO4S | 358.21 | Florfenicol; Nuflor; Sch-25298; Sch25298; Sch 25298; (-)-Florfenicol; Aquafen; thiamphenicol, 3-fluoro. |
Floramelon | 1205-17-0 | C11H12O3 | 192.21 | HYDROCINNAMALDEHYDE, ALPHA-METHYL-3,4- (METHYLENEDIOXY); HELIOFRESH(R); HELIONAL; AQUANAL; A-METHYL-1,3-BENZODIOXOLE-5-PROPIONALDEHYDE; 2-METHYL-3-(3,4-METHYLENEDIOXYPHENYL)-PROPANAL; 2-METHYL-3-(3,4-METHYLENEDIOXYPHENYL) PROPIONALDEHYDE; 1,3-Benzodioxole |
Flopropione | 2295-58-1 | C9H10O4 | 182.17 | Compacsul, Cospanon, Ecapron, |
Flavoxate HCL | 3717-88-2 | C24H25NO4.HCl | 427.92 | NSC-114649 |
Flomoxef Sodium Salt | 92823-03-5 | C15H17F2N6NaO7S2 | 518.45 | (6R,7R)-7-[[[(Difluoromethyl)thio]acetyl]amino]-3-[[[1-(2-hydroxyethyl)-1H-tetrazol-5-yl]thio]methyl]-7-methoxy-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Sodium; |
flomoxef | 99665-00-6 | C15H18F2N6O7S2 | 496.47 | FLOMOXEF; 5-OXA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLIC ACID, 7-[[[(DIFLUOROMETHYL)THIO]ACETYL]AMINO]-3-[[[1-(2-HYDROXYETHYL)-1H-TETRAZOL-5-YL]THIO]METHYL]-7-METHOXY-8-OXO-, (6R-CIS)-; FLOMOXEF [5-OXA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLIC ACID, 7-[[ |
Flibanserin | 167933-07-5 | C20H21F3N4O | 390.40 | Flibanserin;Bimt 17;3-[2-[4-[4-(Trifluoromethyl)phenyl]piperazin-1-yl]ethyl]-1H-benzimidazol-2-one |
FLI-06 | 313967-18-9 | C25H30N2O5 | 438.524 | FLI 06; cyclohexyl 2,7,7-trimethyl-4-(4-nitrophenyl)-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate |
Flezelastine | 135381-77-0 | C29H30FN3O | 455.57 | Flezelastine; 135381-77-0; flezelastine[inn]; AC1Q4NQW; AC1L1T8K; SCHEMBL62291 |
Fleroxacin | 79660-72-3 | C17H18F3N3O3 | 369.34 | Fleroxacin, Quinodis, Megalocin, AM 833, Ro 236240; AM833, Ro236240; AM-833, Ro-236240 |
Flemiphilippinin D | 99119-72-9 | C25H28O6 | 424.5 | Kushenol E; 5,7,2',4'-Tetrahydroxy-6,8-diprenylflavanone |
Flemiphilippinin A | 140366-64-9 | C30H32O6 | 488.58 | |
Flecainide-d4 Acetate [bis(2,2,2-trifluoroethoxy-1,1-d2)] | 1276197-21-7 | C17H16D4F6N2O3·CH3CO2H | 478.42 | N-(2-Piperidylmethyl)-2,5-bis-(2,2,2-trifluoroethoxy)benzamide Acetate |
Flecainide-d3 | 127413-31-4 | C17H17F6N2O3D3 | 417.37 | N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide-d3 |
Flecainide Impurity E | 57415-36-8 | C17H14F6N2O3 | 408.30 | N-(2-Pyridinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide ; 2,5-Bis(2,2,2-trifluoroethoxy)-N-(2-pyridylmethyl)benzamide; |
Flecainide Impurity C | 152171-74-9 | C17H20F6N2O4 | 430.35 | 4-Hydroxy Flecainide; 4-Hydroxy-N-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide; (±)-4-Hydroxy-N-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide; |
Flecainide Acetate | 54143-56-5 | C19H24F6N2O5 | 474.40 | 2,5-bis-(2,2,2-trifluoroethoxy)-n-(2-piperidinylmethyl)benzamideacetate;acetic acid;N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide; |
Flecainide | 54143-55-4 | C17H20F6N2O3 | 414.35 | N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide; |
Flazin | 100041-05-2 | C17H12N2O4 | 308.293 | Flazine; 1-[5-(hydroxymethyl)furan-2-yl]-9H-pyrido[3,4-b]indole-3-carboxylic acid; 9H-Pyrido[3,4-b]indole-3-carboxylicacid, 1-[5-(hydroxymethyl)-2-furanyl]- |
Flavoxate | 15301-69-6 | C24H25NO | 391.47 | 2-(1-piperidyl)ethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate; |
Flavopiridol Hydrochloride | 131740-09-5 | C21H20ClNO5.HCl | 438.3 | NSC 649890 HCl |
Flavokawain C | 37308-75-1 | C17H16O5 | 300.3 | Flavokavain C; Flavokawin C |
Flavokawain B | 1775-97-9 | C17H16O4 | 284.3 | Flavokawin B; 4',6'-Dimethoxy-2'-hydroxychalcone |
Flavoglaucin | 523-73-9 | C19H28O3 | 304.43 | 2-heptyl-3,6-dihydroxy-5-(3-methylbut-2-enyl)benzaldehyde |
Flavodilol | 79619-31-1 | C21H23NO4 | 353.412 g/mol | |
FITC isomer I | 3326-32-7 | C21H11NO5S | 389.38 | Fluorescein-5-isothiocyanate; Fluorescein isothiocyanate isomer I |
Flavidinin | 83925-00-2 | C16H14O3 | 254.285 | |
Flavidin | 83924-98-5 | C15H12O3 | 240.258 | 2,7-dihydroxy-9,10-dihydro-phenanthro-4,5-bcd-pyran |
FK 3311 | 116686-15-8 | C15H13F2NO4S | 341.33 | FK-3311; FK3311 |
FITM | 932737-65-0 | C18H18FN5OS | 371.43 | |
FISH OIL | 8002-50-4 | FatsandGlyceridicoils,menhaden; fishoilfrommenhaden; menhaden; Menhadenfishoil,coldpressed,refined,bleached; Menhadenoil,bleached; mossbunkeroil; oils,menhaden; pogyoil | ||
FISETINIDOL-(4A8)-CATECHIN | 69127-11-3 | C30H26O11 | 562.52 | FISETINIDOL-(4A8)-CATECHIN |
Fisetin | 528-48-3 | C15H10O6 | 286.24 | 2-(3,4-Dihydroxyphenyl)-3,7-dihydroxy-4H-chromen-4-one; 5-Desoxyquercetin; Fisetholz; Superfustel |
Fischeria A | 221456-63-9 | C19H28O2 | 288.43 | (3aR,6aR,8R,10aR)-8-ethenyl-4,4,8,10a-tetramethyl-5,6,6a,7,9,10-hexahydro-3aH-benzo[6,7]cyclohepta[4,6-c]furan-2-one |
Firtecan pegol | 946062-05-1 | C118H122N12O37 | 2300.321 | EZN-2208 (Pegylated SN-38). PEG-SN38, Firtecan pegol |
Firocoxib-D6 | 1353853-37-8 | 3-Cyclopropylmethoxy-4- (4-methanesulfonyl- phenyl)-5,5-dimethyl-D6- 5H-furan-2-one | ||
FIREMASTER BP-6 | 59536-65-1 | C12H4Br6 | 627.58416 | biphenyl,hexabromo-(technicalgrade); firemasterbp-6; hexabromobiphenyl(technicalgrade); PBBS; POLYBROMATEDBIPHENYLS; POLYBROMOBIPHENYLS |
Firategrast | 402567-16-2 | C27H27F2NO6 | 499.5 | SB 683699 |
Fipronil Sulfone | 120068-36-2 | C12H4Cl2F6N4O2S | 453.15 | 5-Amino-1-(2,6-dichloro-4-trifluoromethylphenyl)-3-cyano-4-trifluoromethylsulfonylpyrazole; 5-Amino-1-[2,6-Dichloro-4-(trifluoromethyl)phenyl]-4-(trifluoromethylsulfonyl)pyrazole-3-carbonitrile; |
Fipronil Sulfide | 120067-83-6 | C12H4Cl2F6N4S | 421.15 | 1-(2,6-Dichloro-4-trifluoromethylphenyl)-3-cyano-5-amino-4-(trifluoromethylthio)pyrazole; 5-Amino-1-(2,6-dichloro-4-trifluoromethylphenyl)-4-trifluoromethylthio-1H-pyrazole- 3-carbonitrile; |
Fipronil Impurity 2 | 120068-81-7 | C11H6ClF3N4 | 286.65 | 5-Amino-1-[2-chloro-4-(trifluoromethyl)phenyl]-1H-pyrazole-3-carbonitrile; |
Fipronil Impurity 1 | 270564-31-3 | C11H7Cl2F3N4O | 339.11 | 1-(2,6-Dichloro-4-trifluoromethylphenyl)-3-carboxamido-5-aminopyrazole; 5-Amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-1H-Pyrazole-3-carboxamide |
Fipronil Desulfinyl | 205650-65-3 | C12H4Cl2F6N4 | 389.09 | 5-Amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-(trifluoromethyl)-1H-pyrazole-3-carbonitrile; Desulfinylfipronil; |
Fipronil carboxamide | 205650-69-7 | C12H6Cl2F6N4O2S | 455.156 | 5-Amino-1-(2,6-dichloro-4-trifluoromethyl phenyl)-4-trifluoromethane-sulfinyl-1H-pyrazole-3-carboxylic acid amide |
Fipronil | 120068-37-3 | C12H4Cl2F6N4OS | 437.15 | Fluocyanobenpyrazole; (RS)-5-Amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-(trifluoromethylsulfinyl)pyrazole-3-carbonitrile; |
FIPI hydrochloride | 1781834-93-2 | C23H24FN5O2.HCl | 457.93 | AOB33782; AKOS024457709; N-[2-[4-(2,3-Dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]ethy]-5-fluoro-1H-indole-2-carboxamide hydrochloride; 5-fluoro-N-[2-[4-(2-oxo-3H-benzimidazol-1-yl)piperidin-1-yl]ethyl]-1H-indole-2-carboxamide hydrochloride |
FIPI | 939055-18-2 | C23H24FN5O2 | 421.47 | 5-Fluoro-2-Indolyl des-Chlorohalopemide;N-[2-[4-(2,3-Dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]ethyl]-5-fluoro-1H-indole-2-carboxamide;5-Fluoro-N-(2-(4-(2-Oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)ethyl)-1H-indole-2-carboxamide |
Fipexide | 34161-24-5 | C20H21ClN2O4 | 388.85 | 1-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-2-(4-chlorophenoxy)ethanone; |
Fingolimod-D4 Hydrochloride | 1346604-90-7 | C19H30D4ClNO2 | 347.96 | 2-Amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol-d4 Hydrochloride; FTY720-d4 Hydrochloride |
Fingolimod-D4 | 1346747-38-3 | C19H29D4NO2 | 311.50 | 2-Amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol-d4; FTY720-d4 |
Fingolimod Stearate Amide | 1242271-27-7 | C37H67NO3 | 573.95 | N-(1-Hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)stearamide |
Fingolimod Palmitate Amide | 1242271-26-6 | C35H63NO3 | 545.90 | N-(1-Hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)palmitamide |
Fingolimod Phosphate HCl | 1348803-59-7 | C19H34NO5P. HCl | 387.46 36.46 | |
Fingolimod Methyl Impurity | 162361-47-9 | C20H35NO2 | 321.51 | |
Fingolimod impurity C | 296282-46-7 | C19H31NO3 | 321.46 | |
Fingolimod Impurity A | 1343408-33-2 | C19H33NO3 | 323.48 36.46 | |
Fingolimod Impurity 9 | 767262-51-1 | C19H33NO2 | 307.48 | ortho-Fingolimod; 2-Amino-2-(2-octylphenethyl)propane-1,3-diol |
Fingolimod Impurity 8 | 162358-96-5 | C16H25I | 344.28 | |
Fingolimod Impurity 7 | 374077-88-0 | C19H31NO4 | 337.46 | 2-Nitrodeamino Fingolimod; 2-Nitro-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol; |
Fingolimod Impurity 6 | 899822-99-2 | C19H31NO5 | 353.46 | 1-Hydroxy-3-nitrodeamino Fingolimod; 3-(Hydroxymethyl)-3-nitro-1-(4-octylphenyl)-1,4-butanediol |
Fingolimod Impurity 5 | 268557-49-9 | C25H37NO6 | 447.58 | |
Fingolimod Impurity 4 | 177259-52-8 | C20H33NO2 | 319.49 | N-Acetyl Deshydroxymethyl Fingolimod; Fingolimod Impurity; N-[1-(hydroxymethyl)-3-(4-octylphenyl)propyl]acetamide; |
Fingolimod Impurity 3 | 162358-08-9 | C25H39NO5 | 433.59 | Diethyl 2-Acetamido-2-[2-(4-octylphenylethyl)malonate; 2-(Acetylamino)-2-[2-(4-octylphenyl)ethyl]propanedioic Acid 1,3-Diethyl Ester; |
Fingolimod Impurity 2 | 249289-10-9 | C21H35NO3 | 349.52 | |
Fingolimod Impurity 14 | 162361-49-1 | C19H33NO3 | 323.48 | |
Fingolimod Impurity 13 | 882691-14-7 | C21H35NO3 | 349.51 | |
Fingolimod Impurity 12 | 177260-59-2 | C18H31NO . HCl | 277.45 36.46 | |
Fingolimod Heptyl Impurity | 745767-97-9 | C18H31NO2 | 293.45 | |
Fingolimod | 162359-55-9 | C19H33NO2 | 307.47 | FTY 720; FTY-720; FTY720; 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol |
Finerenone | 1050477-31-0 | C21H22N4O3 | 378.43 | (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide;BAY94-8862;BAY-94-8862;BAY948862;BAY-948862 |
Finasteride Impurity C | 1329611-51-9 | C23H34N2O2 | 370.54 | 5,6-Dehydro Finasteride; |
Finasteride acetate | 222989-99-3 | C25H40N2O4 | 432.60 | (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide;acetic acid Finasteride (acetate) |
Finafloxacin HCl | 209342-41-6 | C20H19FN4O4 . HCl | 434.85 | 8-Cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b]-1,4-oxazin-6(2H)-yl]-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid Hydrochloride; |
Finafloxacin | 209342-40-5 | C20H19FN4O4 | 398.39 | 7-[(4aS,7aS)-3,4,4a,5,7,7a-hexahydro-2H-pyrrolo[3,4-b][1,4]oxazin-6-yl]-8-cyano-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid Finafloxacin Xtoro 209342-40-5 UNII-D26OSN9Q4R CHEBI:85176 Finafloxacin (INN) Finafloxacin [INN] 8-cyano-1-cycl |
FIN56 | 1083162-61-1 | C25H31N3O5S2 | 517.66 | 2-N,7-N-dicyclohexyl-9-hydroxyiminofluorene-2,7-disulfonamide; s8254 |
Fimasartan Impurity 2 | 1361024-52-3 | C46H45N7OS | 743.98 | |
Fimasartan | 247257-48-3 | C27H31N7OS | 501.6 | Kanarb; 2-[2-butyl-4-methyl-6-oxo-1-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]pyrimidin-5-yl]-N,N-dimethylethanethioamide |
Fimaporfin | 1443547-43-0 | C44H32N4O6S2 | 776.88 | Fimaporfin; TPCS2a; Disulfonated tetraphenyl chlorin. |
Filorexant | 1088991-73-4 | C24H25FN4O2 | 420.48 | FILOREXANT; MK-6096; UNII-E6BTT8VA5Z; MK6096; MK 6096 |
Filociclovir | 632325-71-4 | C11H13N5O3 | 263.26 | Cyclopropavir;2-Amino-9-[(Z)-[2,2-bis(hydroxymethyl)cyclopropylidene]methyl]-3H-purin-6-one;MBX-400;MBX400;ZSM-162;ZSM162;(Z)-2-amino-9-((2,2-bis(hydroxymethyl)cyclopropylidene)methyl)-1,9-dihydro-6H-purin-6-one |
Filixic acid ABA | 38226-84-5 | C32H36O12 | 612.63 | 2,4-Bis[(5-acetyl-2,4-dihydroxy-3,3-dimethyl-6-oxo-1,4-cyclohexadienyl)methyl]-6-butyrylbenzene-1,3,5-triol; Trisalbaspidin ABA |
Filipin III | 480-49-9 | C35H58O11 | 654.8 | 14-Deoxylagosin |
Filipin II | 38620-77-8 | C35H58O10 | 638.8 | |
Filipin complex | 11078-21-0 | C35H58O11 (for Flipin III) | 654.8 | |
Filicenol B | 145103-37-3 | C30H50O | 426.729 | |
Filic-3-en-25-al | 147850-78-0 | C30H48O | 424.713 | |
Filgrastim | 143011-72-7 | C845H1343N223O243S9 | 18802.8 | Granulocyte Colon; rhG-CSF; |
Filgotinib | 1206161-97-8 | C21H23N5O3S | 425.507 | GLPG0634; GLPG-0634; N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide |
Filanesib | 885060-09-3 | C20H22F2N4O2S | 420.479 | ARRY-520; ARRY 520; ARRY520. |
Filaminast | 141184-34-1 | C15H20N2O4 | 292.33 | UNII-CDD69JC61J; Way-pda-641; WAY-PDA 641; WAY-PDA-641; CDD69JC61J; SCHEMBL73843; 1-(3-(Cyclopentyloxy)-4-methoxyphenyl)ethanone-(E)-O-(aminocarbonyl)oxime |
FILAMID RED GR | 172306-87-5 | 0 | C.I. Solvent Red 225(9CI); FILAMID RED GR | |
FIIN-3 | 1637735-84-2 | C34H36Cl2N8O4 | 691.61 | FIIN3; FIIN 3; FIIN-3. |
FIIN-2 | 1633044-56-0 | C35H38N8O4 | 634.73 | FIIN2; FIIN 2; FIIN-2. |
FIIN-1 | 1256152-35-8 | C32H39Cl2N7O4 | 656.609 | FIIN-1; FIIN-1; FIIN 1 |
Fiduxosin hydrochloride | 208992-74-9 | C30H29N5O4S.HCl | 592.11 | 3-[4-[(3aR,9bR)-9-methoxy-3,3a,4,9b-tetrahydro-1H-chromeno[3,4-c]pyrrol-2-yl]butyl]-8-phenyl-1H-pyrazino[1,2]thieno[3,4-b]pyrimidine-2,4-dione;hydrochloride; Fiduxosin hydrochloride; Fiduxosin HCl; 208993-54-8 (Fiduxosin) ; 208992-74-9 ( Fiduxosin Hydroch |
Fiduxosin | 208993-54-8 | C30H29N5O4S | 555.65 | 3-[4-[(3aR,9bR)-9-methoxy-3,3a,4,9b-tetrahydro-1H-chromeno[3,4-c]pyrrol-2-yl]butyl]-8-phenyl-1H-pyrazino[1,2]thieno[3,4-b]pyrimidine-2,4-dione; 3-(4-(9-methoxy-1,2,3,3a,4,9b-hexahydro(1)benzopyran(3,4-c)pyrrol-2-yl)butyl)-8-phenylpyrazino(2',3'-4,5)thieno |
Fidaxomicin | 873857-62-6 | C52H74CL2O18 | 1058.06 | OPT80; OPT-80; OPT 80; PAR101; PAR 101; PAR-101; FidaxoMicin; 3-(((6-Deoxy-4-O-(3,5-dichloro-2-ethyl-4,6-dihydroxybenzoyl)-2-O-methyl-b-D-mannopyranosyl)oxy)-methyl)-12(R)-[(6-deoxy-5-C-methyl-4-O-(2-methyl-1-oxopropyl)-b-D-lyxo-hexopyranosyl)oxy]-11(S)-e |
Fidarestat | 136087-85-9 | C12H10FN3O4 | 279.23 | SK 860;(2S,4S)-6-fluoro-2',5'-dioxospiro[chromane-4,4'-imidazolidine]-2-carboxamide; Aldos;SNK 860 |
FICZ | 172922-91-7 | C19H12N2O | 284.31 | 6-Formylindolo[3,2-b]carbazole |
Ficusin A | 173429-83-9 | C25H24O5 | 404.5 | 5,7-Dihydroxy-3-(4-hydroxyphenyl)-8-[(1R,6R)-6-isopropenyl-3-meth yl-2-cyclohexen-1-yl]-4H-chromen-4-one |
Ficaprenol 11 | 26296-50-4 | C55H90O | 767.3 | (2Z,6Z,10Z,14Z,18Z,22Z,26Z,30E,34E,38E)-3,7,11,15,19,23,27,31,35, 39,43-Undecamethyl-2,6,10,14,18,22,26,30,34,38,42-tetratetraconta undecaen-1-ol |
FG8119 | 106447-61-4 | C17H15N5O2 | 321.33 | 3-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)-5-methyl-4H-imidazo[1,5-a][1,4]benzodiazepin-6-one; 3-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)-5,6-dihydro-5-methyl-6-oxo-4H-imidazo(1,5a)(1,4)benzodiazepine; COMeIB; FG 8119; FG-8119 |
FH535 | 108409-83-2 | C13H10Cl2N2O4S | 361.20 | 2,5-dichloro-N-(2-methyl-4-nitrophenyl)benzenesulfonamide |
FH 1 | 2719-05-3 | C17H18N2O2 | 282.34 | N,N'-(Methylenedi-4,1-phenylene)bis-acetamide; 4,4'-Diacetamidodiphenylmethane; Bis(4-acetamidophenyl)methane; Methylenebis-4,4'-acetanilide; N,N'-Diacetyl-4,4'-diaminodiphenylmethane; BRD-K4477 |
FGIN-1-43 | 145040-29-5 | C28H36Cl2N2O | 487.51 | N,N-Dihexyl-2-(4-chlorophenyl)-5-chloroindole-3-acetamide; 2-[5-chloro-2-(4-chlorophenyl)-1H-indol-3-yl]-N,N-dihexylacetamide |
FGIN-1-27 | 142720-24-9 | C28H37FN2O | 436.61 | N,N-Dihexyl-2-(4-fluorophenyl)indole-3-acetamide; 2-[2-(4-fluorophenyl)-1H-indol-3-yl]-N,N-dihexylacetamide |
FGH10019 | 1046045-61-7 | C18H19N3O2S2 | 373.49 | |
FGFR4-IN-1 | 1708971-72-5 | C24H27N7O5 | 493.52 | N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((3-oxomorpholino)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide; FGFR4-IN-1; FGFR4-IN1; FGFR4-IN 1. |
FGF-401 | 1708971-55-4 | C25H30N8O4 | 506.56 | N-[5-cyano-4-(2-methoxyethylamino)pyridin-2-yl]-7-formyl-6-[(4-methyl-2-oxopiperazin-1-yl)methyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide |
FGF basic (119-126) (human, bovine, ovine, rabbit) | 152051-61-1 | C44H76N14O12 | 993.16 | LYS-ARG-THR-GLY-GLN-TYR-LYS-LEU; HBGF-2 (119-126) (HUMAN, BOVINE, OVINE, RABBIT); HEPARIN-BINDING GROWTH FACTOR 2 (119-126) (HUMAN, BOVINE, OVINE, RABBIT); FGF BASIC (118-125) (MOUSE, RAT); FGF BASIC (119-126) (HUMAN); FGF BASIC (119-126) (HUMAN, BOVINE, |
FG-2216 | 223387-75-5 | C12H9ClN2O4 | 280.66 | FG-2216; FG 2216; FG2216; YM311; YM-311; YM 311. |
Fezolamine | 80410-36-2 | C20H23N3 | 305.423 | |
FFN-102 trifluoroacetate salt | 1234064-11-9 | C11H10ClNO3·CF3COOH | 353.7 | 4-(2-aminoethyl)-6-chloro-7-hydroxy-2H-1-benzopyran-2-one 2,2,2-trifluoroacetate |
FFN 511 | 1004548-96-2 | C17H20N2O2 | 284.35 | 9-(2-Aminoethyl)-2,3,6,7-tetrahydro-1H,5H,11H-[1]-benzopyrano[6,7,8-ij]quinolizin-11-one |
FFN 206 dihydrochloride | 1883548-88-6 | C12H14N2O2.2HCl | 291.17 | 4-(2-Aminoethyl)-7-(methylamino)-2H-1-benzopyran-2-one dihydrochloride |
Fexofenadine HCl | 153439-40-8 | C32H39NO4.HCl | 538.12 | MDL 16455A; MDL16455A; MDL-16455A |
Fenretinide-d4 | 2118244-64-5 | C26H29D4NO2 | 395.58 | N-(4-Hydroxyphenyl-d4)retinamide |
Fenretinide Glucuronide | 79982-82-4 | C32H41NO8 | 567.69 | |
Fenretinide | 65646-68-6 | C26H33NO2 | 391.54572 | 4-HPR; McNR-1967; McNR1967; McNR 1967; HPR; Fenretinide. N-(4-Hydroxyphenyl)retinamide; 4-HPR; 4-hydroxyphenylretinamide; 4-Hydroxyphenyl retinamide |
Fenpiverinium Bromide | 125-60-0 | C22H29N2O Br | 417.38 | 1-(4-Amino-4-oxo-3,3-diphenylbutyl)-1-methylpiperidinium Bromide; 1-(3-Carbamoyl-3,3-diphenylpropyl)-1-methylpiperidinium Bromide; |
Fenpipalone | 21820-82-6 | C17H22N2O2 | 286.373 | Fenpipalone; 5-[2-[3,6-Dihydro-4-phenylpyridin-1(2H)-yl]ethyl]-3-methyl-2-oxazolidinone; 5-[2-[3,6-Dihydro-4-phenylpyridin-1(2H)-yl]ethyl]-3-methyloxazolidin-2-one; AHR-1680 |
Fenoxypropazine | 3818-37-9 | C9H14N2O | 166.223 | Phenoxypropazine; Fenoxypropazine; 3818-37-9; NCGC00183828-01; Fenoxipropazina; Fenoxipropazinum |
Fenoxycarb | 72490-01-8 | C17H19NO4 | 301.34 | Ethyl 2-[p-phenoxy] ethyl carbamate; Carbamic acid, 2-(4-phenoxyphenoxy)ethyl-, ethyl ester; fenoxycarb (ansi,bsi,iso); FENOXYXARB; Ethyl 2-(4-phenoxyphenoxy)ethylcarbamate; Fenoxycarb; ethyl [2-(4-phenoxyphenoxy)ethyl]carbamate fenoxycarb; 2-(4-Phenoxyph |
Fenoxazoline | 4846-91-7 | C13H18N2O | 218.30 | 2-[(2-propan-2-ylphenoxy)methyl]-4,5-dihydro-1H-imidazole |
Fenoxaprop-p-ethyl | 71283-80-2 | C18H16ClNO5 | 361.78 | Ethyl (2R)-(+)-2-[4-(6-chlorobenzoxazol-2-yloxy)phenoxy]propionate; Ethyl(r)-2-[4-(6-chlorobenzoxazol-2-yloxy)phenoxy]propionate; ethyl (2R)-2-[4-[(6-chloro-1,3-benzoxazol-2-yl)oxy]phenoxy]propanoate; |
Fenoterol-d6 | 1286129-04-1 | C17H15NO4D6 | 309.40 | 5-[1-Hydroxy-2-[[2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl-d6]-1,3-benzenediol Hydrobromide |
Fenoterol Impurity A | 391234-95-0 | C17H21NO4 | 303.36 | 5-[(1S)-1-hydroxy-2-[[(1R)-2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl]-1,3-Benzenediol |
Fenoterol hydrochloride | 1944-10-1 | C17H22ClNO4 | 339.81 | 5-[(1R)-1-hydroxy-2-[[(2R)-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]benzene-1,3-diol;hydrochloride; Fenoterol hydrochloride; Fenoterol HCl; TH-1179 hydrochloride; UNII-3DM11M5URG; Fenoterol hydrochloride [MI]; NSC-292265 |
Fenoterol HBr | 1944-12-3 | C17H21NO4. HBr | 384.26 | Fenoterol Hydrobromide; 5-[1-Hydroxy-2-[[2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl]-1,3-benzenediol Hydrobromide; |
Fenoterol Degradation Impurity A | 161040-25-1 | C18H21NO4 | 315.37 80.91 | |
Fenoprofen calcium;Phenyloxy brufen,calcium salt | 53746-45-5 | C30H30CaO8 | 558.63200 | |
Fenoprofen Calcium Salt | 34597-40-5 | C30H26CaO6 | 522.6 | 2-(3-phenoxyphenyl)propanoic acid Calcium; |
Fenoprofen calcium hydrate | 71720-56-4 | C15H14O3·1/2 Ca·H2O | 242.27 | NCI-C56086 |
Fenoprofen | 29679-58-1 | C15H14O3 | 242.28 | 2-(3-phenoxyphenyl)propanoic acid; |
Fenoldopam Mesylate | 67227-57-0 | C17H20ClNO6S | 401.86 | 6-Chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol; Methanesulfonate; Corlopam; Fenoldopam Methanesulfonate; Fenoldopam Monomethanesulfonate; SKF 82526J; |
Fenoldopam hydrochloride | 181217-39-0 | C16H16ClNO3.HCl | 342.22 | SR-01000075882; SKF 82526 Hydrochloride; 6-Chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol hydrochloride |
Fenoldopam | 67227-56-9 | C16H16ClNO3 | 305.76 | 9-chloro-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol; SKF 82526; |
Fenofibric Acyl Glucuronide | 60318-63-0 | C23H23ClO10 | 494.88 | Fenofibric acid acyl glucuronide |
Fenofibric acid-d6 | 1092484-69-9 | C17H9D6ClO4 | 324.80 | 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methyl-propanoic-d6 Acid; |
Fenofibric acid | 42017-89-0 | C17H15ClO4 | 318.75 | Trilipix; FNF acid |
Fenofibrate-d6 | 1092484-56-4 | C20H15D6ClO4 | 366.87 | 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methyl-propanoic Acid-d6 1-Methylethyl Ester; LF 178-d6; Lipanthyl-d6; Lipantil-d6; Lipidil Supra-d6; Lipirex-d6; Lipoclar-d6; Lipofene-d6; Liposit-d6; Lipsin-d6; MeltDose-d6; NSC 281319-d6; Nolipax-d6; |
Fenofibrate Related Compound A | 42019-78-3 | C13H9ClO2 | 232.67 | 4-Chloro-4'-Hydroxybenzophenone; (4-Chlorophenyl)(4-hydroxyphenyl)methanone; |
Fenofibrate Impurity G | 217636-48-1 | C24H27ClO6 | 446.93 | Fenofibric Acid 1,1-Dimethyl-2-(1-methylethoxy)-2-oxoethyl Ester; |
Fenofibrate Impurity F | 154356-96-4 | C16H15ClO2 | 274.75 | (4-Chlorophenyl)[4-(1-methylethoxy)phenyl]methanone |
Fenofibrate impurity E | 42019-08-9 | C19H19ClO4 | 346.81 | Fenofibric Acid Ethyl Ester; 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic Acid Ethyl Ester; |
Fenofibrate impurity D | 42019-07-8 | C18H17ClO4 | 332.79 | Fenofibric Acid Methyl Ester; |
Fenofibrate Impurity C | 217636-47-0 | C17H15ClO3 | 302.76 | 3-[4-(4-Chlorobenzoyl)phenoxy]-2-butanone; |
Fenofibrate Impurity A | 10547-60-1 | C14H11ClO2 | 246.70 | 4-Chloro-4'-methoxybenzophenone; 4-Chloro-4'-methoxybenzophenone; |
Fenofibrate Impurity 4 | 1797121-54-0 | C21H21ClO6 | 404.85 | Fenofibric Acid 1-Carboxyl-1-methylethyl Ester; 2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic Acid 1-Carboxyl-1-methylethyl Ester; |
Fenofibrate Impurity 1 | 2985-79-7 | C13H9ClO2 | 232.67 | (4-chlorophenyl)(2-hydroxyphenyl)methanone; |
Fenofibrate | 49562-28-9 | C20H21ClO4 | 360.83 | |
Evocalcet | 870964-67-3 | C24H26N2O2 | 374.48 | MT4580; KHK-7580;2-(4-((S)-3-(((R)-1-(naphthalen-1-yl)ethyl)amino)pyrrolidin-1-yl)phenyl)acetic acid |
Evobrutinib | 1415823-73-2 | C25H27N5O2 | 429.51 | 1-[4-[[[6-amino-5-(4-phenoxyphenyl)pyrimidin-4-yl]amino]methyl]piperidin-1-yl]prop-2-en-1-one; M-2951; M 2951; M2951; MSC-2364447C; MSC 2364447C; MSC2364447C |
Everolimus-d4 | 1338452-54-2 | C53H79NO14D4 | 962.27 | 40-O-(2-Hydroxyethyl-d4)rapamycin; 42-O-(2-Hydroxy)ethyl-d4 Rapamycin |
Everolimus Ring-Opening Impurity | 1708118-13-1 | C53H83NO14 | 958.25 | Everolimus Retroaldol Degradation Product; |
Everolimus Related Compound 5 | 2607-52-5 | C15H22O | 218.34 | Di-tert-butyl-4-methylene-2,5-cyclohexadienone; 2,6-Di-t-butyl-4-methylene-2,5-cyclohexadienone; |
Everolimus Related Compound 3 | 147438-30-0 | C32H49NO9 | 591.75 | (2S)-1-[[(2R,3R,6S)-6-[(2S,3E,5E,7E,9S,11R)-2,13-Dimethoxy-3,9,11-trimethyl-12-oxo-3,5,7-tridecatrienyl]tetrahydro-2-hydroxy-3-methyl-2H-pyran-2-yl]oxoacetyl]-2-piperidinecarboxylic Acid; |
Everolimus Related Compound 1 | 745779-75-3 | C52H81NO14 | 944.22 | O-Desmethyl Everolimus; |
Ethyl linolenate | 1191-41-9 | C20H34O2 | 306.5 | (9Z,12Z,15Z)-Ethyl octadeca-9,12,15-trienoate; Linolenic acid ethyl ester |
Ethyl lignocerate | 24634-95-5 | C26H52O2 | 396.69 | Ethyl lignocerate; Lignoceric acid ethyl ester |
ETHYL 3-METHYL PENTANOATE | 5870-68-8 | C8H16O2 | 144.21 | ETHYL 3-METHYL PENTANOATE, Ethyl 3-methylpentanoate, Ethyl 3-methylvalerate, Pentanoic acid, 3-methyl-, ethyl ester |
DITHIOLAN-2-IMINE | 4472-81-5 | C3H5NS2 | 119.2085;g/mol | 1,3-dithiolan-2-imine;1,3-Dithiolan-2-imine;Dithiolan-2-imine;4472-81-5;NSC202537;1072-49-7 |
Dithio-Desmethyl Carbodenafil | 1333233-46-7 | C23H30N6OS2 | 470.65 | |
Dithio-Desethyl Carbodenafil | 1610830-81-3 | C22H28N6OS2 | 456.63 | |
Disialyllactose | 18409-15-9 | C34H54N2O27Na2 | 968.77 | GD3-Oligosaccharide |
ethyl 2-[(2,3-dichloro-6-nitrophenyl)methylamino]acetate hydrochloride | 70380-50-6 | C11H12Cl2N2O4 HCl | 307.14 36.46 | Ethyl 2-(6-Nitro-2,3-dichlorobenzyl)glycine |
ETHYL 2,7-DIMETHYLIMIDAZO[1,2-A]PYRIDINE-3-CARBOXYLATE | 81448-48-8 | C12H14N2O2 | 218.25 | ETHYL 2,7-DIMETHYLIMIDAZO[1,2-A]PYRIDINE-3-CARBOXYLATE; BUTTPARK 13\05-85; Imidazo[1,2-a]pyridine-3-carboxylic acid, 2,7-dimethyl-, ethyl ester |
Ethyl 2,5-diiodobenzoate | 28769-00-8 | C9H8I2O2 | 0 | Ethyl 2,5-diiodobenzoate |
Ethonafide | 175293-23-9 | C22H22N2O3 | 362.429 | AMP-53 |
Ethofumesate-2-keto | 26244-33-7 | Methansulfonic acid-3,3- dimethyl-2-oxo-2,3-dihy- dro-benzofuran-5-yl ester | ||
Ethisterone | 434-03-7 | C21H28O2 | 312.45 | |
Ethionamide Sulfoxide | 536-28-7 | C8H10N2OS | 182.25 | 2-Ethyl-4-pyridinecarbothioamide S-Oxide; 2-Ethylthioisonicotinamide S-Oxide; Ethionamide-S-oxide; |
Ethionamide | 536-33-4 | C8H10N2S | 166.24 | Bayer 5312; Bayer5312; Bayer-5312 |
Fenobam | 57653-26-6 | C11H11ClN4O2 | 266.68 | 1-(3-Chlorophenyl)-3-(4,5-dihydro-1-methyl-4-oxo-1H-imidazol-2-yl)urea;NPL-2009;NPL2009 |
Fennel, Foeniculumvulgare dulce, ext. | 84455-29-8 | |||
Fenimide | 60-45-7 | C13H15NO2 | 217.26 | 4-Ethyl-3-methyl-3-phenylpyrrolidine-2,5-dione;CI419;CI-419;Fenimidum;NSC172121;NSC248080;NSC-17212;NSC-248080;2,5-Pyrrolidinedione, 4-ethyl-3-methyl-3-phenyl- |
Fenharmane | 15301-68-5 | C18H18N2 | 262.354 | Fenharmane |
Fenfluthrin | 75867-00-4 | C15H11Cl2F5O2 | 389.15 | (pentafluorophenyl)methyl (1R,3S)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate. 2,3,4,5,6-pentafluorobenzyl (1R,3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate |
fenfluraminehydrochloride | 404-82-0 | C12H16F3N | 231.25700 | |
Fendiline hydrochloride | 13636-18-5 | C23H25N.HCl | 351.91 | FENDILINE HYDROCHLORIDE;N-[3,3-DIPHENYLPROPYL]-ALPHA-METHYLBENZYLAMINE HYDROCHLORIDE;difmecor;gamma-phenyl-n-(1-phenylethyl)benzenepropanaminehydrochloride;gamma-phenyl-n-(1-phenylethyl)-benzenepropanaminhydrochloride;hk137;n-(1-phenylethyl)-3,3-diphenyl |
FD-838 | 110341-78-1 | C22H21NO7 | 411.41 | (5R,8S,9R)-2-(5-Ethyl-2-furyl)-3-methyl-8-benzoyl-8-methoxy-9-hydroxy-1-oxa-7-azaspiro[4.4]nona-2-ene-4,6-dione |
Felodipine Metabolite Lactone | 85825-42-9 | C17H13Cl2NO4 | 366.20 | |
Felodipine Impurity B (Clevidipine Impurity 3) | 91189-59-2 | C17H17Cl2NO4 | 370.24 | |
Felodipine | 72509-76-3 | C18H19Cl2NO4 | 384.25 | Plendil; Flodil; Munobal; Renedil |
FELDSPAR | 68476-25-5 | AlO8Si3.Na | 263.23100 | |
Felbamate-d5 | 1191888-51-3 | C11H9N2O4D5 | 243.28 | 2-Phenyl-1,3-propanedioldicarbamate-d5 |
Felbamate-d4 | 106817-52-1 | C11H10N2O4D4 | 242.27 | 2-Phenyl-1,3-propanedioldicarbamate-d4; Carbamic Acid 2-Phenyltrimethylene-d4 Ester |
Felbamate Methyl Impurity | 22131-25-5 | C12H16N2O4 | 252.27 | Methylfelbamate; 2-Methyl-2-phenyl-1,3-propanediol Dicarbamate; 2-methyl-2-phenyltrimethylene Ester Carbamic Acid; |
Felbamate hydrate | 1177501-39-1 | C11H16N2O5 | 256.26 | MLS000758238; SMR000449307; MLS001401392; CHEMBL2130858; HY-B0184A |
Felbamate Ethyl Impurity | 53054-24-3 | C13H18N2O4 | 266.30 | Ethylfelbamate; 2-Ethyl-2-phenyl-1,3-propanediol Dicarbamate; |
Felbamate Dimer Impurity | 1796927-91-7 | C21H24N2O7 | 416.43 | 3,3'-Carbonylbis(oxy)bis(2-phenylpropane-3,1-diyl) Dicarbamate |
Felbamate | 7239-48-7 | C52H98N16O13.xH2SO4 (lot specific) | 1155.43 (Free base) | |
Felbamate | 25451-15-4 | C11H14N2O4 | 238.24 | W-554; W 554; W554; ADD-03055; ADD03055; ADD 03055; Felbamate; brand name: Felbatol; Felbamyl; Taloxa. |
Feglymycin | 209335-49-9 | C95H97N13O30 | 1900.9 | |
Fedovapagon | 347887-36-9 | C27H34N4O3 | 462.59 | VA-106483; (2S)-N2,N2-Dimethyl-N1-[[2-methyl-4-[(2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl]phenyl]methyl]-1,2-pyrrolidinedicarboxamide; (S)-N2,N2-Dimethyl-N1-(2-methyl-4-(2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)benzyl)pyrrolidine-1,2-dica |
Fedotozine tartrate | 133267-27-3 | C22H31NO4.C4H6O6 | 523.57 | (2S,3S)-2,3-dihydroxybutanedioic acid;(2R)-N,N-dimethyl-2-phenyl-1-[(3,4,5-trimethoxyphenyl)methoxy]butan-2-amine |
Febuxostat-D9 | 1246819-50-0 | C16H7D9N2O3S | 325.43 | 2-[3-Cyano-4-(2-methylpropoxy-d9)phenyl]-4-methyl-5-thiazolecarboxylic Acid; 2-(3-Cyano-4-isobutyloxyphenyl-d9)-4-methyl-5-thiazolecarboxylic Acid; TEI 6720-d9; TMX 67-d9; |
FCE 26644 | 154788-16-6 | C45H36N10Na4O17S4 | 1209.04 | Fce 26644; Fce-26644; PNU 145156E; 7,7'-(Carbonyl-bis(imino-N-methyl-4,2-pyrrolcarbonylimino(N-methyl-4,2-pyrrol)carbonylimino))-bis(1,3-naphthalenedisulfonic acid); 1,3-Naphthalenedisulfonic acid, 7,7'-(carbonylbis(imino(1-methyl-1H-pyrrole-4,2-diyl)carb |
FCCP | 370-86-5 | C10H5F3N4O | 254.17 | 2-[[4-(trifluoromethoxy)phenyl]hydrazinylidene]propanedinitrile; |
Famotidine Sulfoxide | 90237-03-9 | C8H15N7O3S3 | 353.45 | 3-[2-(Diaminomethyleneamino)-1,3-thiazol-4-ylmethylsulphinyl]-N-sulphamoylpropanamidine Famotidine Sulfoxide |
Fazarabine | 65886-71-7 | C8H12N4O5 | 244.2 | Fazarabine. Ara-AC; Kymarabine |
Fayalite, naturally occuring mineral, grains, approximately 0.06-0.19in | 13918-37-1 | Fe2SiO4 | 203.78 | |
Faxeladol | 433265-65-7 | C15H23NO | 233.36 | GCR 9905; EM-906; 3-((1R,2R)-2-((dimethylamino)methyl)cyclohexyl)phenol |
FAUC73 | 23255-54-1 | C14H23N | 205.34 | |
FAUC-365 | 474432-66-1 | C23H25Cl2N3OS | 462.4 | N-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyl]-benzo[b]thiophene-2-carboxamide |
Fattyacids,lanolin | 68424-43-1 | |||
Fattyacids, tall-oil, reaction products with diethylenetriamine | 61790-69-0 | |||
Fattyacids, tall-oil, ethoxylated | 61791-00-2 | 0 | ethoxylatedtalloilfatty; Ethoxylatedtalloilfattyacid; Ethoxylatedtalloilfattyacids; Fattyacids,tall-oil,ethoxylated; Fattyacids,talloil,monoesterswithpolyethyleneglycol; Polyethyleneglycol,monoesterwithtalloilacids; Polyethyleneglycol,monotallate; Polyeth | |
Fattyacids, soya, epoxidized, Me esters | 68082-35-9 | |||
Fattyacids, soya | 68308-53-2 | 0 | Fatty acids, soya; SOY ACID; Soya oil acid; Fettsuren, Soja; Sojalfettsure; Soya bean oil fatty acid; SOYAFATTYACIDS | |
Fattyacids, C6-12 | 67762-36-1 | |||
Fattyacids, C16-18 and C18-unsatd., Me esters | 67762-38-3 | |||
Fatty acids, tallow | 61790-37-2 | 0 | Fatty acids, tallow; TALLOW ACID; TALGFETTSAEURE; tallow acids | |
Famotidine Impurity G | 76823-97-7 | C9H13N7S2 | 283.38 | N-Desaminosulfonyl-N-cyano Famotidine; 3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]-N-cyanopropanimidamide; |
Famotidine Impurity F | 107880-74-0 | C8H12N4O2S2 | 260.34 | Famotidine Acid Impurity; 3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]propanoic Acid; 3-[[[2-[(Diaminomethylene)amino]thiazol-4-yl]methyl]thio]propanoic Acid; USP Famotidine Related Compound F; |
Famotidine Impurity E | 129083-44-9 | C10H14N8S4 | 374.53 | Bis[(2-guanidino-4-thiazolyl)methyl]disulfide; |
Famotidine Impurity D | 76824-16-3 | C8H13N5OS2 | 259.35 | 3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]propanamide; USP Famotidine Related Compound C; |
Famotidine Impurity C HCl | 76824-17-4 | C8H14N6O3S3 HCl | 338.43 36.46 | [3-[[[2-(Diaminomethyleneamino)-4-thiazolyl]methyl]thio]propionyl]sulfamide Hydrochloride |
Famotidine Impurity B | 89268-62-2 | C16H23N11O2S5 | 561.75 | 3,5-Bis[2-[[[2-[(Diaminomethylene)amino]thiazol-4-yl]methyl]thio]-ethyl]-4H-1,2,4,6-thiatriazine-1,1-dioxide; |
Famotidine Impurity A | 88061-72-7 | C8H14N6S2 | 258.37 | 3-[[[2-[(Diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]propanimidamide dihydrochloride |
Famotidine Impurity 1 HCl | 100599-91-5 | C5H8N4S. HCl | 192.7 | N-(4-Methyl-1,3-thiazol-2-yl)-guanidine hydrochloride |
F-5 | 73898-42-7 | 0 | ||
Famotidine | 76824-35-6 | C8H15N7O2S3 | 337.45 | |
Famitinib | 945380-27-8 | C23H27FN4O2 | 410.493 | Famitinib; SHR1020; |
Faldaprevir | 801283-95-4 | C40H49BrN6O9S | 869.84 | (1S,2R)-1-[[(2S,4R)-4-[8-bromo-7-methoxy-2-[2-(2-methylpropanoylamino)-1,3-thiazol-4-yl]quinolin-4-yl]oxy-1-[(2S)-2-(cyclopentyloxycarbonylamino)-3,3-dimethylbutanoyl]pyrrolidine-2-carbonyl]amino]-2-ethenylcyclopropane-1-carboxylic acid; BI 201335; BI-201 |
Falcarinol | 21852-80-2 | C17H24O | 244.4 | 1,9-Heptadecadiene-4,6-diyn-3-ol;(3R,9Z)-heptadeca-1,9-dien-4,6-diyn-3-ol; (S)-Falcarino |
Falcarindiol | 225110-25-8 | C17H24O2 | 260.4 | (3R,8S,9Z)-1,9-Heptadecadiene-4,6-diyne-3,8-diol; (+)-(3R,8S)-falcarindiol |
Falcarindiol | 55297-87-5 | C17H24O2 | ||
Fagomine | 53185-12-9 | C6H13NO3 | 147.17 | D-Fagomine; (2S,3R,4S)-2-(Hydroxymethyl)-3,4-piperidinediol |
Facinicline | 677306-35-3 | C15H18N4O | 270.34 | RG-3487;MEM-3454;RO-5313534;RG3487;MEM3454;RO5313534;(S)-N-(quinuclidin-3-yl)-1H-indazole-3-carboxamide;N-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-1H-indazole-3-carboxamide |
Fabiatrin | 18309-73-4 | C21H26O13 | 486.426 | 6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-2-one |
FAAH inhibitor 1 | 326866-17-5 | C24H23N3O3S3 | 497.65 | FAAH inhibitor 1 |
FA2G1 N-Glycan | 721918-59-8 | C62H104N4O45 | 1625.49 | Asialo, core fucosylated, bi-antennary N-linked glycan; NA2G1F N-Glycan |
F1839-I | 159096-49-8 | C23H32O4 | 372.505 | (2R,2'R,4'aS,6'R,8'aS)-2',4-dihydroxy-1',1',4'a,6,6'-pentamethyl-spiro[3H-benzofuran-2,5'-decalin]-7-carbaldehyde |
Ezutromid | 945531-77-1 | C19H15NO3S | 337.39 | 5-(ethylsulfonyl)-2-(naphthalen-2-yl)benzo[d]oxazole; BMN-195; BMN 195; BMN195; SMTC-1100; SMTC1100; SMTC 1100; VOX-C1100; Ezutromid |
Ezlopitant | 147116-64-1 | C31H38N2O | 454.658 | Ezlopitant; CJ-11,974; CJ-11974; CJ11974; CJ 11974. |
Ezetimibe-d4 | 1093659-89-2 | C24H17D4F2NO3 | 413.5 | Ezetrol-d4; (3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl-d4)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone; Sch-58235-d4 |
Ezetimibe Tetrahydropyran Impurity | 1296129-15-1 | C24H21F2NO3 | 409.44 | (2R,3R,6S)-N,6-Bis(4-fluorophenyl)tetrahydro-2-(4-hydroxyphenyl)-2H-pyran-3-carboxamide; SCH59566 |
Ezetimibe Ring-Open Impurity | 1197811-72-5 | C24H23FNO3 | 411.45 | 2-(4-Hydroxybenzyl)-N,5-bis-(4-fluorophenyl)-5-hydroxypentanamide |
Ezetimibe Related Impurity 7 | 204589-68-4 | C24H19F2NO2 | 391.42 | (3R,4R)-1-(3-fluorophenyl)-3-((E)-3-(3-fluorophenyl)allyl)-4-(4-hydroxyphenyl)azetidin-2-one |
Ezetimibe Phenexy Glucuronide | 190448-57-8 | C30H29F2NO9 | 585.55 | Ezetimibe phenoxy Glucuronide |
Ezetimibe Ketone | 191330-56-0 | C24H19F2NO3 | 407.42 | (3R,4S)-1-(4-Fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]-4-(4-hydroxyphenyl)-2-azetidinone; |
Ezetimibe Impurity B | 870634-36-9 | C12H15FO3 | 226.25 | methyl 5-(4-fluorophenyl)-5-hydroxypentanoate |
Ezetimibe Impurity 9 | 272778-12-8 | C39H46F2N2O5Si2 | 716.98 | (S)-3-((2R,5S)-5-(4-Fluorophenyl)-2-((S)-((4-fluorophenyl)amino)(4-((trimethylsilyl)oxy)phenyl)methyl)-5-((trimethylsilyl)oxy)pentanoyl)-4-phenyloxazolidin-2-one; 3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl(amino)]][4-[trimethylsilyl]-oxy]phenyl |
Ezetimibe Impurity 8 Enantiomer | 404874-93-7 | C20H18FNO4 | 355.37 | 3-[5-(1,5-Dioxo-5-(p-fluophenylpentyl]-4R-phenyl-2-oxazolidinone |
Ezetimibe Impurity 8 | 189028-93-1 | C20H18FNO4 | 355.37 | (S)-1-(4-fluorophenyl)-5-(2-oxo-4-phenyloxazolidin-3-yl)pentane-1,5-dione |
Ezetimibe impurity (3-[5-(4-Fluoro-phenyl)-5-(S)-hydroxy-pentanoyl]-4-(R)-phenyl-oxazolidin-2-one) | 189028-95-3 | C20H20FNO4 | 357.39 | (4R)-4-Phenyl-3-[(5S)-5-(4-fluorophenyl)-5-hydroxypentanoyl]-1,3-oxazolidin-2-one |
Ezetimibe impurity (3-[5-(4-Fluoro-phenyl)-5-(R)-hydroxy-pentanoyl]-4-(S)-phenyl-oxazolidin-2-one) | 528565-93-7 | C20H20FNO4 | 357.39 | (S)-3-((R)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one |
Ezetimibe Fluoro Isomer | 1798008-25-9 | C24H21F2NO3 | 409.44 | 3'-(2-Fluorophenyl) Ezetimibe; (3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(2-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone; |
Ezetimibe Diol | 1374250-08-4 | C24H25F2NO3 | 413.47 | (1S,4R)-1-(4-Fluorophenyl)-4-[(S)-[(4-fluorophenyl)amino](4-hydroxyphenyl)methyl]-1,5-pentanediol |
Ezetimibe Diacid Impurity | 1013025-04-1 | C25H24FNO5 | 437.47 | ((2R,3S)-2-[(4-Benzyloxyphenyl)-4-(4-Fluorophenylamino)methyl]pentanedioic acid) |
Ezetimibe Diacetate | 163380-20-9 | C28H25F2NO5 | 493.51 | (3R,4S)-3-[(3S)-3-(Acetyloxy)-3-(4-fluorophenyl)propyl]-4-[4-(acetyloxy)phenyl]-1-(4-fluorophenyl)-2-azetidinone |
Ezetimibe Desfluoro Methyl Impurity | 1700622-07-6 | C25H24FNO3 | 405.47 | 4"DeFluoro-4""methyl-ezetimibe; (3R |
Ezetimibe Deprotected Impurity | 1185883-40-2 | C33H30F2N2O5 | 572.61 | ((S)-3-{(2R, 5S)-5-(4-Fluorophenyl)-2-[(S)-(4-Fluorophenylamino)-(4-OH-phenyl)methyl]-5-O |
Ezetimibe Dehydoxy Impurity | 204589-58-2 | C24H21F2NO2 | 393.44 | 3-Dehydroxy Ezetimibe; (3R,4S)-1-(4-Fluorophenyl)-3-[3-(4-fluorophenyl)propyl]-4-(4-hydroxyphenyl)-2-azetidinone; |
Ezetimibe d4 | 1093659-90-5 | C24H17D4F2NO3 | 413.45 | (3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone-d4 |
Ezetimibe Benzyl Impurity (MBZT-2) | 851860-29-2 | C31H27F2NO3 | 499.56 | (3R,4R)-3-(3-(benzyloxy)-3-(4-fluorophenyl)propyl)-1-(3-fluorophenyl)-4-(4-hydroxyphenyl)azetidin-2-one |
Ezetimibe Azetidinone Ring-opened Impurity | 1391053-63-6 | C24H23F2NO4 | 427.45 | Ezetimibe Azetidinone Ring-opened Sodium Salt Impurity (Technical Grade, >75%) |
Ezetimibe Aniline Impurity | 1354716-98-5 | C24H22F2N2O2 | 408.45 | 4-Dehydroxy-4-amino Ezetimibe; (3R,4S)-4-(4-Aminophenyl)-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-2-azetidinone; |
Ezetimibe 3-Fluoro Impurity | 1700622-06-5 | C24H21F2NO3 | 409.44 | (3R,4R)-1-(3-fluorophenyl)-3-(3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one |
Ezetimibe | 163222-33-1 | C24H21F2NO3 | 409.4 | SCH 58235; SCH-58235; SCH58235; Ezetimibe, Zetia, Ezetrol, |
Ezatiostat hydroChloride | 286942-97-0 | C27H35N3O6S.HCl | 566.11 | ethyl (2S)-2-amino-5-[[(2R)-3-benzylsulfanyl-1-[[(1R)-2-ethoxy-2-oxo-1-phenylethyl]amino]-1-oxopropan-2-yl]amino]-5-oxopentanoate;hydrochloride ezatiotsat gamma-Glu-S-BzCys-PhGly diethyl ester gamma-glutamyl-S-(benzyl)cysteinyl-phenylglycine diethyl es |
Ezatiostat | 168682-53-9 | C27H35N3O6S | 529.652 | Telintra; Gamma-Glu-S-BzCys-PhGly diethyl ester; TLK-199; TLK 199 |
Extracellular Death Factor | 960129-66-2 | C27H36N10O10 | 660.6 | EDF |
Exoticin | 13364-94-8 | C23H26O10 | 462.5 | 3,3',4',5,5',6,7,8-octamethoxyflavone; 3,5,6,7,8-Pentamethoxy-2-(3,4,5-trimethoxyphenyl)-4H-chromen-4-on e |
Exo-Tetrahydrodicyclopentadiene | 2825-82-3 | |||
exo-IWR 1 | 1127442-87-8 | C25H19N3O3 | 409.44 | rel-4-[(3aR,4R,7S,7aS)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide; 4-[(3aR,4R,7S,7aS-rel)-1,3,3a,4,7,7a-Hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl]-N-8-quinolinylbenzamide |
Etravirine D4 | 1142095-93-9 | C20H15BrN6O | 439.30 | Etravirine D4; HY-90005S; CS-O-06604 |
Exemestane Related Compound B | 184972-09-6 | C20H26O3 | 314.43 | Androsta-1,4-diene-3,17-dione, 6-(hydroxymethyl) |
Exemestane Related Compound A | 19457-55-7 | C20H26O2 | 298.43 | 1,2-Dihydro Exemestane; 6-Methyleneandrost-4-ene-3,17-dione; 6-Methyleneandrost-4-en-3,17-dione; |
Excisanin B | 78536-36-4 | C22H32O6 | 392.49 | 1alpha,7alpha,14beta-Trihydroxy-12alpha-acetoxykaura-16-ene-15-one |
Excisanin A | 78536-37-5 | C20H30O5 | 350.45 | 1alpha,7alpha,12alpha,14beta-Tetrahydroxy-ent-kaur-16-en-15-one |
Excavatin M | 250293-31-3 | C19H20O7 | 360.4 | 7-({3-[(4-Hydroxy-4-methyl-5-oxotetrahydro-2-furanyl)methyl]-3-me thyl-2-oxiranyl}methoxy)-2H-chromen-2-one (non-preferred name) |
Exatecan Mesylate | 169869-90-3 | C25H26FN3O7S | 531.55 | DX8951f; DX 8951f; DX-8951f |
Exatecan | 171335-80-1 | DX 8951; Dx 8951 | ||
EX-527 R-enantiomer | 848193-69-1 | C13H13ClN2O | 248.71 | Selisistat R-enantiomer |
EX-527 | 49843-98-3 | C13H13ClN2O | 248.71 | SEN0014196 |
EX229 | 1219739-36-2 | C24H18ClN3O3 | 431.87 | Compound 991; AMPK Activator 991; 5-[[6-chloro-5-(1-methylindol-5-yl)-1H-benzimidazol-2-yl]oxy]-2-methylbenzoic acid |
EX1314 | 674343-47-6 | C24H32ClN7O5 | 534.01 | [3-[(1S)-1-[(2-amino-2-methylpropanoyl)amino]-2-phenylmethoxyethyl]-[1,2,4]triazolo[4,3-a]pyridin-5-yl]methyl N-(2-amino-2-oxoethyl)-N-methylcarbamate hydrochloride;BMS-604992;EX-1314;Carbamic acid, (2-amino-2-oxoethyl)methyl-, (3-((1S)-1-((2-amino-2-meth |
Ex 26 | 1233332-37-0 | C28H28ClFN2O3 | 494.98 | 1-[[[5'-[[1-(4-Chloro-3-methylphenyl)ethyl]amino]-2'-fluoro-3,5-dimethyl[1,1'-biphenyl]-4-yl]carbonyl]amino]-cyclopropanecarboxylic acid |
EW-7197 | 1352608-82-2 | C22H18FN7 | 399.433 | Vactosertib; N-(2-fluorophenyl)-5-(6-methyl-2-pyridinyl)-4-[1,2,4]triazolo[1,5-a]pyridin-6-yl-1H-imidazole-2-methanamine |
EVP-6124 | 550999-75-2 | C16H17ClN2OS | 320.84 | Encenicline |
EVP-0015962 | 1447811-26-8 | C22H19ClF6O3 | 480.83 | SCHEMBL3660255; ZSERTYLZGRJLOO-UHFFFAOYSA-N; 2-(5-chloro-6-(2,2,2-trifluoroethoxy)-4'-(trifluoromethyl)biphenyl-3-yl)-3-cyclobutylpropanoic acid |
Evomonoside | 508-93-0 | C29H44O8 | 520.65 | (3b,5b)-3-[(6-Deoxy-a-L-mannopyranosyl)oxy]-14-hydroxycard-20(22)-enolide; Digitoxigenin 3-rhamnoside; Digitoxigenin rhamnoside |
Evolocumab | 1256937-27-5 | C6242H9648N1668O1996S56 | 141800 | AMG 145 |
Evolitrine | 523-66-0 | C13H11NO3 | 229.23 | Evolitrin; 4,7-dimethoxyfuro[2,3-b]quinoline |
Evogliptin Tartrate | 1222102-51-3 | C19H26F3N3O3 . C4H6O6 | 401.43 150.09 | |
Evogliptin hydrochloride | 1246960-27-9 | C19H27ClF3N3O3 | 401.42 | |
Evogliptin | 1222102-29-5 | C19H26F3N3O3 | 401.43 | (3R)-4-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-[(2-methylpropan-2-yl)oxymethyl]piperazin-2-one;CHEMBL1779710; UNII-09118300L7; DA-1229; 1222102-29-5; Evogliptin [INN];1246960-27-9 (HCl) |
Evofosfamide | 918633-87-1 | C9H16Br2N5O4P | 449.04 | TH-302; TH 302; TH302; 2-bromo-N-[(2-bromoethylamino)-[(3-methyl-2-nitroimidazol-4-yl)methoxy]phosphoryl]ethanamine |
Evofolin C | 163634-05-7 | C14H18O2 | 218.29 | 3-[4-[(3-Methyl-2-butenyl)oxy]phenyl]-2-propen-1-ol |
Evofolin B | 168254-96-4 | C17H18O6 | 318.3 | |
Evodosin A | 1291053-38-7 | C14H16O6 | 280.3 | 7-hydroxy-3-((1R,2S)-1,2,3-trihydroxy-3-methylbutyl)-2H-chromen-2-one |
Evodiamine | 518-17-2 | C19H17N3O | 303.36 | Isoevodiamine; Evodiamine; Q-100579; Q100579; Q 100579; SC-16015; SC16015; SC 16015 |
Evodenoson | 844873-47-8 | C23H29N7O6 | 499.53 | ATL313; DE-112;methyl 4-[3-[6-amino-9-[(2R,3R,4S,5S)-5-(cyclopropylcarbamoyl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]prop-2-ynyl]piperidine-1-carboxylate |
Evocarpine | 15266-38-3 | C23H33NO | 339.51 | 1-Methyl-2-(8Z)-8-Tridecenyl-4(1H)-Quinolinone |
Everolimus O-Silyl Impurity | 159351-68-5 | C59H97NO14Si | 1072.52 | 42-O-tert-Butyldimethylsilyloxyethyl Rapamycin; 42-O-[2-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]ethyl]rapamycin; |
Everolimus O-Ethyl Impurity | 1704711-12-5 | C54H85NO14 | 972.28 | 7-O-Desmethyl-7-O-ethyl Everolimus |
Everolimus Isomer C | 908340-97-6 | C53H83NO14 | 958.25 | 9,14-Deepoxy-15-deoxo-14-deoxy-9,15-epoxy-15-hydroxy-42-O-(2-hydroxyethyl)-14-oxorapamycin |
Everolimus Hydrolized Impurity | 769905-89-7 | C53H85NO15 | 976.27 | seco Everolimus B; (2S)-1-[2-[(2R,3R,6S)-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,20S,21R)-14,20-Dihydroxy-22-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15-docosatetraen-1-yl]tetrahydro- |
Everolimus | 159351-69-6 | C53H83NO14 | 958.24 | RAD-001; RAD001; RAD 001; Afinitor; Certican; Zortress; RAD001; SDZ-RAD; 40-O-(2-Hydroxyethyl)rapamycin; 42-O-(2-Hydroxy)ethyl Rapamycin |
Evernic Acid | 537-09-7 | C17H16O7 | 332.3 | NSC 81164; 2-hydroxy-4-(2-hydroxy-4-methoxy-6-methylbenzoyl)oxy-6-methylbenzoic acid |
Evernia furfuracea, ext. | 90028-67-4 | 0 | Evernia furfuracea, ext.; EVERNIA FURFURACEA(TREEMOSS) EXTRACT; TREEMOSSEXTRACT; Evernia furfuracea, Extrakt; MOUSSE D'ARBRE; Extract from Pseudevernia furfuracea; Treemoss Extract solution | |
Evening primrose oil | 90028-66-3 | EVENING PRIMROSE OIL | ||
Evenamide | 1092977-61-1 | C16H26N2O2 | 278.40 | 2-[2-(3-Butoxyphenyl)ethylamino]-N,N-dimethylacetamide;NW-3509;NW3509 |
Evariquinone | 594860-23-8 | C16H12O6 | 300.26 | 1,2,3-trihydroxy-8-methoxy-6-methylanthracene-9,10-dione |
Etravirine | 269055-15-4 | C20H15BrN6O | 435.28 | R165335; R-165335; R 165335; TMC 125; TMC-125; TMC125; Etravirine. Intelence. |
ETP-46464 | 1345675-02-6 | C30H22N4O2 | 470.52 | N/A |
ETP-46321 | 1252594-99-2 | C20H27N9O3S | 473.556 | 5-[2-[(4-methylsulfonylpiperazin-1-yl)methyl]-8-morpholin-4-ylimidazo[1,2-a]pyrazin-6-yl]pyrimidin-2-amine |
Etoricoxib N-Oxide | 325855-74-1 | C18H15ClN2O3S | 374.85 | 5-Chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine 1'-Oxide; |
ETP 45658 | 1198357-79-7 | C16H17N5O2 | 311.34 | 3-[1-Methyl-4-(4-morpholinyl)-1H-pyrazolo[3,4-d]pyrimidin-6-ylphenol |
Etoxybamide | 66857-17-8 | C6H13NO3 | 147.17 | Butanamide, 4-hydroxy-N-(2-hydroxyethyl)-;N-(2-Hydroxyethyl)-4-hydroxybutyramide;N-(2-hydroxyethyl)-gamma-hydroxybutyramide;4-Hydroxy-N-(2-hydroxyethyl)butyramide |
Etosalamide | 15302-15-5 | C11H15NO3 | 209.24 | 2-(2-ethoxyethoxy)benzamideEtosalamide ethosalamide UNII-1PU994YJUH Etosalamide [INN] AC1L4LNV AC1Q5FQ9 1PU994YJUH 2-(2-ethoxyethoxy)benzamide SCHEMBL2109187 CHEMBL2104260 HY-B1015 ZINC3623372 AR-1I7815 CCG-213900 CS-4528 OR224796 AB015633 |
Etoricoxib Impurity D | 221615-75-4 | C15H15NO3S | 289.36 | 2-(4-Methanesulfonyl-phenyl)-1-(6-methyl-pyridin-3-yl)-ethanone |
Etoricoxib Impurity 8 | 1421227-97-5 | C22H20N2O4S | 408.48 | 1-(6-methylpyridin-3-yl)-2-({4-[2-(6-methylpyridin-3-yl)-2-oxoethyl]phenyl}sulfonyl)ethanone; |
Etoricoxib Impurity 7 | 646459-39-4 | C20H21N3O2S | 367.47 | N,N-dimethyl-6-(6-methylpyridin-3-yl)-5-(4-methylsulfonylphenyl)pyridin-3-amine; |
Etoricoxib Impurity 5 Lithium Salt | 1421227-96-4 | C9H9O4S Li | 220.17 | lithiuM 2-(4-(Methylsulfonyl)phenyl)acetate; |
Etoricoxib impurity 2 | 349536-41-0 | C18H15ClN2O3S | 374.85 | 6'-Desmethyl-6'-methylhydroxy Etoricoxib; 5-Chloro-3-[4-(methylsulfonyl)phenyl]-[2,3'-bipyridine]-6'-methanol |
Etoricoxib Impurity 15 | 73312-69-3 | C5H8ClNO | 133.58 | 2-Chlor-3-dimethylamino-propenal; 3-dimethylaminochloroacrolein |
Etoricoxib Impurity 12 | 646459-41-8 | C21H16ClN3O2S | 409.90 | 6-chloro-2-(6-methyl-3-pyridinyl)-3-[4-(methylsulfonyl)phenyl]-1,8-Naphthyridine |
Etoricoxib Impurity 11 | 202409-31-2 | C17H13ClN2O2S | 344.82 | Desmethyl Etoricoxib; 5-chloro-3-(4-methylsulfonylphenyl)-2-pyridin-3-ylpyridine |
Etoricoxib Impurity 10 | 316149-01-6 | C18H15ClN2OS | 342.85 | 5-chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfinylphenyl)pyridine |
Etoricoxib impurity 1 | 349536-39-6 | C18H13ClN2O4S | 388.83 | 6'-Desmethyl-6'-carboxy Etoricoxib; 5-Chloro-3-[4-(methylsulfonyl)phenyl]-[2,3'-bipyridine]-6'-carboxylic Acid |
Etoricoxib D4 | 1131345-14-6 | C18H11D4ClN2O2S | 362.87 | Arcoxia D4; MK-663 D4; MK-0663 D4 |
Etoricoxib | 202409-33-4 | C18H15ClN2O2S | 358.84 | 5-Chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine; Algix; Arcoxia; Etobrix; Etocox; Etoxib; Etropain; Kingcox; MK 0663; MK 663; Tauxib; Torcoxia; Etoricoxib crystal form V |
Etifoxine Hydrochloride | 56776-32-0 | C17H18Cl2N2O | 337.24 | 6-Chloro-N-ethyl-4-methyl-4-phenyl-4H-3,1-benzoxazin-2-amine Hydrochloride; 2-Ethylamino-6-chloro-4-methyl-4-phenyl-4H-3,1-benzoxazine Hydrochloride |
Etoposide D-glucuronide | 100007-55-4 | C36H42O18 | 762.73 | |
Etoposide Phosphate | 117091-64-2 | C29H33O16P | 668.541 | Eposin, Etopophos, Vepesid, VP-16, Etopophos. ETOP. |
Etoposide | 33419-42-0 | C29H32O13 | 588.55 | 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-b-D-glucopyranoside) |
Etomoxir | 124083-20-1 | C17H23ClO4 | 326.82 | Etomoxir |
Etomidate Impurity C HCl | 66512-39-8 | C15H18N2O2 HCl | 258.32 36.46 | (R)-isopropyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate HCl |
Etomidate Impurity 1 | 844658-92-0 | C11H12N2 | 172.23 | 1-[(1R)-1-phenylethyl]-1H-Imidazole; |
Etomidate Hydrochloride | 53188-20-8 | C14H17ClN2O2 | 280.75 | Amidate hydrochloride; (+)-Ethyl, 3-(alpha-methylbenzyl)-4-imidazolecarboxylate hydrochloride; ethyl 3-[(1R)-1-phenylethyl]imidazole-4-carboxylate;hydrochloride; |
Etomidate EP Impurity A | 3157-27-5 | C12H12N2O2 | 216.24 | 1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid |
Etomidate | 33125-97-2 | C14H16N2O2 | 244.29 | R16659 |
etoglucid | 1954-28-5 | C12H22O6 | 0 | etoglucid; Triethylene glycol diglycidyl ether.; Ethoglucid; 2,2'-(2,5,8,11-Tetraoxa-1,12-dodecanediyl)bisoxirane; Epodyl; Etoglucide |
Etofibrate | 31637-97-5 | C18H18ClNO5 | 363.79 | Etofibrate |
etofenprox-desethyl | 80854-21-3 | C23H24O3 | 348.44 | |
Etofenamate-d4 | 1329837-73-1 | C18H14F3NO4D4 | 373.37 | 2-[[3-(Trifluoromethyl)phenyl]amino]benzoic Acid-d4 2-(2-Hydroxyethoxy)ethyl Ester; 2-(2-Hydroxyethoxy)ethyl-d4 Fufenamate; Bayrogel-d4 |
Etofenamate | 30544-47-9 | C18H18F3NO4 | 369.34 | TVX485; TVX-485; TVX 485; WHR-5020; WHR 5020; WHR5020; Etofenamate; Bay d 1107; Bayrogel; Rheumon. 2-[[3-(Trifluoromethyl)phenyl]amino]benzoic Acid 2-(2-Hydroxyethoxy)ethyl Ester; 2-(2-Hydroxyethoxy)ethyl Fufenamate; Bayrogel; Reumon; Rheumon; Traumon Gel |
Etodolac methyl ester | 200880-31-5 | C18H23NO3 | 301.38 | 200880-31-5; (S)-Methyl2-(1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetate; AC1LT3WL; ZINC1420680; CE0098; ZINC01420680 |
Etodolac Impurity K | 122188-02-7 | C18H23NO3 | 301.39 | 1,8-Diethyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indole-1-acetic Acid Methyl Ester; |
Etodolac Impurity J | 115066-03-0 | C16H21NO | 243.35 | |
Etodolac Impurity B | 41340-19-6 | C16H19NO3 | 273.33 | 8-Methyl Etodolac; 1-Ethyl-1,3,4,9-tetrahydro-8-methylpyrano[3,4-b]indole-1-acetic Acid; |
Etodolac Impurity A | 41339-67-7 | C15H17NO3 | 259.31 | 8-Desethyl Etodolac |
Etodolac Acyl Glucuronide | 79541-43-8 | C23H29NO9 | 463.48 | 1-(1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetate) b-D-glucopyranuronic acid; Etodolac glucuronide |
Etisazole | 7716-60-1 | C9H10N2S | 178.25 | Etisazolum; Etisazolum [INN-Latin]; Netrosylla; Bay VA 9387; BAY-VA 9387; Ectimar; EINECS 231-739-9; N-ethyl-1,2-Benzisothiazol-3-amine |
Etirinotecan pegol | 1193151-09-5 | C161H196Cl4N20O40 | 3193.239 | NKTR102; NKTR 102; NKTR-102; pegylated irinotecan NKTR 102; Etirinotecan pegol |
Etiracetam | 33996-58-6 | C8H14N2O2 | 170.21 | UCB 6474; 2-(2-oxopyrrolidin-1-yl)butanamide |
Etimizol | 64-99-3 | C9H14N4O2 | 210.23 | Ethymisole; Antiffine; Ethylnorantiffeine |
Etilefrine Pivalate | 85750-39-6 | C15H23NO3 | 265.353 | [3-[2-(ethylamino)-1-hydroxyethyl]phenyl] 2,2-dimethylpropanoate |
Etilefrine Impurity D | 42146-10-1 | C17H19NO2 | 269.35 | 2-(benzyl(ethyl)amino)-1-(3-hydroxyphenyl)ethanone |
Etilefrine Hydrochloride | 943-17-9 | 217.69 | Etilefrine Hydrochloride | |
Etiguanfacine | 1346686-31-4 | C12H13Cl2N3O3 | 318.16 | SSP1871;ethyl N-{[2-(2,6-dichlorophenyl)acetyl]carbamimidoyl}carbamate |
Etifoxine-d5 | 1346598-10-4 | C17H12ClN2OD5 | 305.82 | 6-Chloro-N-ethyl-4-methyl-4-(phenyl-d4)-4H-3,1-benzoxazin-2-amine; 2-Ethylamino-6-chloro-4-methyl-4-(phenyl-d4)-4H-3,1-benzoxazine |
Etifoxine-d3 | 1246815-89-3 | C17H14ClN2OD3 | 303.81 | 6-Chloro-N-ethyl-4-(methyl-d3)-4-phenyl-4H-3,1-benzoxazin-2-amine; 2-Ethylamino-6-chloro-4-(methyl-d3)-4-phenyl-4H-3,1-benzoxazine; Etifoxin-d3 |
Etifoxine | 21715-46-8 | C17H17ClN2O | 300.78 | 6-chloro-N-ethyl-4-methyl-4-phenyl-3,1-benzoxazin-2-amine 2-ethylamino-6-chloro-4-methyl-4-phenyl-4H-3,1-benzoxazine etafenoxine etafenoxine hydrochloride etifoxin etifoxine etifoxine hydrochloride HOE 36801 Stresam |
Etifenin | 63245-28-3 | C16H22N2O5 | 322.36 | Etifenin |
Etidronate disodium | 7414-83-7 | C2H6Na2O7P2 | 249.99 | Didronel; Sodium etidronate; Disodium etidronate; Disodium hydroxy-[1-hydroxy-1-[hydroxy(oxido)phosphoryl]ethyl]phosphinate |
Eticlopride hydrochloride | 97612-24-3 | C17H25ClN2O3.HCl | 377.31 | FLB 131; 3-Chloro-5-ethyl-N-[[(2S)-1-ethyl-2-pyrrolidinyl)methyl]-6-hydroxy-2-methoxy-benzamide hydrochloride |
Eticlopride | 84226-12-0 | C17H25ClN2O3 | 340.85 | 5-chloro-3-ethyl-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-hydroxy-6-methoxybenzamide |
ETHYNYLSULFURPENTAFLUORIDE | 917-89-5 | C2HF5S | 152.09 | ETHYNYLSULFURPENTAFLUORIDE; ETHYNYLSULPHURPENTAFLUORIDE; (Pentafluorothio)acetylene |
Ethynylmagnesium bromide solution | 4301-14-8 | C2HBrMg | 129.24 | magnesium; ethyne; bromide; EthynylmagnesiumBromide; Ethynylmagnesiumbromidesolution; 4301-14-8 |
ETHYNYLFERROCENE | 1271-47-2 | C12H10Fe | 210.05 | ETHYNYLFERROCENE; Ethynylferrocene,97%; Ethylnylferrocene |
Ethynylestradiol Impurity M | 1818-11-7 | C21H24O2 | 308.42 | (8R,9S,13S,14S,17S)-3-cyanato-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-ol |
Ethynylestradiol Impurity F | 56324-28-8 | C20H24O3 | 312.41 | 6-beta-Hydroxy Ethynylestradiol; |
Ethynylestradiol Impurity E | 27521-34-2 | C20H24O3 | 312.41 | 6-alpha-Hydroxy Ethynylestradiol; |
Ethynylcytidine | 180300-43-0 | C11H13N3O5 | 267.241 | ECyd; TAS-106; TAS 106; TAS106; 3'-C-Ethynylcytidine; AIDS241582; AIDS 241582; AIDS-241582; SB-596168; SB596168; SB 596168; 3'-Ethynylcytidine. |
Ethynyl estradiol 17-b-D-glucuronide | 75803-39-3 | C26H32O8 | 472.53 | (17a)-3-Hydroxy-19-norpregna-1,3,5(10)-trien-20-yn-17-yl b-D-glucopyranosiduronic acid |
Ethynyl estradiol 17-acetate-3-(2,3,4-tri-O-acetyl-b-D-glucuronide) methyl ester | 242130-33-2 | C35H42O12 | 654.70 | |
Ethynyl 2-deoxy-5-O-DMT-ribosyl 3-CE phosphoramidite | 1173797-55-1 | C37H45N2O6P | 644.74 | |
Ethynodiol Impurity | 64850-62-0 | C22H28O2 | 324.47 | 17-alfa-Ethinyl-17-beta-Acettoxy-3,5-Estradien Impurity |
ethynodiol diacetate | 297-76-7 | C24H32O4 | 384.51 | 8080 CB |
Ethyltetrahydrofurfurylether | 62435-71-6 | C7H14O2 | 130.18 | ETE; ETHYLTETRAHYDROFURFURYL ETHER; 2-(Ethoxymethyl)-tetrahydrofuran; 2-(Ethoxymethyl)oxolane |
ETHYLSULFURIC ACID SODIUM SALT | 546-74-7 | C2H5NaO4S | 148.11 | sulfuricacid,monoethylester,sodiumsalt; SODIUM ETHYL SULFATE; ETHANESULFURIC ACID SODIUM SALT; ETHYLSULFURIC ACID SODIUM SALT; ETHYL SODIUM SULFATE; 2-ETHOXYL SULFONATE SODIUM; sodium ethyl sulphate; ETHYLSULFURIC ACID SODIUM SALT 98+% |
ETHYLSILANE | 2814-79-1 | C2H8Si | 60.17 | 1-Silapropane; C2H5SiH3; ETHYLSILANE; ETHYLSILANE 97% |
ethylp-methoxycinnamate | 24393-56-4 | C12H14O3 | 4-methoxycinnamic acid ethyl ester | |
Ethylphosphonous acid O,O-dimethyl ester | 15715-42-1 | C4H11O2P | 122.102702;g/mol | Dimethylethylphosphonite;15715-42-1;EthylphosphonousacidO,O-dimethylester;2511-19-5;PHOSPHINICACID,DIMETHYL-,ETHYLESTER(6CI,7CI,8CI,9CI);ethyl(dimethoxy)phosphane |
Ethyllucidone | 1195233-59-0 | C17H16O4 | 284.3 | (2Z)-2-[(2E)-1-Ethoxy-3-phenyl-2-propen-1-ylidene]-4-methoxy-4-cyclopentene-1,3-dione; 2-(1-Ethoxy-3-phenylallylidene)-4-Methoxycyclopent-4-ene-1,3-dione |
Ethyl-L-NIO hydrochloride | 150403-97-7 | C9H19N3O2·HCl | 237.7 | L-N5-(1-Iminobutyl)ornithine hydrochloride |
Ethyllithium, typ. 8 % solution in Dibutyl Ether (typ. 1.7 M) | 811-49-4 | 2H5Li | 36.00210 | |
ETHYLHYDROCUPREINE HYDROCHLORIDE | 3413-58-9 | C21H29ClN2O2 | 376.92 | OPTICHIN HYDROCHLORIDE; ETHYLHYDROCUPREINE HYDROCHLORIDE; hydrocupreine,ethylester,hydrochloride; neumolisina; numoquinhydrochloride; o-ethyl-hydrocupreinhydrochloride; optochinhydrochloride; optoquinhydrochloride |
ETHYLHYDROCUPREINE | 522-60-1 | C21H28N2O2 | 340.46 | ETHYLHYDROCUPREINE; 6'-ethoxy-10,11-dihydro-,(8-alpha,9r)-cinchonan-9-o; 6'-ethoxy-hydrocinchonidin; hydrocupreineethylether; numoquin; o(sup6')-ethyl-hydrocuprein; optochin; optoquine |
ETHYLHYDRAZINE | 624-80-6 | C2H8N2 | 60.1 | C2H5NHNH2; ethyl-hydrazin; Ethylhydrazine, monooxalate; Hydrazine, ethyl-, ethanedioate (1:1); Hydrazine, ethyl-, oxalate (1:1); 1-ETHYLHYDRAZINE; ETHYLHYDRAZINE; ETHYLHYDRAZINE 80-90% |
ethylg-fluoroacetoacetate | 372-37-2 | |||
Ethyl viologen diperchlorate | 36305-51-8 | C14H18Cl2N2O8 | 413.21 | ETHYL VIOLOGEN DIPERCHLORATE; 1,1'-DIETHYL-4,4'-BIPYRIDINIUM DIPERCHLORATE; ethylene viologen diperchlorate |
ETHYL VANILLIN PROPYLENE GLYCOL ACETAL | 68527-76-4 | C12H16O4 | 224.25 | Ethyl vanillin PGA, ETHYL VANILLIN PROPYLENE GLYCOL ACETAL, Phenol, 2-ethoxy-4-(4-methyl-1,3-dioxolan-2-yl)- |
ETHYL VANILLIN HEXYLENE GLYCOL ACETAL | 52514-67-7 | C15H22O4 | 266.11 | ETHYL VANILLIN HEXYLENE GLYCOL ACETAL, Ethyl vanillin HGA, Phenol, 2-ethoxy-4-(4,4,6-trimethyl-1,3-dioxan-2-yl)- 70-75% [52514-67-7]; 22-27% [107-41-5]; 2-5% [121-32-4], PRODUCT COMPOSITION: 70-75% Ethyl Vanillin Hexylene Glycol Acetal; 22-27% Hexylene Gl |
ethyl trisulfide | 3600-24-6 | C4H10S3 | 154.320 | Diethyl trisulfide; 3,4,5-Trithiaheptane |
Ethyl triphenyl phosphonium bromide | 1530-32-1 | C20H20BrP | 371.250562;g/mol | ethyl(triphenyl)phosphanium; bromide; Ethyltriphenylphosphoniumbromide; 1530-32-1; Ethyltriphenylphosphoniumbromide; Triphenylethylphosphoniumbromide |
ETHYL TRIFLUOROMETHYL ETHER | 690-22-2 | C3H5F3O | 114.07 | ETHYL TRIFLUOROMETHYL ETHER |
Ethyl triethoxyacetate | 57267-03-5 | C10H20O5 | 220.26 | ethyl2,2,2-triethoxyacetate; Ethyl2,2,2-triethoxyacetate; 57267-03-5; Ethyltriethoxyacetate; Triethoxy-aceticacidethylester; triethoxyaceticacidethylester |
ethyl tridecanoate | 28267-29-0 | C15H30O2 | 242.4 | ETHYL TRIDECANOATE; N-TRIDECANOIC ACID ETHYL ESTER; RARECHEM AL BI 0158; TRIDECANOIC ACID ETHYL ESTER; ETHYL TRIDECANOATE, 99+% |
Ethyl trans-4-aminocyclohexanecarboxylate | 1678-68-8 | C9H17NO2 | 171.24 | TRANS-4-AMINOCYCLOHEXANE CARBOXYLIC ACID ETHYL ESTER; (trans-4-Carboethoxycyclohexyl)amine; Ethyl trans-4-Aminocyclohexanecarboxylate |
Ethyl trans-2-Octenoate | 7367-82-0 | C10H18O2 | 170.25 | |
Ethyl trans-2-hydroxycyclohexanecarboxylate | 6125-55-9 | C9H16O3 | 172.22 | ETHYL TRANS-2-HYDROXY-1-CYCLOHEXANECARBOXYLATE, 95; Ethyl trans-2-hydroxy-1-cyclohexanecarboxylate,85% |
Ethyl trans-2-hydroxycyclohexanecarboxylate | 1883-91-6 | C9H16O3 | 172.23 | Ethyl trans-2-hydroxycyclohexanecarboxylate |
ETHYL TIGLATE | 5837-78-5 | C7H12O2 | 128.17 | 2-Butenoic acid, 2-methyl-, ethyl ester, (2E)-, ETHYL TIGLATE |
Ethyl thiobutyrate | 20807-99-2 | C6H12OS | 132.22 | ETHYL THIOBUTYRATE |
Ethyl b-D-fructopyranoside | 53431-77-9 | C8H16O6 | 208.21 | |
ethyl azetidine-3-carboxylate hydrochloride | 405090-31-5 | C6H11NO2ClH | 165.62 | |
ethyl L-cysteinate | 3411-58-3 | C5H11NO2S | 149.213 | EthylL-cysteinate; Cysteineethylester; H-Cys-OEt; L-Cysteineethylester; L-Cysteine,ethylester; 3411-58-3 |
ETHYL 4-AMINO-3-NITROBENZOATE | 76918-64-4 | C9H10N2O4 | 210.19 | ETHYL 4-AMINO-3-NITROBENZOATE; ethyl 3-nitro-4-aminobenzoate; 4-Amino-3-nitrobenzoic acid ethyl ester |
ethyl 6-(aminomethyl)picolinate | 104086-21-7 | C9H12N2O2 | 180.21 | 6-(Aminomethyl)-2-pyridinecarboxylic acid ethyl ester; Ethyl6-(aminomethyl)picolinate; Ethyl 6-(aminomethyl)pyridine-2-carboxylate |
Ethyl 5-phenyl-1,3-oxazole-4-carboxylate | 32998-97-3 | C12H11NO3 | 217.22 | Ethyl 5-phenyl-1,3-oxazole-4-carboxylate; 5-Phenyl-oxazole-4-carboxylic acid ethyl ester |
ETHYL 5-METHYL-3,4-DIHYDRO-2H-1,4-BENZOXAZINE-2-CARBOXYLATE | 220120-57-0 | C12H15NO3 | 221.2524 | ETHYL 5-METHYL-3,4-DIHYDRO-2H-1,4-BENZOXAZINE-2-CARBOXYLATE |
Ethyl 5-formylpyrrole-2-carboxylate | 7126-50-3 | C8H9NO3 | 167.16 | ETHYL 5-FORMYL-1H-PYRROLE-2-CARBOXYLATE |
ethyl 5-chloro-1H-pyrrolo[2,3-c]pyridine-2-carboxylate | 800401-67-6 | C10H9ClN2O2 | 224.64 | ethyl 5-chloro-1H-pyrrolo[2,3-c]pyridine-2-carboxylate |
ETHYL 4-AMINO-1-METHYL-1H-INDOLE-2-CARBOXYLATE | 91119-15-2 | C12H14N2O2 | 218.25 | ETHYL 4-AMINO-1-METHYL-1H-INDOLE-2-CARBOXYLATE |
Ethyl 4-amino-1-methyl-1H-imidazole-5-carboxylate | 61982-18-1 | C7H11N3O2 | 169.18 | ETHYL 4-AMINO-1-METHYL-1H-IMIDAZOLE-5-CARBOXYLATE; 4-Amino-1-methyl-1H-imidazole-5-carboxylic acid ethyl ester |
ethyl 4-acetyl-3,5-dimethyl-1H-pyrrole-2-carboxylate | 2386-26-7 | C11H15NO3 | 209.24 | 3-Acetyl-2,4-dimethyl-5-carbethoxypyrrole; 2,4-Dimethyl-3-acetyl-5-carbethoxypyrrole |
Ethyl 4-acetoxybutanoate | 25560-91-2 | C8H14O4 | 174.19 | ETHYL 4-ACETOXYBUTANOATE |
Ethyl 4,6-O-benzylidene-D-thiomannopyranoside | 142924-31-0 | C15H20O5S | 312.38 | |
Ethyl 4,6-O-benzylidene-b-D-thioglucopyranoside | 20701-61-5 | C15H20O5S | 312.38 | |
Ethyl 4,6-O-benzylidene-b-D-thiogalactopyranoside | 56119-28-9 | C15H20O5S | 312.39 | Ethyl 4,6-O-benzylidene-1-thio-b-D-galactopyranoside |
Ethyl 4,6-O-benzylidene-b-D-galactopyranoside | 101833-22-1 | C15H20O6 | 296.32 | |
Ethyl 4,6-O-benzylidene-2-deoxy-2-phthalimido-b-D-thioglucopyranoside | 129519-28-4 | C23H23NO6S | 441.5 | |
Ethyl 3-O-benzyl-4,6-O-benzylidene-2-deoxy-2-N-phthalamido-a-D-thioglucopyranoside | 123212-53-3 | b-D-Glucopyranoside, ethyl 2-deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-3-O-(phenylmethyl)- 4,6-O-[(R)-phenylmethylene]-1- | ||
Ethyl 3-nitropropanoate | 3590-37-2 | C5H9NO4 | 147.13 | Ethyl 3-nitropropanoate; 3-Nitropropanoic acid ethyl ester |
Ethyl 3-methylpiperidine-3-carboxylate | 170843-43-3 | C9H17NO2 | 171.23 | |
Ethyl 3-methylisoxazole-4-carboxylate | 20328-15-8 | C7H9NO3 | 155.15 | 3-Methylisoxazole-4-carboxylic Acid Ethyl Ester |
Ethyl 3-Hydroxy-4,4,4-Trifluorobutyrate | 372-30-5 | C6H9O3F3 | 186.13 | Ethyl 3-hydroxy-4,4,4-trifluorobutyrate; 3-Hydroxy-4,4,4-trifluorobutyric acid ethyl ester |
Ethyl 3-bromo-4-oxo-piperidine-1-carboxylate | 95629-02-0 | C8H12BrNO3 | 250.09 | 3-BROMO-4-OXO-PIPERIDINE-1-CARBOXYLIC ACID ETHYL ESTER; ETHYL 3-BROMO-4-OXO-PIPERIDINE-1-CARBOXYLATE; N-Carboethoxy-3-Bromo-4-Piperidone; 1CARBETHOXY-3-BRONO-4-PIPERIDONE; 1CARBETHOXY-3-BROMO-4-PIPERIDONE; 3-Bromo-4-oxo-piperidine-1-caroboxylic acid ethyl |
Ethyl 3-Bromo-2-Oxobutanoate | 57332-84-0 | C6H9BrO3 | 209.03786;g/mol | ethyl3-bromo-2-oxobutanoate; 57332-84-0; 3-bromo-2-oxo-butyricacidethylester; Ethyl3-bromo-2-oxo-butanoate; Ethyl3-bromo-2-oxobutanoate; ethyl3-bromo-2-oxobutyrate |
Ethyl 3-azabicyclo3.1.0hexane-6-carboxylate | 174456-77-0 | C8H13NO2 | 155.19432;g/mol | ethyl(1S,5R)-3-azabicyclo[3.1.0]hexane-6-carboxylate; 174456-77-0; Ethylcis-3-azabicyclo[3.1.0]hexane-6-carboxylate; ethyl(1R,5S)-3-azabicyclo[3.1.0]hexane-6-carboxylate; (1R,5S,6r)-rel-Ethyl3-azabicyclo[3.1.0]hexane-6-carboxylate; AC1LTTJJ |
Ethyl 3-Amino-2,2-dimethylpropanoate Hydrochloride | 80253-38-9 | C7H15NO2.HCl | 181.66000 | 3-Amino-2,2-dimethylsuccinic acid 1-tert-butyl ester; Ethyl 3-amino-2,2-dimethylpropanoate hydrochloride |
Ethyl 3-amino-2,2-dimethylpropanoate | 59193-77-0 | C7H15NO2 | 145.2 | RARECHEM AL BW 0424; 3-AMINO-2,2-DIMETHYL-PROPIONIC ACID ETHYL ESTER |
Ethyl 2-bromo-5-chlorothiazole-4-carboxylate | 425392-44-5 | C6H5BrClNO2S | 270.5314 | ETHYL 2-BROMO-5-CHLOROTHIAZOLE-4-CARBOXYLATE |
Ethyl 2-bromo-3-methylbutyrate | 609-12-1 | C7H13BrO2 | 209.08100 | |
ETHYL 2-BROMO-2-PHENYLPROPANOATE | 55004-59-6 | C11H13BrO2 | 257.12 | |
Estrone-d4 3-Sulfate Sodium Salt | 285979-80-8 | C18H17O5SD4·Na | 376.41 | Estra-1,3,5(10)-trien-17-one 3-(Sulfooxy)-d4 Sodium Salt |
Ethacridine lactate monohydrate | 6402-23-9 | C15H15N3O·C3H6O3·H2O | 361.39 | AMN-107 |
Ethaboxam | 162650-77-3 | C14H16N4OS2 | 320.4 | N-[cyano(thiophen-2-yl)methyl]-4-ethyl-2-(ethylamino)-1,3-thiazole-5-carboxamide; Ethaboxam; 162650-77-3; Ethaboxam[ISO]; SCHEMBL20484; CHEBI:82857 |
ETH-(E)-YLIDENE-PHENYL-AMINE | 6052-11-5 | C8H9N | 119.16376 | |
Esomeprazole Impurity H215/02 | 1803449-02-6 | C32H32N6O4S2 | 628.76 | 2,2'-(disulfanediylbis(methylene))bis(1-(5-methoxy-1H-benzo[d]imidazol-2-yl)-3,5-dimethylpyridin-4(1H)-one) |
Esomeprazole Impurity 4 | 2080-75-3 | C8H8N2O2 | 164.17 | 5-Methoxy-1, 3-Dihydro-benzoimidazol-2-One; |
Esomeprazole Impurity 3 | 1346599-85-6 | C26H30N4O4S | 494.62 | N-(4-Methoxy-3,5-dimethyl-2-pyridinyl)methyl Omeprazole; |
Esomeprazole Impurity 22 | 727375-13-5 | C8H11NO2 | 153.18 | 2-Pyridinemethanol, 4-hydroxy-3,5-dimethyl- (9CI) |
Esmolol-d7 HCl | 1346598-13-7 | C16H18NO4D7·HCl | 338.88 | 4-[2-Hydroxy-3-[(1-methylethyl-d7)amino]propoxy]benxzenepropanoic Acid Methyl Ester Hydrochloride |
Esculentoside H | 66656-92-6 | C48H76O21 | 989.1 | |
Ertapenem Ring Open Impurity | 357154-27-9 | C22H27N3O8S | 493.54 | |
Ertapenem N-Carbonyl Dimer Impurity | 1199797-43-7 | C44H48N6O13S2 | 933.03 | (4R,5S,6S)-3-[[(3S,5S)-1-[3-[[[(2S,4S)-4-[[(4R,5S,6S)-2-Carboxy-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-en-3-yl]thio]-2-pyrrolidinyl]carbonyl]amino]benzoyl]-5-[[(3-carboxyphenyl)amino]carbonyl]-3-pyrrolidinyl]thio]-6-[(1R)-1-hydro |
Ertapenem Impurity Pro-maba | 724700-26-9 | C12H14N2O3 | 234.26 | (S)-3-(pyrrolidine-2-carboxamido)benzoic acid |
Ertapenem Impurity DIPP | 220031-86-7 | C18H27N2O6PS | 430.46 | 3-((2S,4S)-1-(diisopropoxyphosphoryl)-4-mercaptopyrrolidine-2-carboxamido)benzoic acid |
Ertapenem Disodium | 153832-38-3 | C22H23N3Na2O7S | 519.48 | Ertapenem sodium; disodium (4R,5S,6S)-3-[(3S,5S)-5-[(3-carboxylatophenyl)carbamoyl]pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate |
Ertapenem Dimer II | 402955-38-8 | C44H50N6O14S2 | 951.05 | Ertapenem Dimer Ester Impurity; (4R,5S,6S)-3-[[(3S,5S)-5-[[[3-[[(1R,2S)-2-Carboxy-2-[(2S,3R)-5-carboxy-4-[[(3S,5S)-5-[[(3-carboxyphenyl)amino]carbonyl]-3-pyrrolidinyl]thio]-3,4-dihydro-3-methyl-2H-pyrrol-2-yl]-1-methylethoxy]carbonyl]phenyl]amino]carbonyl |
Ertapenem Dimer I | 1199797-41-5 | C44H50N6O14S2 | 951.05 | (4R,5S,6S)-3-[[(3S,5S)-1-[(2S,3R)-2-[(2S,3R)-5-Carboxy-4-[[(3S,5S)-5-[[(3-carboxyphenyl)amino]carbonyl]-3-pyrrolidinyl]thio]-3,4-dihydro-3-methyl-2H-pyrrol-2-yl]-3-hydroxy-1-oxobutyl]-5-[[(3-carboxyphenyl)amino]carbonyl]-3-pyrrolidinyl]thio]-6-[(1R)-1-hyd |
Ertapenem Dimer Amide Impurity | 1199797-42-6 | C44H50N6O14S2 | 951.05 | Ertapenem Dimer III; (4R,5S,6S)-3-[[(3S,5S)-5-[[[3-[[(2S,3R)-5-Carboxy-2-[(1S,2R)-1-carboxy-2-hydroxypropyl]-4-[[(3S,5S)-5-[[(3-carboxyphenyl)amino]carbonyl]-3-pyrrolidinyl]thio]-2,3-dihydro-3-methyl-1H-pyrrol-1-yl]carbonyl]phenyl]amino]carbonyl]-3-pyrr |
Dutasteride | 164656-23-9 | C27H30F6N2O2 | 528.53 | LS-173584; LS 173584; LS173584; GI198745, GG745; GI1 98745, GG 745; GI1-98745, GG-745 |
durvalumab | 1428935-60-7 | C6502H10018N1742O2024S42 | 146.3 | Imfinzi |
Durantoside II | 53526-66-2 | C27H34O14 | 582.56 | Durantoside II |
Durantoside I | 53526-67-3 | C26H32O13 | 552.53 | 2-Methyl-5,7-dihydroindeno[2,1-b]fluorene |
duramycin from streptoverticillium*cinnamoneus | 1391-36-2 | C89H125N23O25S3 | 2011.84 | 2-l-lysine-6-(3-aminoalanine)-10-l-phenylalanine-12-l-phenylalanine-ancoveni; antibioticpa48009; cyclic6-19)-imine; leucopeptin; DURAMYCIN; duramycin from streptoverticillium*cinnamoneus; lancovutide |
dupracetam | 59776-90-8 | C12H18N4O4 | 282.29600 | |
Doxorubicin Impurity 2 | 64845-67-6 | C19H12O6 | 336.3 | 6,8,11-Trihydroxy-1-methoxy-5,12-naphthacenedione |
Doxorubicin Impurity 1 | 1159977-24-8 | C19H12O7 | 352.3 | 7,8-Desacetyl-9,10-dehydro Daunorubicinone; 6,8,10,11-Tetrahydroxy-1-methoxy-5,12-naphthacenedione |
Doxofylline-d6(dimethyl-d6) | 1219805-99-8 | C11H3D6N4O4 | 272.29 | 7-(1,3-Dioxolan-2-ylmethyl)-1,3-dimethylxanthine; 7-(1,3-Dioxolan-2-ylmethyl)thiophyline |
Doxofylline Impurity 1 | 1429636-74-7 | C10H16N4O3 | 240.26 | 1-(1,3-Dioxolan-2-ylmethyl)-N-methyl-4-(methylamino)-1H-imidazole-5-carboxamide |
Doxofylline | 69975-86-6 | C11H14N4O4 | 266.25 | Doxofylline; Ansimar; ABC-12-3; ABC-1213; ALT-07; DO-309; ABC 12 3; ABC 1213; ALT 07; DO 309; ABC12; 3; ABC1213; ALT07; DO309 |
Dofequidar fumarate | 153653-30-6 | C34H35N3O7 | 597.66 | MS-209 |
Dofequidar | 129716-58-1 | C30H31N3O3 | 481.596 | Dofequidar |
Dodovisone D | 1616683-53-4 | C22H22O8 | 414.41 | |
Dodovisone C | 1616683-52-3 | C27H30O8 | 482.53 | |
Dodovisone B | 1616683-51-2 | C27H32O9 | 500.54 | |
Dodovisone A | 1616683-50-1 | C27H30O8 | 482.53 | |
Dodovislactone B | 1616683-55-6 | C21H30O5 | 362.46 | |
Dodovislactone A | 1616683-54-5 | C18H26O4 | 306.40 | |
Dodoviscin J | 1372527-42-8 | C22H22O7 | 398.41 | 5,7-Dihydroxy-2-[4-hydroxy-3-methoxy-5-(3-methyl-2-buten-1-yl)phenyl]-3-methoxy-4H-1-benzopyran-4-one; 3,3'-Dimethoxy-4',5,7-trihydroxy-5'-prenylflavone |
ETHYL 3-[1,6]NAPHTHYRIDIN-2-YL-3-OXO-PROPIONATE | 338760-66-0 | C13H12N2O3 | 244.25 | ETHYL 3-[1,6]NAPHTHYRIDIN-2-YL-3-OXO-PROPIONATE |
Ethyl 3,6-di-O-benzyl-2-deoxy-2-N-phthalamido-b-D-thioglucopyranoside | 115533-35-2 | C30H31NO6S | 533.64 | |
Ethyl 2-O-benzoyl-4,6-di-O-benzyl-3-Fmoc-b-D-thiogalactopyranoside | 1042374-62-8 | |||
Ethyl 2-O-benzoyl-3,6-di-O-benzyl-4-O-Fmoc-b-D-thioglucopyranoside | 1416144-50-7 | |||
ethyl 2-methylthiophene-3-carboxylate | 19432-66-7 | C8H10O2S | 170.2288;g/mol | ethyl2-methylthiophene-3-carboxylate;Ethyl2-methylthiophene-3-carboxylate;19432-66-7;2-METHYL-3-THIOPHENECARBOXYLICACIDETHYLESTER;2-Methyl-3-thiophenecarboxylicacid,ethylester;2-Methyl-3-ThiophenecarboxylicAcid,EthylEster |
ETHYL 2-METHYLENE-4-PENTYNOATE | 54109-54-5 | C8H10O2 | 138.1638;g/mol | ethyl2-methylene-4-pentynoate;54109-54-5;ethyl2-methylidenepent-4-ynoate;ethyl2-methylenepent-4-ynoate;AC1LD6Y8;SCHEMBL3871222 |
Ethyl 2-methylcyclopropane-1-carboxylate | 20913-25-1 | C7H12O2 | 128.17 | ETHYL 2-METHYLCYCLOPROPANE-1-CARBOXYLATE; ETHYL 2-METHYLCYCLOPROPANECARBOXYLATE; Cyclopropanecarboxylic acid, 2-methyl-, ethyl ester; Ethyl 2-methylcyclopropane; 2-Methylcyclopropanecarboxylic acid ethyl ester |
ETHYL 2-METHYLBENZOYLFORMATE | 66644-67-5 | C11H12O3 | 192.21 | ETHYL 2-METHYLBENZOYLFORMATE |
Ethyl 2-methylaminomethyl-3-p-tolyl-propionate | 886366-02-5 | C14H21NO2 | 235.32 | Ethyl 2-methylaminomethyl-3-p-tolyl-propionate |
ETHYL 2-METHYLAMINOMETHYL-3-M-TOLYL-PROPIONATE | 886366-15-0 | C14H21NO2 | 0 | |
Ethyl 2-methyl-6-phenylpyridine-3-carboxylate | 1702-14-3 | C15H15NO2 | 241.29 | |
ETHYL 2-METHYL-3,4-PENTADIENOATE | 60523-21-9 | C8H12O2 | 140.18 | 3,4-Pentadienoic acid, 2-methyl-, ethyl ester, ETHYL 2-METHYL-3,4-PENTADIENOATE, Ethyl 2-methylpenta-3,4-dienoate |
ETHYL 2-METHYL-2-PENTENOATE | 58625-96-0 | C8H1402 | 142.06 | (* Alt. CAS #) CAS: 1617-40-9; Ethyl trans-2-methyl-2-pentenoate, 2-Pentenoic acid, 2-methyl-, ethyl ester, ETHYL 2-METHYL-2-PENTENOATE, FEMA CAS: 1617-40-9, ETHYL 2-METHYL-2-PENTENOATE NO ANTIOXIDANT (special order) |
Ethyl 2-methyl-2-(piperidin-4-yl)propanoate hydrochloride | 243836-26-2 | C11H22ClNO2 | 235.75 | |
ETHYL 2-METHYL PENTANOATE | 39255-32-8 | C8H16O2 | 144.21 | ETHYL 2-METHYL PENTANOATE, ETHYL 2-METHYL VALERATE, Ethyl 2-Methylpentanoate, Ethyl 2-methylvalerate, Manzanate, Pentanoic acid, 2-methyl-, ethyl ester |
Ethyl 2-mercaptoimidazole-4-carboxylate | 64038-64-8 | C6H8N2O2S | 172.2 | Ethyl 2-mercaptoimidazole-4-carboxylate; 1H-Imidazole-4-carboxylic acid,2,3-dihydro-2-thioxo-,ethyl ester |
ETHYL 2-HYDROXYPYRIMIDINE-4-CARBOXYLATE | 306961-02-4 | C7H8N2O3 | 168.15 | ETHYL 2-HYDROXYPYRIMIDINE-4-CARBOXYLATE; 4-Pyrimidinecarboxylicacid,1,2-dihydro-2-oxo-,ethylester(9CI) |
ETHYL 2-HYDROXY-6-METHYLBENZOATE | 6555-40-4 | C10H12O3 | 180.20000 | |
Ethyl 2-hydroxy-4-methylvalerate | 10348-47-7 | C8H16O3 | 160.21 | |
ETHYL 2-HYDROXY-2-(TRIFLUOROMETHYL)-4-METHYLPENT-4-ENOATE 97 | 217195-91-0 | C9H13F3O3 | 226.1929296 | ETHYL 2-HYDROXY-2-(TRIFLUOROMETHYL)-4-METHYLPENT-4-ENOATE; ETHYL 2-HYDROXY-2-(TRIFLUOROMETHYL)-4-METHYLPENT-4-ENOATE 97; Ethyl 2-hydroxy-2-(trifluoromethyl)-4-methylpent-4-enoate 97%; ETHYL 2-HYDROXY-2-(TRIFLUOROMETHYL)-4-METHYL-4-PENTENOATE |
ETHYL 2-HEXENOATE | 27829-72-7 | C8H14O2 | 142.19 | 2-Hexenoic acid, ethyl ester, (2E)-, ETHYL 2-HEXENOATE, ETHYL 2-HEXENOATE (TRANS), Ethyl e-2-Hexenoate, Ethyl trans-2-Hexenoate |
Ethyl 2-fluoroacrylate | 760-80-5 | C5H7FO2 | 118.10 | Ethyl 2-fluoroacrylate; 2-Fluoroethyl acrylate |
Ethinyl Estradiol-3-Glucuronide | 60134-76-1 | C26H32O8 | 472.53 | (17a)-17-Hydroxy-19-norpregna-1,3,5(10)-trien-20-yn-3-yl b-D-glucopyranosiduronic acid; 17a-Ethynylestradiol 3-glucuronide |
Ethinyl Estradiol Impurity M | 3240-39-9 | C21H26O2 | 310.44 | 2-Methyl Ethinyl Estradiol |
Ethinyl Estradiol Impurity J (1-Methyl Ethinyl Estradiol) | 15071-66-6 | C21H26O2 | 310.44 | 1-Methyl Ethinyl Estradiol; |
Ethinyl Estradiol | 57-63-6 | C20H24O2 | 296.4 | Ethynyl estradiol; Ethynylestradiol; ETHINYLESTRADIOL; Ethinyloestradiol |
Erythrinin D | 1616592-59-6 | C21H18O6 | 366.4 | 4-Hydroxy-6-(4-hydroxyphenyl)-2-(1-methoxy-1-methylethyl)-5H-furo[3,2-g][1]benzopyran-5-one |
Erythrinin C | 63807-85-2 | C20H18O6 | 354.4 | 2-(1-Methyl-1-hydroxyethyl)-4-hydroxy-6-(4-hydroxyphenyl)-2,3-dihydro-5H-furo[3,2-g][1]benzopyran-5-one;2,3-Dihydro-2-(1-hydroxy-1-methylethyl)-4-hydroxy-6-(4-hydroxyphenyl)-5H-furo[3,2-g][1]benzopyran-5-one |
Erythrabyssin II | 77263-06-0 | C25H28O4 | 392.5 | (6aR,11aR)-6a,11a-Dihydro-2,10-bis(3-methyl-2-buten-1-yl)-6H-benzofuro[3,2-c][1]benzopyran-3,9-diol |
Erythbidin A | 210050-83-2 | C20H20O4 | 324.37 | Erythbidin A; (3R)-3,4-Dihydro-2',2'-dimethyl-[3,8'-bi-2H-1-benzopyran]-5',7-diol |
Erysubin B | 221150-19-2 | C20H16O6 | 352.3 | (-)-5-Hydroxy-2-(hydroxymethyl)-7-(4-hydroxyphenyl)-2-methyl-2H,6H-benzo[1,2-b:5,4-b']dipyran-6-one |
Eicosatetraynoic Acid | 1191-85-1 | C20H24O2 | 296.4 | ETYA; 5,8,11,14-eicosatetraynoic acid; Octadehydroarachidonic acid |
D-Tagatose | 87-81-0 | C6H12O6 | 180.16 | |
DuP-697 | 88149-94-4 | C17H12BrFO2S2 | 411.3 | 5-bromo-2-(4-fluorophenyl)-3-(4-(methylsulfonyl)phenyl)-thiophene |
Duocarmycin SA | 130288-24-3 | C25H23N3O7 | 477.47 | Cyclopropa(c)pyrrolo(3,2-e)indole-6-carboxylic acid, 1,2,4,5,8,8a-hexahydro-4-oxo-2-((5,6,7-trimethoxy-1H-indol-2-yl)carbonyl)-, methyl ester, |
D-Lactose monohydrate | 64044-51-5 | C12H22O11 H2O | 360.31 | 4-O-b-D-Galactopyranosyl-D-glucopyranose monohydrate; b-D-Gal-(1,4)-D-Glc |
D-Lactal | 65207-55-8 | C12H20O9 | 308.28 | |
DL-5-HYDROXYTRYPTOPHANE | 114-03-4 | C11H12N2O3 | 220.23 | TIMTEC-BB SBB003354; 5-hydroxy-dl-tryptopha; dl-hydroxytryptophan; dl-tryptopha; HYDROXYTRYPTOPHAN; DL-5-HTP |
DL-5-Hydroxylysine hydrochloride | 13204-98-3 | C6H15ClN2O3 | 198.65 | 2,6-Diamino-5-hydroxycaproic acid hydrochloride, 2,6-Diamino-5-hydroxyhexanoic acid hydrochloride |
DL-5-FLUOROLYSINE HYDROCHLORIDE | 118101-18-1 | C6H14ClFN2O2 | 200.64 | DL-5-FLUOROLYSINE HYDROCHLORIDE; 5-FLUORO-DL-LYSINE HYDROCHLORIDE; H-5-F-DL-Lys-OH.HCl; DL-5-Fluorolysine hydrochloride 97%; DL-5-Fluorolysinehydrochloride97% |
Disialyllacto-N-tetraose | 61278-38-4 | C48H79N3O37 | 1290.16 | |
Ethyl 2-deoxy-2-phthalimido-b-D-thioglucopyranoside | 130539-43-4 | |||
Ethyl 2-deoxy-2-[(trichloroacetyl)amino]-b-D-thioglucopyranoside | 635684-80-9 | C10H16Cl3NO5S | 368.66 | Ethyl 2-deoxy-1-thio-2-[(trichloroacetyl)amino]-b-D-glucopyranoside |
Ethyl 2-cyclopropylpyrimidine-5-carboxylate | 648423-77-2 | C10H12N2O2 | 192.21 | ethyl 2-cyclopropylpyrimidine-5-carboxylate |
Ethyl 2-chloroacetimidate | 37622-36-9 | C4H8ClNO | ||
Ethyl 2-chloro-7,8-dihydropyrido[3,4-b]pyrazine-6(5H)-carboxylate | 949922-49-0 | C10H12ClN3O2 | 241.67 | ethyl 2-chloro-7,8-dihydropyrido[3,4-b]pyrazine-6(5H)-carboxylate |
Ethyl 2-benzylideneacetoacetate | 620-80-4 | C13H14O3 | Ethyl 2-benzylideneacetoacetate; 3-Oxo-2-(phenylmethylene)butanoic acid ethyl ester | |
Ethyl 2-aminothiazole-5-carboxylate | 32955-21-8 | C6H8N2O2S | 172.2 | |
ETHYL 2-AMINOINDOLE-3-CARBOXYLATE | 6433-72-3 | C11H12N2O2 | 204.23 | ETHYL 2-AMINOINDOLE-3-CARBOXYLATE; 2-AMINOINDOLE-3-CARBOXYLIC ACID, ETHYL ESTER; ethyl 2-aminoindoline-3-carboxylate; 2-AMINOINDOLE-3-CARBOXYLIC ETHYL ESTER; 1H-Indole-3-carboxylicacid,2-amino-,ethylester(9CI) |
ETHYL 2-AMINO-5-BROMOTHIOPHENE-3-CARBOXYLATE | 56387-07-6 | C7H8BrNO2S | 250.11 | ETHYL 2-AMINO-5-BROMOTHIOPHENE-3-CARBOXYLATE |
Ethyl 2-acetamido-2-deoxy-b-D-thioglucopyranoside | 122331-70-8 | C10H19NO5S | 265.33 | |
Ethyl 2-acetamido-2-deoxy-b-D-thiogalactopyranoside | 95074-13-8 | C10H19NO5S | 265.33 | Mercaptoethyl 2-(acetylamino)-2-deoxy-b-D-galactopyranoside |
Ethyl 2-acetamido-2-deoxy-b-D-glucopyranoside | 2495-96-7 | C10H19NO6 | 249.26 | |
Ethyl 2,4-Dihydroxyquinoline-3-Carboxylate | 40059-53-8 | C12H11NO4 | 233.22 | 1,2-Dihydro-4-hydroxy-2-oxo-3-quinolinecarboxylic acid ethyl ester; Ethyl 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxylate; 4-Hydroxy-2-oxo-1,2-dihydro-quinoline-3-carboxylic acid ethyl ester |
Ethyl 2,4-dihydroxyphenylacetate | 67828-62-0 | C10H12O4 | 196.2 | Benzeneacetic acid, 2,4-dihydroxy-, ethyl ester; |
Ethyl 2,4-difluorobenzoate | 108928-00-3 | C9H8O2F2 | 186.1554 | ETHYL 2,4-DIFLUOROBENZOATE; RARECHEM AL BI 0213; 2,4-difluorobenzoic acid ethyl ester; Ethyl 2,4-difluorobenzoate 97%; Ethyl2,4-difluorobenzoate97% |
ETHYL 2,4-DICHLORO-6-METHYLPYRIDINE-3-CARBOXYLATE | 86129-63-7 | C9H9Cl2NO2 | 234.08 | BUTTPARK 43\57-69; AURORA KA-4546; ETHYL 2,4-DICHLORO-6-METHYLNICOTINATE; ETHYL 2,4-DICHLORO-6-METHYLPYRIDINE-3-CARBOXYLATE; ETHYL 2,4-DICHLORO-6-METHYLPYRIDINE-3-CARBOXYLATE 95+%; EthylEster,2,4-Dichloro-6-Methyl-3-PyridinecarboxylicAcid; 2,4-Dichloro-6- |
Ethyl 2,4-dibromobutyrate | 36847-51-5 | C6H10Br2O2 | 273.95 | 2,4-dibromo-butanoicaciethylester; ETHYL 2,4-DIBROMOBUTANOATE; ETHYL 2,4-DIBROMOBUTYRATE; ETHYL-ALPHA,GAMMA-DIBROMOBUTYRATE; 2,4-DIBROMO-BUTYRIC ACID ETHYL ESTER; 2,4-Dibromobutanoic acid ethyl ester |
Ethyl 2,4,6-tri-O-benzoyl-b-D-thiogalactopyranoside | 1423018-01-2 | C29H28O8S | 536.59 | Ethyl-b-D-thiogalactopyranoside 2,4,6-tribenzoate; ETBTG |
Ethyl 2,4,6-tri-O-acetyl-a-D-thiomannopyranoside | 1637783-63-1 | C14H22O8S | 350.39 | Ethyl 1-thio-a-D-mannopyranoside 2,4,6-triacetate |
Ethyl 2,4,6-trihydroxybenzoate | 90536-74-6 | C9H10O5 | 198.2 | Benzoic acid, 2,4,6-trihydroxy-, ethyl ester |
Ethyl 2,3-O-isopropylidene-a-L-thiorhamnopyranoside | 145124-97-6 | C11H20O4S | 248.34 | |
Ethyl 2,3-di-O-benzyl-4,6-O-benzylidene-b-D-thioglucopyranoside | 141263-01-6 | C29H32O5S | 492.63 | |
Ethyl 2,3-di-O-benzyl-4,6-O-benzylidene-a-D-thiomannopyranoside S-oxide | 188357-34-8 | C29H32O6S | 508.63 | 2,3-Di-O-benzyl-4,6-O-benzylidene 1-deoxy-1-(ethylsulfinyl)-a-D-mannopyranose |
Ethyl 2,3-di-O-benzyl-4,6-O-benzylidene-a-D-thiomannopyranoside | 218937-71-4 | C29H32O5S | 492.63 | |
Ethyl 2,3-di-O-benzoyl-b-D-thiogalactopyranoside | 154391-05-6 | |||
Ethyl 2,3-di-O-benzoyl-4,6-O-benzylidene-b-D-thiogalactopyranoside | 56119-30-3 | C29H28O7S | 520.59 | |
Ethyl 2,3,4-tri-O-benzyl-b-L-thiofucopyranoside | 116391-11-8 | C29H34O4S | 478.64 | |
Ethyl 2,3,6-tri-O-benzyl-b-D-thioglucopyranoside | 141263-02-7 | C29H34O5S | 494.64 | |
Ethyl 2,3,4-tri-O-benzyl-L-thiofucopyranoside | 169532-17-6 | C29H34O4S | 478.64 | Ethyl 6-deoxy-2,3,4-tris-O-(phenylmethyl)-1-thio-L-galactopyranoside |
Ethyl 2,3,4-tri-O-benzyl-b-D-thioglucopyranoside | 126461-54-9 | C29H34O5S | 494.64 | |
Ethyl 2,3,4-tri-O-benzyl-b-D-thiogalactopyranoside | 139574-31-5 | |||
Ethyl 2,3,4-tri-O-benzoyl-b-D-thioglucopyranosiduronic acid methyl ester | 302965-09-9 | C30H28O9S | 564.60 | Ethyl 1-thio-b-D-glucopyranosiduronic acid methyl ester tribenzoate |
Ethyl 2,3,4-tri-O-acetyl-b-L-thiofucopyranoside | 127501-41-1 | C14H22O7S | 334.39 | |
Ethyl 2,3,4-tri-O-acetyl-b-D-glucuronide methyl ester | 77392-66-6 | C15H22O10 | 362.33 | |
Ethyl 2,3,4,6-tetra-O-benzyl-b-D-thioglucopyranoside | 108739-67-9 | C36H40O5S | 584.77 | |
Ethyl 2,3,4,6-tetra-O-benzyl-b-D-thiogalactopyranoside | 125411-99-6 | C36H40O5S | 584.77 | |
Ethyl 2,3,4,6-tetra-O-benzoyl-b-D-thiogalactopyranoside | 138661-53-7 | |||
Ethyl 2,3,4,6-tetra-O-acetyl-D-thiomannopyranoside - min 80% a-anomer | 79389-52-9 | C16H24O9S | 392.42 | |
Ethyl 2,3,4,6-tetra-O-acetyl-b-D-thioglucopyranoside | 52645-73-5 | C16H24O9S | 392.5 | |
Ethyl 2,3,4,6-tetra-O-acetyl-b-D-thiogalactopyranoside | 55722-49-1 | C16H24O9S | 392.42 | 1-S-Ethyl 2,3,4,6-tetra-O-acetyl-b-D-thiogalactopyranoside |
Ethyl 2,3,4,6-tetra-O-acetyl-a-D-thioglucopyranoside | 41670-79-5 | C16H24O9S | 392.42 | |
Ethyl 2,3,4,6-tetra-O-acetyl-a-D-thiogalactopyranoside | 126187-25-5 | C16H24O9S | 392.42 | |
ethyl 2,2-dimethyl-3-oxo-3-phenylpropanoate | 25491-42-3 | C13H16O3 | 220.26434;g/mol | ethyl2,2-dimethyl-3-oxo-3-phenylpropanoate; 25491-42-3; NSC71604; AC1L5JKA; AC1Q5ERW; SCHEMBL4621876 |
Ethyl 2,2-difluoroacetoacetate | 2266-48-0 | C6H8F2O3 | 166.12 | 2,2-difluoro-acetoaceticacidethylester; ETHYL 2,2-DIFLUOROACETOACETATE; 2,2-DIFLUORO-3-OXO-BUTYRIC ACID ETHYL ESTER; ETHYL 2,2-DIFLUOROACETOACETATE: TECH., 90% |
Ethyl 2-(trifluoromethyl sulfonyloxy)-1-cyclohenxene-1-carboxylate | 122135-83-5 | C10H13F3O5S | 302.26 | Ethyl 2-(trifluoromethyl sulfonyloxy)-1-cyclohenxene-1-carboxylate |
Ethyl 2-(trifluoromethyl sulfonyloxy) benzoate | 179538-97-7 | C10H9F3O5S | 298.23 | Ethyl 2-(trifluoromethyl sulfonyloxy) benzoate |
Ethyl (E)-3-iodoacrylate | 31930-37-7 | 31930-37-7 | 226.0 | (E)-ETHYL3-IODOACRYLATE; 31930-37-7; Ethyl(E)-3-iodoacrylate; Ethyl(E)-3-iodoacrylate; Ethyl3-iodo-2E-acrylate; Ethyl3-iodo-2E-propenoate |
Ethyl (2Z)-chloro[(4-methoxyphenyl)hydrazono]acetate | 473927-63-8 | C11H13ClN2O3 | 256.68552;g/mol | ethyl2-chloro-2-[(4-methoxyphenyl)hydrazinylidene]acetate; Aceticacid,chloro[(4-methoxyphenyl)hydrazono]-,ethylester,(2Z)-; 473927-63-8; ethyl-2-chloro-2-[2-(4-methoxyphenyl)hydrazin-1-ylidene]acetate; 27143-07-3; Chloro((4-methoxyphenyl)hydrazono]acetica |
Ethyl (2-thenoyl)acetate | 13669-10-8 | C9H10O3S | 198.24 | BUTTPARK 146\18-24; ETHYL (2-THENOYL)ACETATE; ETHYL-2-THIOPHENOYL-ACETATE; ETHYL 3-OXO-3-(THIOPHEN-2-YL)PROPANOATE; ETHYL 3-OXO-3-THIOPHEN-2-YL-PROPIONATE; ETHYL 3-OXO-3-(2-THIENYL)PROPANOATE; 3-OXO-3-THIOPHEN-2-YL-PROPIONIC ACID ETHYL ESTER; 3-OXO-3-THIO |
Ethyl (2S,3S)-2,3-Epoxybutyrate | 110508-08-2 | C6H10O3 | 130.1418;g/mol | 110508-08-2; ethyl(2s,3s)-2,3-epoxy-3-methylpropanoate; ethyl(2S,3S)-3-methyloxirane-2-carboxylate; ZINC02016531; AC1OE4M4; 2-Oxiranecarboxylicacid,3-methyl-,ethylester,(2S,3S)- |
ETHYL (2''-METHOXY-BIPHENYL-3-YL)-ACETATE | 187270-16-2 | C17H18O3 | 270.326 | ETHYL (2''-METHOXY-BIPHENYL-3-YL)-ACETATE |
(E)-4-Hydroxycrotonoic Acid Ethyl Ester | 10080-68-9 | C6H10O3 | 130.14 | Ethyl trans-4-Hydroxy-2-butenoate; (2E)-4-Hydroxy-2-butenoic Acid Ethyl Ester |
ethyl (2E)-4,4-difluorobut-2-enoate | 37746-82-0 | C6H8F2O2 | 150.1233 | |
Ethyl (1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetate | 60263-06-1 | C10H12O4 | ||
ETHOTOIN | 86-35-1 | C11H12N2O2 | 204.23 | (±)-Ethotoin; 1-Ethyl-2,5-dioxo-4-phenylimidazolidine; 3-Ethyl-5-phenyl-2,4-imidazolidinedione; 3-Ethyl-5-phenylhydantoin; 3-Ethyl-5-phenylimidazolidin-2,4-dione; AC-695; Accenon; Peganone; 3-Ethyl-5-phenyl-2,4-Imidazolidinedione; |
Ethosuximide-d3 | 1189703-33-0 | C7H8NO2D3 | 144.19 | 3-(Ethyl-d3)-3-methyl-2,5-pyrrolidinedione; 2-(Ethyl-d3)-2-methylsuccinimide |
Ethosuximide | 77-67-8 | C7H11NO2 | 141.17 | 3-Ethyl-3-methyl-2,5-pyrrolidinedione; 2-Ethyl-2-methylsuccinimide; Atysmal; Capitus; Emeside; Etosuximid; H 940; Mesentol; NSC 64013; Simatin; Succimal; Succimitin; Suxilep; Suximal; |
Ethopropazine hydrochloride | 1094-08-2 | C19H25ClN2S | 348.93 | 10-(2-(diethylamino)propyl)-phenothiazin monohydrochloride;Isothazine hydrochloride;Lysivane hydrochloride;10H-Phenothiazine-10-ethanamine,N,N-diethyl-a-methyl- hydrochloride (1:1);N,N-diethyl-1-phenothiazin-10-ylpropan-2-amine hydrochloride;Dibutil HCl;P |
Ethephon-d4 | 1020719-29-2 | 2-Chloroethyl-D4-phos- phonic acid | ||
Ethephon | 16672-87-0 | C2H6ClO3P | 144.50 | 2-Chloroethylphosphonic acid |
ethenyldisulfanylethene | 15805-34-2 | C4H6S2 | 118.22 g/mol | Vinyldisulfide; Divinyldisulfide; Disulfide,diethenyl; (ethenyldisulfanyl)ethene; ETHENYLDISULFANYLETHENE; 15805-34-2 |
1,N6-Ethenoadenosine-5'-triphosphate sodium salt | 60777-99-3 | C12H14N5Na2O13P3 | 575.17 | 1,N[6]-ethenoadenosine 5'-triphosphate, sodium salt; Disodium 3-{5-O-[hydroxy({[(hydroxyphosphinato)oxy]phosphinato}oxy)phosphoryl]pentofuranosyl}-3H-imidazo[2,1-i]purine |
1,N6-Ethenoadenosine-5'-monophosphate sodium salt | 103213-41-8 | C12H14N5NaO7P | 394.23 | Etheno-AMP |
Ethaselen | 217798-39-5 | C16H12N2O2Se2 | 422.199 | Ethaselen; 1, 2-[bis (1,2-benzisoselenazolone-3 (2H)-ketone)] ethane, BBSKE. |
Ethanone,2-phenyl-1-(3-pyridinyl)- | 14627-92-0 | C13H11 N O | 197.23 | AKOS 92854; 2-PHENYL-1-PYRIDIN-3-YL-ETHANONE |
Ethanone,2-hydroxy-1,2-bis(4-methylphenyl)- | 1218-89-9 | C16H16 O2 | 240.297 | 4,4'-DIMETHYLBENZOIN; Dimethylbenzoin; 4,4'-Dimethylbenzoin 98%; 4,4''-DIMETHYLBENZOIN 98+%; Toluoin; 1,2-Bis(4-methylphenyl)-2-hydroxyethanone |
ETH 157 | 61595-77-5 | C36H32N2O4 | 556.6503 | |
eteplirsen | 1173755-55-9 | C364H569N177O122P30 | 10305.738 | Exondys 51; AVI-4658 |
Etelcalcetide hydrochloride | 1334237-71-6 | C38H74ClN21O10S2 | 1084.72 | Velcalcetide Hydrochloride; KAI-4169 HCl |
etelcalcetide | 1262780-97-1 | C38H73N21O10S2 | 1048.26 | Parsabiv |
Etebenecid | 1213-06-5 | C11H15NO4S | 257.31 | N,N-DIETHYL-4-SULFAMOYLBENZOIC ACID;4-((diethylamino)sulfonyl)-benzoicaci;p-(diethylsulfamoyl)-benzoicaci;p-(diethylsulfamoyl)benzoicacid;Antidipsin;Etebenecid |
ETC-159 | 1638250-96-0 | C19H19N7O3 | 393.41 | ETC-159; ETC159; ETC 159; ETC-1922159; ETC 1922159; ETC1922159. |
ETC-1002 | 738606-46-7 | C19H36O5 | 344.49 | ESP-55016; Bempedoic acid |
Etazolate hydrochloride | 35838-58-5 | C14H19N5O2.HCl | 325.8 | 1-Ethyl-4-[(1-methylethylidene)hydrazino]-1H-pyrazolo-[3,4-b]-pyridine-5-carboxylic acid, ethyl ester hydrochloride; Etazolate HCl |
Etarfolatide | 479578-27-3 | C29H34N10O11S | 730.71 | |
Etaracizumab | 892553-42-3 | 0 | etaracizumab; Abegrin; Vitaxin | |
Etaqualone | 7432-25-9 | C17H16N2O | 264.33 | 3-(2-ethylphenyl)-2-methyl-4(3H)-quinazolinone |
Estrone-d4 | 53866-34-5 | C18H18O2D4 | 274.40 | 1,3,5(10)-Estratrien-3-ol-17-one-d4, 3-Hydroxy-1,3,5(10)-estratrien-17-one-d4 |
Estrone-3-Glucuronide (Estrone beta-D-Glucuronide) | 2479-90-5 | C24H30O8 | 446.50 | 17-oxoestra-1,3,5(10)-trien-3-yl beta-D-glucopyranosiduronic acid |
Estrone b-D-glucuronide sodium salt | 15087-01-1 | C24H29O8 Na | 468.47 | E3G |
Estrone Acetate | 901-93-9 | C20H24O3 | 312.41 | Estra-1,3,5(10)-trien-17-one, 3-(acetyloxy)-; 17-oxoestra-1,3,5(10)-trien-3-yl acetate; (13alpha,14beta)-17-oxoestra-1,3,5(10)-trien-3-yl acetate |
Estrone 3-Sulfate Sodium Salt | 438-67-5 | C18H21O5S. Na | 372.41 | Estra-1,3,5(10)-trien-17-one 3-(Sulfooxy) Sodium Salt; Estrone Sulfate Sodium Salt; Conestoral; Estrone Sodium Sulfate; Morestin; NSC 18313; Sodium Estrone-3-sulfate; |
Estrone | 53-16-7 | C18H22O2 | 270.372 | 3-Hydroxyestra-1,3,5(10)-trien-17-one; (+)-Estrone; 1,3,5(10)-Estratrien-3-ol-17-one; 3-Hydroxy-17-keto-estra-1,3,5-triene; Aquacrine; Crinovaryl; Cristallovar; Crystogen; WAY 164397; Wynestron; |
Estriol 3-O-b-D-glucuronide sodium salt | 15087-06-6 | C24H31NaO9 | 486.49 | |
Estramustine phosphate sodium | 52205-73-9 | C23H30Cl2NNa2O6P | 564.347 | estramustine Phosphate, Emcyt, Estracyt, Leo-299; Ro 22-2296/000. |
Estramustine | 2998-57-4 | C23H31Cl2NO3 | 440.4 | [(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] N,N-bis(2-chloroethyl)carbamate; |
Estradiol Valerate Impurity C | 95959-20-9 | C23H30O3 | 354.49 | |
Estradiol Valerate | 979-32-8 | C23H32O3 | 356.506 | Altadiol; Deladiol; Delestrogen; Estraval; Progynova; Valergen; oestradiol valerate |
Erythromycin phosphate | 4501-00-2 | 831.924 | ERYTHROMYCIN PHOSPHATE; (2R,3R,4S,5R,8R,9S,10S,11R,12R,14R)-11-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyl-oxan-2-yl]oxy-5-ethyl-3,4,12-trihydroxy-9-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-oxan-2-yl]oxy-2,4,8,10,12,14-hexamethyl-6-oxacyclo | |
Erythromycin Impurity E | 857839-61-3 | C37H65NO12 | 715.93 | (2S,4'R,4aR,5'S,6'S,7R,8S,9R,10R,12R,14R,15S,16S,16aS)- 15-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6- methyloxan-2-yl]oxy}-7-ethyl-5',8,9,14- tetrahydroxy-4'-methoxy-4',6',8,10,12,14,16- heptamethyl-tetradecahydrospiro[[1,3]dioxino[5,4- c]oxacyclotetr |
Erythromycin F | 82230-93-1 | C37H67NO14 | 749.94 | 6,12-Di-O-methylerythromycin; |
Erythromycin Ethylsuccinate | 1264-62-6 | C43H75NO16 | 862.05 | N/A |
ent-Paroxol | 389573-45-9 | C13H18FNO | 223.29 | (3R,4S)-4-(4-Fluorophenyl)-1-methyl-3-piperidinemethanol; (+)-Paroxol; (+)-trans-4-(4'-Fluorophenyl)-3-hydroxymethyl-1-methylpiperidine; (3R,4S)-4-(4-Fluorophenyl)-3-hydroxymethyl-1-methylpiperidine |
ent-Paroxetine Hydrochloride | 130855-30-0 | C19H20FNO3.HCl | 365.83 | (3R-trans)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine Hydrochloride; (3R,4S)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine Hydrochloride; USP Paroxetine Related Compound C; Paroxetine EP Impurity D |
Entospletinib | 1229208-44-9 | C23H21N7O | 411.46 | GS-9973 |
ent-Labda-8(17),13Z-diene-15,16,19-triol 19-O-glucoside | 1245636-01-4 | C26H44O8 | 484.6 | |
Ent-kaurene | 562-28-7 | C20H32 | 272.48 | (±)-Kaura-16-ene |
D-Valine-d8 | 1116448-82-8 | (CD3)2CDCD(NH2)COOH | 125.2 | (R)-2-Aminoisovaleric Acid-d8; H-D-Val-OH-d8 |
D-Valine methyl ester hydroChloride | 21685-47-2 | C6H13NO2.HCl | 167.63 | D-VALINE METHYL ESTER HCL; D-VALINE-OME HCL; H-D-VAL-OME HCL; H-D-Val-OMeD-Valine methyl ester hydrochloride; (R)-methyl 2-amino-3-methylbutanoate hydrochloride |
D-Valganciclovir Hydrochloride | 1393911-57-3 | C14H23N6O5Cl | 390.83 | 2-[(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl Ester D-Valine Hydrochloride |
D-Phenylalanine,2,4,6-trimethyl- | 146277-48-7 | C12H17 N O2 | 219.1605296 | 2,4,6-Trifluoro-D-Phenylalanine; D-2,4,6-Trifluoro-Phe-OH [146277-48-7]; (R)-2-amino-3-(2,4,6-trifluorophenyl)propanoic acid; D-2,4,6-Trifluoro-Phe-OH |
Doxercalciferol | 54573-75-0 | C28H44O2 | 412.65 | Hectorol; 1.alpha.-Hydroxyvitamin D2. |
Dolasetron | 115956-12-2 | C19H20N2O3 | 324.37 | Dolasetron; UNII-82WI2L7Q6E; 82WI2L7Q6E; HSDB 7565; HSDB7565; HSDB-7565; CHEMBL1237118 |
Dofetilide D4 | 1189700-56-8 | C19H23N3O5S2D4 | 445.60 | N-[4-[2-[Methyl[2-[4-[(methylsulfonyl)amino]phenoxy]ethyl]amino]ethyl]phenyl]-methanesulfonamide-d4; UK-68798-d4; Tikosyn-d4 |
Dofetilide | 115256-11-6 | C19H27N3O5S2 | 441.56 | UK 68798; UK 68798; UK 68798; Dofetilide; Dofetilidum; Tikosyn |
Dodoviscin I | 1372527-40-6 | C21H22O7 | 386.4 | (+)-5,7-Dihydroxy-2-[4-hydroxy-3-(4-hydroxy-3-methylbutyl)phenyl]-3-methoxy-4H-1-benzopyran-4-one |
Dodoviscin H | 1372527-39-3 | C26H30O7 | 454.5 | (-)-5,7-Dihydroxy-2-[4-hydroxy-3-(4-hydroxy-3-methylbutyl)-5-(3-methyl-2-buten-1-yl)phenyl]-3-methoxy-4H-1-benzopyran-4-one |
DL-Pinocembrin | 68745-38-0 | C15H12O4 | 256.257 | 5,7-Dihydroxyflavanone; Dihydrochrysin; Galangin flavanone; 5,7-dihydroxy-2-phenyl-2,3-dihydrochromen-4-one |
DL-p-Hydroxyphenyllactic acid | 6482-98-0 | C9H10O4 | 182.17 | (RS)-3-(4-HYDROXYPHENYL)LACTIC ACID; 2-HYDROXY-3-(P-HYDROXYPHENYL)PROPIONIC ACID; 2-HYDROXY-3-(4-HYDROXYPHENYL)PROPANOIC ACID; DL-4-HYDROXYPHENYLLACTIC ACID; DL-P-HYDROXYPHENYLLACTIC ACID; BETA ,4-DIHYDROXYBENZENEPROPANOIC ACID; A-(P-HYDROXYPHENYL)-DL-LAC |
DL-Phosphinothricin | 77182-82-2 | C5H15N2O4P | 198.16 | |
DL-Phenyl-d5-alanine-3,3-d2 | 74228-83-4 | C6D5CD2CH(NH2)COOH | 172.23 | (±)-2-Amino-3-phenylpropionic Acid-d7; H-DL-Phe-OH-d7; 2-amino-3,3-dideuterio-3-(2,3,4,5,6-pentadeuteriophenyl)propanoic acid |
DL-Phenyl-d5-alanine-2,3,3-d3 | 29909-00-0 | C6D5CD2CD(NH2)COOH | 173.24 | (±)-2-Amino-3-phenylpropionic Acid-d8; H-DL-Phe-OH-d8; 2-amino-2,3,3-trideuterio-3-(2,3,4,5,6-pentadeuteriophenyl)propanoic acid |
DL-Phenyl-d5-alanine | 284664-89-7 | C6D5CH2CH(NH2)COOH | 170.22 | (±)-2-Amino-3-phenylpropionic Acid-d5; H-DL-Phe-OH-d5; Phenylalanine-d5; 2-amino-3-(2,3,4,5,6-pentadeuteriophenyl)propanoic acid |
DL-Phenylalanine-3-13C | 286425-42-1 | C6H513CH2CH(NH2)COOH | 166.19 | (±)-2-Amino-3-phenylpropionic Acid-13C; H-DL-Phe-OH-13C; 2-amino-3-phenylpropanoic acid |
Estradiol Impurity C | 6171-48-8 | C19H26O2 | 286.42 | 4-Methyl Estradiol; |
Estradiol hexahydrobenzoate | 15140-27-9 | C25H34O3 | 382.53566 | Estradiol hexahydrobenzoate; Estra-1,3,5(10)-triene-3,17beta-diol 17-cyclohexanecarboxylate |
Estradiol Hemihydrate Impurity D | 791-69-5 | C18H22O2 | 270.37 | delta9,11-Estradiol |
Estradiol bis[4-[bis(2-chloroethyl)amino]benzeneacetate] | 22966-79-6 | C42H50Cl4N2O4 | 788.67 | Estradiolmustard; Oestradiolmustard; 22966-79-6; CHEBI:82520; NSC112259; CCRIS283 |
Estradiol Benzoate Impurity E | 6045-53-0 | C25H28O3 | 376.50 | 17-epi- Estradiol Benzoate; |
Estradiol Benzoate | 50-50-0 | C25H28O3 | 376.49 | |
Estradiol 3-sulfate 17b-glucuronide dipotassium salt | 10392-35-5 | C24H32K2O11S | 606.77 | (17b)-3-(Sulfooxy)estra-1,3,5(10)-trien-17-yl b-D-glucopyranosiduronic acid dipotassium salt |
Estradiol 3-sulfamate | 172377-52-5 | C18H25NO4S | 351.46 | [(8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] sulfamate; E2MATE cpd; estradiol-3-O-sulfamate |
Estradiol 3-Enanthate | 55540-97-1 | C25H36O3 | 384.56 | (8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl heptanoate |
Estradiol | 50-28-2 | C18H24O2 | 272.38 | Beta-Estradiol; 17beta-Estradiol; Oestradiol; Dihydrofolliculin |
S-Deoxo Fulvestrant | 153004-31-0 | C32H47F5O2S | 590.77 | (7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]-estra-1,3,5(10)-triene-3,17-diol |
Estr-4-en-3-one | 33765-68-3 | C20H30O2 | 302.451;g/mol | oxendolone;Prostetin;33765-68-3;16b-Ethyl-19-nortestosterone;TSAA-291;UNII-MN4I850D4P |
Esterastin | 67655-93-0 | C28H46N2O6 | 506.69 | N2-Acetyl-L-asparagine (1S,3Z,6Z)-1-[[(2S,3S)-3-Hexyl-4-oxo-2-oxetanyl] methyl]-3,6-dodecadien-1-yl Ester; |
Esterase, acetylcholine | 9000-81-1 | 0 | ACETYLCHOLINE ESTERASE; ACETYLCHOLINESTERASE; ACETYLCHOLINE ACETYLHYDROLASE; ACETYLCHOLINE ACETYLHYDROLASE HUMAN; ACETYLCHOLINE ACETYLHYDROLASE TYPE VI-S; ACETYLCHOLINE ACETYLHYDROLASE TYPE V-S; ACETYLCHOLINE ACETYLHYDROLASE TYPE XII-S; EC 3.1.1.7 | |
Esterase Paenibacillus barcinonensis, recombinant | 9016-18-6 | |||
ESTER OF 2-DIAZO-1-NAPHTHOL-5-SULFONE WITH 2,3,4-TRIHYDROXYBENZOPHENONE | 5610-94-6 | C23H15N2O7S+ | 463.44 | 1-naphthalenesulfonicacid,6-diazo-5,6-dihydro-5-oxo-,4-benzoyl-1,2,3-benzene; 1-Naphthalenesulfonicacid,6-diazo-5,6-dihydro-5-oxo-,4-benzoyl-1,2,3-benzenetriylester; triylester; ESTER OF 2-DIAZO-1-NAPHTHOL-5-SULFONE WITH 2,3,4-TRIHYDROXYBENZOPHENONE; 4-be |
Esreboxetine succinate | 635724-55-9 | C23H29NO7 | 431.48 | Butanedioic acid (2S)-2-[(S)-(2-ethoxyphenoxy)-phenylmethyl]morpholine;(S,S)-Reboxetine succinate;(+)-(2S)-2-((S)-(2-Ethoxyphenoxy)phenylmethyl)morpholine hydrogen butanedioate |
Esreboxetine Metabolite C | 140431-52-3 | C17H19NO3 | 285.35 | 2-(morpholin-2-yl(phenyl)methoxy)phenol; |
Esreboxetine Metabolite B | 140431-51-2 | C19H23NO4 | 329.40 | |
Esreboxetine Metabolite A | 140431-50-1 | C19H23NO4 | 329.40 | |
Espatropate | 132829-83-5 | C19H23N3O3 | 341.41 | UK-88060; UNII-13MIU3750H;(R)-3-Quinuclidinyl (R)-alpha-(hydroxymethyl)-alpha-phenylimidazole-1-acetate |
Esorubicin | 63521-85-7 | C27H29NO10 | 527.526 | Esorubicin; deoxyadriamycin; deoxyadriamycin hydrochloride; deoxydoxorubicin. IMI-58. |
Esomeprazole Sodium Salt | 161796-78-7 | C17H18N3O3S.Na | 367.4 | (S)-Omeprazole Sodium Salt; 6-Methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole Sodium Salt; (S)-5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl] -1H-benzimidazole Sodium Salt; |
Esomeprazole potassium | 161796-84-5 | C17H18KN3O3S | 383.51 | potassium;5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide AstraZeneca Brand of Esomeprazole Magnesium Esomeprazole Esomeprazole Magnesium Esomeprazole Potassium Esomeprazole Sodium Esomeprazole Strontium Esome |
Esomeprazole magnesium trihydrate | 217087-09-7 | C34H42MgN6O9S2 | 767.17 | Esomeprazole (Magnesium trihydrate); (S)-omeprazole magnesium trihydrate; Nexium; KS-1054; KS 1054; KS1054 |
Esomeprazole magnesium salt | 1198768-91-0 | C17H18MgN3O3S | 368.71 | Esomeprazole (magnesium salt) |
Esomeprazole magnesium hydrate | 668985-31-7 | C34H38MgN6O7S2 | 713.12 (anhydrous basis) | (S)-Omeprazole magnesium hydrate, (T-4)-Bis[6-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl-O]-1H-benzimidazolato-N3]-Magnesium hydrate, Nexium hydrate |
Esomeprazole Magnesium | 161973-10-0 | C34H36MgN6O6S2 | 713.12 | (T-4)-Bis[5-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazolato]magnesium; |
Esmolol Isopropyl Amide | 83356-59-6 | C18H28N2O3 | 320.44 | 4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]-N-(1-methylethyl)-benzenepropanamide |
Esmolol HCl | 81161-17-3 | C16H26ClNO4 | 331.83 | NSC 112929; NSC112929; NSC-112929 |
Esmolol Dimer | 98903-89-0 | C31H46N2O7 | 558.72 | 4-[2-hydroxy-3-[[3-[4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]-1-oxopropyl](1-methylethyl)amino]propoxy]-benzenepropanoic Acid Methyl Ester |
Esmolol Acid Sodium Salt | 1346604-59-8 | C15H22NO4. Na | 280.35 22.99 | 4-[2-Hydroxy-3-[(1-methylethyl-)amino]propoxy]benzenepropanoic Acid Acid Sodium Salt |
Eslicarbazepine Acetate | 236395-14-5 | C17H16N2O3 | 296.32 | (10S)-10-(Acetyloxy)-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide; (S)-(-)-10-Acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide; BIA 2-093; Sep 0002093 |
ESI-09 | 263707-16-0 | C16H15ClN4O2 | 330.77 | ESI-09 |
ESI 05 | 5184-64-5 | C16H18O2S | 274.38 | NSC 116966; 1,3,5-Trimethyl-2-[(4-methylphenyl)sulfonyl]benzene |
Esculin sesquihydrate | 66778-17-4 | C15H16O9 1.5H2O | 367.31 | 6,7-Dihydroxycoumarine-6-glucopyranoside; Esculetin-6-b-D-glucopyranoside; Aesculin; Aesculinum |
Esculin | 531-75-9 | C15H16O9 H2O | 358.30 | 6-(b-D-Glucopyranosyloxy)-7-hydroxycoumarin; Esculetin-6-b-D-glucopyranoside; Aesculinum; Aesculin |
Esculetin | 305-01-1 | C9H6O4 | 178.14 | 6,7-DIHYDROXY-CHROMEN-2-ONE |
Esculentoside A | 65497-07-6 | C42H66O16 | 826.96 | Phytolaccasaponin E; Phytolaccoside E |
Escitalopram oxalate | 219861-08-2 | C20H21FN2O.C2H2O4 | 414.43 | Lexapro; (S)-Citalopram Oxalate; Cipralex |
Escitalopram Impurity L | 85118-25-8 | C9H7NO3 | ||
Escitalopram Impurity F | 64169-45-5 | C19H21ClFNO | ||
Escitalopram Impurity A | 59729-33-8 | C20H21FN2O | ||
Escitalopram | 128196-01-0 | C20H21FN2O | 324.39 | (S)-Citalopram; S-(+)-Citalopram; Seroplex |
Esbiothrin | 84030-86-4 | C19H26O3 | 302.42 | 3-Allyl-2-methyl-4-oxo-2-cyclopentenyl chrysanthemate; (RS)-3-allyl-2-methyl-4-oxocyclopent-2-enyl (1R,3R)-2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate |
Esaxerenone | 1632006-28-0 | C22H21F3N2O4S | 466.475 | CS-3150; XL-550; 1-(2-hydroxyethyl)-4-methyl-N-(4-methylsulfonylphenyl)-5-[2-(trifluoromethyl)phenyl]pyrrole-3-carboxamide |
Erythrulose | 40031-31-0 | C4H8O4 | 120.10 | |
Erythroxytriol P | 7121-99-5 | C20H36O3 | 324.5 | 5,15,16-Rosanetriol |
Erythrosine Lake | 12227-78-0 | C60H18Al2I12O15 | 2555.59 | Erythrosine Lake; Food red No.3 aluminum lake |
Erythrosin B | 16423-68-0 | C20H6I4O5. 2 Na | 879.86 | Erythrosine B; 3',6'-Dihydroxy-2',4',5',7'-tetraiodo-spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one; |
Erythropterin | 7449-03-8 | C9H7N5O5 | 265.19 | Erythropterin; 3-(2-Amino-4,5,6,8-tetrahydro-4,6-dioxopteridin-7(3H)-ylidene)-2-oxopropanoic acid; Einecs 231-214-4 |
Erythropoietin | 11096-26-7 | 0 | ERYTHROPOIETIN RAT; EPO; erythropoietin from human urine*approx 100 units; Erythropoietin,from human urine; ERYTHROPOIETIN HUMAN, RECOMB. FROM CHO- CELLS, PGE W. 10 U; ERYTHROPOIETIN FROM HUMAN URINE*APPROX 5 00 UNITS PE; ERYTHROPOIETIN FROM HUMAN URINE*A | |
Erythronolide B | 3225-82-9 | C21H38O7 | 402.53 | (3R,4S,5S,6R,7R,9R,11R,12S,13R,14R)-14-ethyl-4,6,7,12-tetrahydroxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione |
Epiguajadial B | 1411629-26-9 | C30H34O5 | 474.6 | (5aR,7E,11E,14aS,15S)-rel-5a,6,9,10,13,14,14a,15-Octahydro-1,3-dihydroxy-5a,9,9,12-tetramethyl-15-phenylbenzo[b]cycloundeca[e]pyran-2,4-dicarboxaldehyde |
Erythromycylamine | 26116-56-3 | C37H70N2O12 | 734.98 | (9S)-9-Amino-9-deoxoerythromycin; 9(S)-Erythromycylamine; |
Erythromycin, 14-hydroxy-6-O-methyl- | 110671-78-8 | C38H69NO14 | 0 | Erythromycin, 14-hydroxy-6-O-methyl-; 14-Hydroxy-6-O-methylerythromycin; A-62671 |
Erythromycin thiocyanate | 7704-67-8 | C38H68N2O13S | 793.02 | |
Erythromycin Estolate | 3521-62-8 | C52H93NO18S | 1056.39 | |
Erythromycin EP Impurity C | 41451-91-6 | C37H65NO14 | 747.93 | 1'',16-epoxy-Erythromycin; |
Erythromycin C | 1675-02-1 | C36H65NO13 | 719.9 | 3"-O-Demethylerythromycin A" |
Erythromycin B | 527-75-3 | C37H67NO12 | 717.95 | Erythromycin B; Oxacyclotetradecane, erythromycin deriv.; 12-Deoxyerythromycin; |
Erythromycin A oxime | 111321-02-9 | C37H68N2O13 | 748.96 | (9E)-Erythromycin A Oxime; (9E)-Erythromycin 9-Oxime; (E)-Erythromycin A Oxime; (E)-Erythromycin Oxime |
Erythromycin A N-oxide | 992-65-4 | C37H67NO14 | 749.9 | Erythromycin N-oxide |
Erythromycin A enol ether | 33396-29-1 | C37H65NO12 | 715.9 | |
Erythromycin A Dihydrate | 59319-72-1 | C37H67NO13.2H2O | 769.96 | |
Erythromycin A | 114-07-8 | C37H67NO13 | 733.93 | erythromycin; E-Mycin; Erythrocin |
erythro-Hydroxy Bupropion HCl | 357628-62-7 | C13H21Cl2NO | 278.22 | |
Ertiprotafib | 251303-04-5 | C31H27BrO3S | 559.52 | PTP-112; PTP112; PTP 112; Ertiprotafib; CAS#251303-04-5 |
Erythritol bis(carbonate) | 24690-44-6 | C6H6O6 | 174.11 | Erythritol 1,2:3,4-dicarbonate |
Erythristemine | 28619-41-2 | C20H25NO4 | 343.4 | 11-Methoxyerysotrine |
Erythrinin H | 1616592-62-1 | C17H12O7 | 328.28 | 3,8-dihydroxy-1,9-dimethoxy-[1]benzofuro[2,3-b]chromen-11-one |
Erythrinin F | 1616592-60-9 | C20H18O7 | 370.35 | 1''-Hydroxyerythrinin C; Hydroxyerythrinin C; (2S,3S)-3,4-dihydroxy-6-(4-hydroxyphenyl)-2-(2-hydroxypropan-2-yl)-2,3-dihydrofuro[3,2-g]chromen-5-one |
Erysubin A | 221150-18-1 | C20H16O6 | 352.3 | 4-Hydroxy-2-(1-hydroxy-1-methylethyl)-6-(4-hydroxyphenyl)-5H-furo[3,2-g][1]benzopyran-5-one |
Erysotramidine | 52358-58-4 | C19H21NO4 | 327.4 | 8-Oxoerysotrine |
Erysenegalensein E | 154992-17-3 | C25H26O6 | 422.48 | |
Ervamycine | 27773-39-3 | C22H26N2O3 | 366.5 | 11-Methoxytabersonine |
Erucyl Alcohol | 629-98-1 | C22H44O | 324.58 | |
Erucin | 4430-36-8 | C6H11NS2 | 161.29 | 4-(Methylthiol)-1-(isothiocyanato)butane; |
Erteberel | 533884-09-2 | C18H18O3 | 282.33 | LY500307 |
Erlotinib O-Desmethyl Metabolite Isomer (M14) HCl | 183320-51-6 | C21H22ClN3O4 | 415.874 | OSI420; OSI-420; OSI 420; CP473420; CP-473420; CP 473420; Desmethyl Erlotinib. |
Ertapenem Side Chain Enantiomer 2 HCl | 503607-49-6 | C12H14N2O3S. HCl | 266.32 36.46 | 3-((2S,4S)-4-mercaptopyrrolidine-2-carboxamido)benzoic acid HCl; |
Ertapenem Side Chain Enantiomer 1 | 202467-69-4 | C20H19N3O7S | 445.45 | 3-[[[(2S,4S)-1-(4-Nitrobenzyloxycarbonyl)-4-mercaptopyrrolidin-2-yl]carbonyl]amino]benzoic Acid; (2S-cis)-2-[[(3-Carboxyphenyl)amino]carbonyl]-4-mercapto-1-pyrrolidinecarboxylic Acid 1-[(4-Nitrophenyl)methyl] Ester; |
Ermanin | 20869-95-8 | C17H14O6 | 314.3 | 5,7-dihydroxy-3-methoxy-2-(4-methoxyphenyl)-1-benzopyran-4-one |
Erlotinib O-Desmethyl Metabolite Isomer | 183320-29-8 | C21H21N3O4 | 379.42 | Erlotinib 7-O-Desmethyl Metabolite; 2-[[4-[(3-Ethynylphenyl)amino]-6-(2-methoxyethoxy)-7-quinazolinyl] oxy]ethanol ; |
Erlotinib metabolite M12 | 183321-84-8 | C20H19N3O4 | 365.389 | 4-[(3-Ethynylphenyl)amino]-6,7-bis(2-hydroxyethoxy)quinazoline; 2-(4-(3-Ethynylanilino)-7-(2-hydroxyethoxy)quinazolin-6-yl)oxyethanol; 2-[4-(3-ethynylanilino)-7-(2-hydroxyethoxy)quinazolin-6-yl]oxyethanol |
Erlotinib metabolite M11 | 882172-60-3 | C21H19N3O5 | 393.40 | 2-[[4-[(3-Ethynylphenyl)amino]-6-(2-methoxyethoxy)-7-quinazolinyl]oxy]acetic Acid |
Erlotinib mesylate | 248594-19-6 | C23H27N3O7S | 489.54 | Tarceva; CP-358774; OSI-774; NSC 718781; R 1415 |
Erlotinib impurity, 6,7-bis(2-chloroethoxy) | 183321-82-6 | C20H17Cl2N3O2 | 402.28 | 6,7-bis(2-chloroethoxy)-N-(3-ethynylphenyl)quinazolin-4-amine |
Erlotinib impurity, 6-(2-methoxyethoxy)-7-(2-chloroethoxy) | 183321-83-7 | C21H20ClN3O3 | 397.86 | 6-(2-chloroethoxy)-N-(3-ethynylphenyl)-7-(2-methoxyethoxy)quinazolin-4-amine |
Erlotinib impurity, 6-(2-chloroethoxy)-7-(2-methoxyethoxy) | 183321-85-9 | C21H20ClN3O3 | 397.86 | 7-(2-chloroethoxy)-N-(3-ethynylphenyl)-6-(2-methoxyethoxy)-4-Quinazolinamine; |
Erlotinib Impurity F | 1624294-38-7 | C22H25N3O4 | 395.46 | Erlotinib-3-vinyl Hydrochloride; 6,7-Bis(2-methoxyethoxy)-N-(3-vinylphenyl)quinazolin-4-amine Hydrochloride; N-(3-Ethenylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine Hydrochloride |
Erlotinib Impurity 8 | 328528-74-1 | C20H22BrN3O4 | 448.32 | N-(3-Desethynylphenyl)-N-(3-bromophenyl) Erlotinib; N-(3-bromophenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine |
Erlotinib Impurity 7 | 183322-17-0 | C15H23NO6 HCl | 349.81 | 2-amino-4,5-bis(2-methoxyethoxy)benzoic acid ethyl ester hydrochloride |
Erlotinib Impurity 2 (4-Chloro-7-(2-Chloroethoxy)-6-(2-Methoxyethoxy)-Quinazoline) | 183322-20-5 | C13H14Cl2N2O3 | 317.17 | 4-chloro-7-(2-chloroethoxy)-6-(2-methoxyethoxy)quinazoline |
Ergosta-7,24(28)-dien-25,26,26,26,27,27,27-d7-3beta-ol,26,27,27,27-d7-3beta-ol | 221104-74-1 | C28H39D7O | 405.72 | |
Ergosta-7,22-dien-3-one | 32507-77-0 | C28H44O | 396.65 | 17-[(Z)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-1,2,4,5,6,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one |
Ergosta-5,7,24(28)-trien-25,26,26,26,27,27,27-d7-3beta-ol | 145693-07-8 | C28H37D7O | 403.70 | |
Ergosta-5,24(28)-dien-25,26,26,26,27,27,27-d7-3beta-ol | 209112-82-3 | C28H39D7O | 405.72 | |
Ergosta-4,6,8(14),22-tetraen-3-one | 19254-69-4 | C28H40O | 392.6 | Ergone |
Ergosine | 561-94-4 | C30H37N5O5 | 547.64528;g/mol | Ergosine;alpha-Ergosine;561-94-4;EINECS209-226-6;NSC122047;BRN0102152 |
ERGOLINE-8-CARBOXYLIC ACID METHYL ESTER | 30341-92-5 | C16H18N2O2 | 270.33 | ERGOLINE-8-CARBOXYLIC ACID METHYL ESTER; 6-nor-9,10-dihydrolysergic acid methyl ester |
Ergolide | 54999-07-4 | C17H22O5 | 306.4 | Dihydrobigelovin |
ERGOBASINE | 78207-83-7 | C19H23N3O2 | 325.4 | ERGOBASINE; ergobasinine; ergometrinine; 9,10-Didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8beta(S)-carboxamide; 9,10-Didehydro-N-(alpha-(hydroxymethyl)ethyl)-6-methylergoline-8-beta-carboxamide; Einecs 200-485-0; Ergoline-8-beta-carboxamide, 9, |
ERGi-USU | 1147-56-4 | C13H9N3OS | 255.3 | 1-[2-(2-Thiazolyl)diazenyl]-2-naphthalenol; 1-(1,3-thiazol-2-yldiazenyl)naphthalen-2-ol |
E-Retinyl b-glucuronide | 16639-19-3 | C26H38O7 | 462.58 | all-trans-Retinyl b-glucuronide |
Erepsin | 9031-96-3 | 0 | Erepsin; Peptidase | |
Epitaraxerol | 20460-33-7 | C30H50O | 426.73 | Isotaraxerol;D-Friedoolean-14-en-3-ol,(3a)-; D-Friedoolean-14-en-3a-ol (8CI);3-Epitaraxerol; 3a-Taraxerol 3-Picenol,1,2,3,4,4a,5,6,6a,8,8a,9,10,11,12,12a,12b,13,14,14a,14b-eicosahydro-4,4,6a,8 a,11,11,12b,14b-octamethyl-,[3R-(3a,4aa,6ab,8ab,12ab,12ba,14 |
Equilin-d4 | 285979-79-5 | C18H16O2D4 | 272.38 | 1,3,5,7-Estratetraen-3-ol-17-one-d4; 3-Hydroxyestra-1,3,5(10),7-tetraen-17-one-d4 |
equilin sulfate | 27540-07-4 | C18H20O5S | 0 | equilin sulfate |
Equilin 3-Benzoate | 6030-80-4 | C25H24O3 | 372.46 | 3-(Benzoyloxy)-estra-1,3,5(10),7-tetraen-17-one; 3-Hydroxy-estra-1,3,5(10),7-tetraen-17-one Benzoate |
Equilin 3-Sulfate Sodium Salt | 16680-47-0 | C18H19O5S. Na | 370.4 | 3-(Sulfooxy)estra-1,3,5(10),7-tetraen-17-one Sodium Salt; 3-Hydroxyestra-1,3,5(10),7-tetraen-17-one Hydrogen Sulfate Sodium Salt; Sodium Equilin 3-Monosulfate; |
Equilin | 474-86-2 | C18H20O2 | 268.36 | 3-Hydroxy-13-methyl-9,11,12,14,15,16-hexahydro-6H-cylcopenta(a)phenanthren-17-one |
Equilenin Sulfate Sodium | 16680-48-1 | C18H17FO5S Na | 345.40 22.99 | 3-(Sulfooxy)-estra-1,3,5,7,9-pentaen-17-one Sodium Salt; 3-Hydroxyestra-1,3,5,7,9-pentaen-17-one HydrogenSulfate Monosodium Salt; |
Equilenin | 517-09-9 | C18H18O2 | 266.34 | 3-Hydroxyestra-1,3,5,7,9-pentaen-17-one; (+)-Equilenin; 3-Hydroxyestra-1,3,5(10),6,8-pentaen-17-one; |
EPZ-6438 | 1403254-99-8 | C34H44N4O4 | 572.75 | EPZ-6438; EPZ 6438; EPZ6438. |
EPZ-5676 | 1380288-87-8 | C30H42N8O3 | 562.719 | EPZ-5676; EPZ5676; EPZ 5676. |
EPZ020411 HCl | 2070015-25-5 | C25H39ClN4O3 | 479.06 | EPZ-020411 hydrochloride |
EPZ020411 | 1700663-41-7 | C25H38N4O3 | 442.59 | N,N'-dimethyl-N'-[[5-[4-[3-[2-(oxan-4-yl)ethoxy]cyclobutyl]oxyphenyl]-1H-pyrazol-4-yl]methyl]ethane-1,2-diamine EPZ020411 CHEMBL3589039 GTPL9243 SCHEMBL17621957 49L N,N'-Dimethyl-N-({3-[4-({trans-3-[2-(Tetrahydro-2h-Pyran-4-Yl)ethoxy]cyclobutyl}oxy) |
EPZ015866 | 1616391-87-7 | C22H28N4O2 | 380.48 | 2-(cyclobutylamino)-N-[(2S)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]pyridine-4-carboxamide EPZ015866 GSK591 GTPL8954 SCHEMBL16220740 GSK3203591 2-(cyclobutylamino)-N-[(2S)-2-hydroxy-3-(1,2,3,4-tetrahydroisoquinolin-2-yl)propyl]pyridine-4 |
EPZ015666 | 1616391-65-1 | C20H25N5O3 | 383.44 | |
EPZ011989 trifluoroacetate | 1598383-41-5 | C37H52F3N5O6 | 719.83 | N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-[ethyl-[4-[2-methoxyethyl(methyl)amino]cyclohexyl]amino]-2-methyl-5-(3-morpholin-4-ylprop-1-ynyl)benzamide;2,2,2-trifluoroacetic acid EPZ011989 (trifluoroacetate) |
EPZ011989 | 1598383-40-4 | C35H51N5O4 | 605.82 | EPZ011989; EPZ-011989; EPZ 011989. |
EPZ005687 | 1396772-26-1 | C32H37N5O3 | 539.67 | 1-Cyclopentyl-N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-6-[4-(4-morpholinylmethyl)phenyl]-1H-indazole-4-carboxamide; 1-Cyclopentyl-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-6-(4-(morpholinomethyl)phenyl)-1H-indazole-4-carboxamide |
EPZ004777 hydrochloride | 1380316-03-9 | C28H42ClN7O4 | 576.13 | EPZ 004777 hydrochloride; EPZ-004777 hydrochloride |
EPZ004777 | 1338466-77-5 | C28H41N7O4 | 539.681 | EPZ004777; EPZ 004777; EPZ-004777. |
Eptifibatide Acetate | 148031-34-9 | C35H49N11O9S2 | 831.96 | Map-Har-Gly-Asp-Trp-Pro-Cys- NH2 (Disulfide bridge, Map1-Cys6) |
Eptapirone | 179756-58-2 | C16H23N7O2 | 345.41 | 4-Methyl-2-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-1,2,4-triazine-3,5-dione; Eptapirone; F11440; F-11440; F 11440 |
Eptapirone | 179756-85-5 | C16H23N7O2.C4H4O4 | 461.47 | Eptapirone; Eptapirone [INN]; F 11440; 4-methyl-2-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-1,2,4-triazine-3,5-dione |
Epsiprantel | 98123-83-2 | C20H26N2O2 | 326.43300 | |
Epsilon-polylysine | 28211-04-3 | (C6H12N2O)n | epsilon-Polylysin; Polylysine | |
EPSILON-HCH | 6108-10-7 | C6H6Cl6 | 290.83 | BHC (EPSILON ISOMER); BHC; EPSILON-HCH; cyclohexane,1,2,3,4,5,6-hexachloro-,(1alpha,2alpha,3alpha,4beta,5beta,6; epsilon-bhc (jmaf,iso); epsilon-hch (bsi); EPSILON-HEXACHLOROCYCLOHEXANE; 1a,2a,3a,4b,5a,6b-Hexa(1,2,3,4,5,6)chlorocyclohexane (e-isomer) |
epsilon-Cyclodextrin | 156510-98-4 | C60H100O50 | 1621.41 | Cyclomaltodecaose; CD10 |
Eprotirome | 355129-15-6 | C18H17Br2NO5 | 487.14 | KB2115; 3-[[3,5-dibromo-4-[4-hydroxy-3-(1-methylethyl)phenoxy]phenyl]amino-3-oxo-propanoic acid; |
Eprosartan related compound C | 4475-24-5 | C8H8O4S | 200.21 | (2-Thenyl)malonic acid, 2-(2-Thienylmethyl)propanedioic acid, 2-(Thiophen-2-ylmethyl)malonic acid |
Eprosartan related compound A | 1169702-90-2 | C15H18N2O2S | 290.39 | N-Descarboxyphenyl eprospartan; ((E)-3-(2-Butyl-1H-imidazol-5-yl)-2-(thiophen-2-ylmethyl)Acrylic Acid |
Eprosartan Mesylate | 144143-96-4 | C23H24N2O4S.CH4O3S | 520.62 | Eprosartan Mesylate; Teveten; Futuran; Navixen; Regulaten; SK and F 108566; SKF-108566; |
Eprosartan Impurity 4 | 152146-59-3 | C16H18N2O3 | 286.33 | 4-((2-butyl-5-formyl-1H-imidazol-1-yl)methyl)benzoic acid |
Eprociclovir | 145512-85-2 | C11H15N5O3 | 265.27 | UNII-227AL47VGS; AV-10; AC1LAAHS; 227AL47VGS; CHEMBL285442; SCHEMBL4550680; 2-amino-9-[[(1S,2R)-1,2-bis(hydroxymethyl)cyclopropyl]methyl]-3H-purin-6-one |
Epoxy phenol novolac resin | 28064-14-4 | 0 | POLY[(PHENYL GLYCIDYL ETHER)-CO-FORMALDEHYDE]; Phenol,polymerwithformaldehyde,glycidylether; Phenol,polymerwithformaldehyde,oxiranylmethylether; POLY((PHENYL GLYCIDYL ETHER)-CO-FORMALDE HYDE), AVERAGE MN CA. 570; POLY((PHENYL GLYCIDYL ETHER)-CO-FORMALDE H | |
Episyringaresinol | 51152-20-6 | C22H26O8 | 418.44 | (+)-Lirioresinol A |
Episilvestrol | 697235-39-5 | C34H38O13 | 654.66 | Methyl (1R,2R,3S,3aR,8bS)-6-({(2S,3R,6R)-6-[(1S)-1,2-dihydroxyethyl]-3-methoxy-1,4-dioxan-2-yl}oxy)-1,8b-dihydroxy-8-methoxy-3a-(4-methoxyphenyl)-3-phenyl-2,3,3a,8b-tetrahydro-1H-benzo[b]cyclopenta[d] furan-2-carboxylate; |
Episesartemin A | 77449-31-1 | C23H26O8 | 430.45 | 6-[(3aR,6S,6aR)-6-(3,4,5-trimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-4-methoxy-1,3-benzodioxole |
episappanol | 111254-18-3 | C16H16O6 | 304.298 | |
epi-Inositol | 488-58-4 | C6H12O6 | 180.16 | |
Epinastine Related Compound A | 41218-84-2 | C15H16N2 | 224.31 | 6-Aminomethyl-5,6-dihydromorphanthridine |
Epirubicin | 56420-45-2 | C27H29NO11 | 543.52 | Pharmorubicin; Ellence |
EPIROPRIM | 73090-70-7 | C19H23N5O2 | 353.41822 | 5-(3,5-DIETHOXY-4-PYRROL-1-YL-BENZYL)-PYRIMIDINE-2,4-DIAMINE; EPIROPRIM; EPIROPRIM:5-(3,5-DIETHOXY-4-PYRROL-1-YL-BENZYL)-PYRIMIDINE-2,4-DIAMINE; 2,4-Diamino-5-[3,5-diethoxy-4-(1H-pyrrol-1-yl)benzyl]pyrimidine; Ro-11-8958 |
Epirengynic acid | 1310146-00-9 | C8H14O4 | 174.2 | 2-(1,4-Dihydroxycyclohexanyl)-acetic acid |
Epipterosin L 2'-O-glucoside | 61117-89-3 | C21H30O9 | 426.46 | (2S,3R)-Pterosin L 2'-O-beta-D-glucoside |
Epipterosin L | 52611-75-3 | C15H20O4 | 264.3 | (2S,3R)-3-Hydroxy-6-(2-hydroxyethyl)-2-(hydroxymethyl)-2,5,7-trim ethyl-1-indanone |
Epipinoresinol 4-O-glucoside | 24404-49-7 | C26H32O11 | 520.52 | (-)-Pinoresinol 4-O-glucoside; Epipinoresinol-4-O-glucopyranoside; (-)-Pinoresinol glucoside |
Epinortrachelogenin | 125072-69-7 | C20H22O7 | 374.4 | (3R-trans)-Dihydro-3-hydroxy-3,4-bis[(4-hydroxy-3-methoxyphenyl)methyl]-2(3H)-furanone |
Epinodosin | 20086-60-6 | C20H26O6 | 362.42 | Epindosin |
Deoxy Epinephrine Hydrochloride | 62-32-8 | C9H14ClNO2 | 203.67 | 4-[2-(Methylamino)ethyl]-1,2-benzenediol Hydrochloride; 4-[2-(Methylamino)ethyl]pyrocatechol Hydrochloride; 1-(3,4-Dihydroxyphenyl)-2-methylaminoethane Hydrochloride; 3,4-Dihydroxy-N-methylphenethylamine Hydrochloride; 4-(2-Methylaminoethyl)pyrocatechol H |
Epinephrine-d6 | 1219803-77-6 | C9H7NO3D6 | 189.25 | Adrenaline-D6 |
Epinephrine-d3 | 1189977-29-4 | C9H10NO3D3 | 186.23 | (±)-Epinephrine-d3 (N-methyl-d3) |
Epinephrine Sulfonic Acid | 26405-77-6 | C9H13NO5S | 247.27 | 3,4-dihydroxy-a-[(methylamino)methyl]-benzenemethanesulfonicacid; |
Epinephrine Sulfate | 77469-50-2 | C9H13NO6S | 263.27 | 2-hydroxy-4-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenyl hydrogen sulfate |
Epinephrine Hydrochloride | 55-31-2 | C9H13NO3.HCl | 219.67 | Adrenaline |
Epinastine hydrobromide | 127786-29-2 | 330.23 | (+/-)-3-amino-9,13b-dihydro-1h-dibenz[c,f]imidazo[1,5-a]azepine hydrobromide; epinastine hydrobromide; EPINASTIN HBR; (+/-)-3-Amino-9,13b-dihydro-1H-dibenz[c,f]imidazo[1,5-a]azepine hydrobromide | |
Epinastine HCl | 108929-04-0 | C16H15N3.HCl | 285.77 | WAL-801CL HCl; WAL 801CL HCl; Epinastine Hydrochloride; Alesion; Elestat; Epinastine HCl; Epinastin HCl |
Epinastine | 80012-43-7 | C16H15N3 | 249.31 | 9,13b-Dihydro-1H-dibenz[c,f]imidazo[1,5-a]azepin-3- amine;3-Amino-9,13b-dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepine;Apinastine Base;WAL 801 |
Epi-N-Acetyl-lactosamine | 205380-69-4 | C14H25NO11 | 383.35 | Gala1-4GlcNAc; 2-Acetamido-2-deoxy-4-O-a-D-galactopyranosyl-D-glucopyranose |
Epimedonin L | 2215102-38-6 | C30H34O5 | 474.59 | |
Epimedonin K | 2222285-85-8 | C30H34O6 | 490.59 | |
Epimedonin J | 2222285-84-7 | C25H26O6 | 422.47 | |
Epimedonin I | 2222285-83-6 | C21H22O8 | 402.40 | |
Epimedonin H | 2222285-82-5 | C20H18O7 | 370.35 | |
Epimedonin G | 2222285-80-3 | C20H18O6 | 354.35 | |
Elubrixin | 688763-64-6 | C17H17Cl2FN4O4S | 463.30 | 1-(2-Chloro-3-fluorophenyl)-3-(4-chloro-2-hydroxy-3-piperazin-1-ylsulfonylphenyl)urea;SB-656933;SB656933;SB-656933-AAF;SB-656933-AAA;SB656933AAA;SB656933AAF;1-(4-Chloro-2-hydroxy-3-(piperazin-1-ylsulfonyl)phenyl)-3-(2-chloro-3-fluorophenyl)urea |
Eltrombopag Olamine | 496775-62-3 | C29H36N6O6 | 564.64 | SB-497115-GR; 2-mainoethan-1-ol hemi((Z)-3'-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylate); |
Eltrombopag Methyl Ester | 1246929-01-0 | C26H24N4O4 | 456.49 | 3'-[(2Z)-2-[1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy-[1,1'-Biphenyl]-3-carboxylic Acid Methyl Ester |
Eltrombopag Amide | 1246929-02-1 | C25H23N5O3 | 441.48 | 3'-[(2Z)-2-[1-(3,4-Dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazinyl]-2'-hydroxy-[1,1'-Biphenyl]-3-carboxamide |
Eltrombopag | 496775-61-2 | C25H22N4O4 | 442.47 | SB-497115-GR, SB497115 |
Eltoprazine hydrochloride | 98206-09-8 | C12H17N2O2Cl | 256.73 | Piperazine, 1-(2,3-dihydro-1,4-benzodioxin-5-yl)-, monohydrochloride;1-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazine hydrochloride;DU-28853 hydrochloride;DU28853 hydrochloride |
D-Proline,4-phenyl-, trans- (9CI) | 103290-41-1 | C11H13 N O2 | 191.22642;g/mol | (2R,4R)-4-phenylpyrrolidine-2-carboxylicacid; 103290-41-1; SCHEMBL8512122; CP-029; ZINC39297519; D-Proline,4-phenyl-,trans-(9CI) |
D-Proline, 4-hydroxy-,ethyl ester, (4R)- | 132666-67-2 | C7H13 N O3 | 159.18 | 2-(R)-CARBOETHOXY-4-(R)-HYDROXYPYRROLIDINE; D-Proline, 4-hydroxy-, ethyl ester, cis- (9CI) |
DOCOSANOIC ACID ETHYL ESTER | 5908-87-2 | C24H48O2 | 368.64 | behenicacidethylestercrystalline; Ethyl docosanoate; BEHENIC ACID ETHYL ESTER; DOCOSANOIC ACID ETHYL ESTER; ethyl behenate |
Docosanedioic acid | 505-56-6 | C22H42O4 | 370.57 | docosanedioicacid; Docosanedioicacid; Felogenicacid; Phellogenicacid; 1,22-Docosanedioicacid; 505-56-6 |
Docosahexaenoyl Ethanolamide | 162758-94-3 | C24H37NO2 | 371.6 | DHEA; Synaptamide; N-(2-hydroxyethyl)-4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenamide |
Docosahexaenoicacid(DHA) | 25167-62-8 | C22H32O2 | 328.48828;g/mol | Docosa-2,4,6,8,10,12-hexaenoicacid; 25167-62-8; (2E,4E,6E,8E,10E,12E)-docosa-2,4,6,8,10,12-hexaenoicacid; (14C)Docosahexaenoicacid; Docosahexaenoicacid(DHA); AC1O5WID |
DL-Methionine-d3 (S-methyl-d3) | 284665-20-9 | CD3SCH2CH2CH(NH2)COOH | 152.23 | (±)-2-Amino-4-(methylthio)butyric Acid-d3; H-DL-Met-OH-d3; 2-amino-4-(trideuteriomethylsulfanyl)butanoic acid |
DL-Methionine-3,3,4,4-d4 | 93709-61-6 | CH3SCD2CD2CH(NH2)COOH | 153.23 | (±)-2-Amino-4-(methylthio)butyric Acid-d4; H-DL-Met-OH-d4; (inverted exclamation markA)-Methionine-d4; 2-amino-3,3,4,4-tetradeuterio-4-methylsulfanylbutanoic acid |
DL-Carnitine HCl | 461-05-2 | C7H15NO3.HCl | 197.66 | 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium Chloride; (3-Carboxy-2-hydroxypropyl)trimethylammonium chloride; (±)-Carnitine chloride; (±)-Carnitine hydrochloride; Aplegin; Bicarnesine; Carnitine chloride; Carnitine, hydrochloride; DL-Carnitine hydr |
DL-Carnitine | 406-76-8 | C7H15NO3 | 161.20 | (3-carboxy-2-hydroxypropyl)trimethyl-,hydroxide,innersalt,dl-ammoniu;1-propanaminium,3-carboxy-2-hydroxy-n,n,n-trimethyl-,hydroxide,innersalt,;DL-CARNITINE;CARNITIN;(±)-(3-carboxy-2-hydroxypropyl)trimethylammonium hydroxide;1-Propanaminium, 3-carboxy-2-h |
DL-Carnitinamide hydrochloride | 5261-99-4 | C7H17ClN2O2 | 196.67 | |
DL-Canaline2HCl | 65518-20-9 | C4H10 N2 O3 . 2 Cl H | 0 | DL-Canaline2HCl |
DL-Calcium Pantothenate | 6381-63-1 | C9H16NO52Ca | 1010.28154 | CALCIUM DL-PANTOTHENATE; DL-N-(2,4-DIHYDROXY-3,3-DIMETHYLBUTYRYL)-B-ALANINE CALCIUM SALT; DL-N-[2,4-DIHYDROXY-3,3-DIMETHYLBUTYRYL]-BETA-ALANINE HEMICALCIUM SALT; DL-PANTOTHENIC ACID CALCIUM SALT; DL-PANTOTHENIC ACID HEMICALCIUM SALT; D,L-CALCIUM PANTOTHEN |
Divinylbenzene(DVB) | 1321-74-0 | C10H10 | 130.1864;g/mol | Divinylbenzene; 1,2-Divinylbenzene; o-Divinylbenzene; 1321-74-0; Benzene,diethenyl-; MYRTYDVEIRVNKP-UHFFFAOYSA-N |
Diversoside | 55062-36-7 | C25H34O10 | 494.537 | Marmin 6'-O-glucoside; 7-[(E,6R)-7-hydroxy-3,7-dimethyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoct-2-enoxy]chromen-2-one |
Divaric acid | 4707-50-0 | C10H12O4 | 196.1999 | |
Disialyloctasaccharide | 58902-60-6 | C76H125N5O57 | 2020.81 | |
Disialyllactose sodium | 38598-36-6 | C34H54N2O27Na2 | 968.77 | GD3-Oligosaccharide |
dITP - lyophilized | 16595-02-1 | C10H12N4Na3O13P3* 3 H2O | 612.17 | 2'-Deoxyinosine-5'-triphosphate, Sodium salt |
Epigomisin O | 73036-31-4 | C23H28O7 | 416.47 | |
Epiglobulol | 88728-58-9 | C15H26O | 222.372 | (-)-Epiglobulol; (1aR,4S,4aR,7R,7aS,7bS)-1,1,4,7-tetramethyl-2,3,4a,5,6,7,7a,7b-octahydro-1aH-cyclopropa[e]azulen-4-ol |
Epigambogic acid | 887606-04-4 | C38H44O8 | 628.75 | 2-epi-Gambogic acid; S-Gambogic acid |
(-)-Epigallocatechin gallate | 989-51-5 | C22H18O11 | 458.37 | EGCG cpd; epigallo-catechin gallate; epigallocatechin gallate; epigallocatechin-3-gallate; epigallocatechin-3-O-gallate; EGCG; 989-51-5; Tea catechin; Teavigo; Catechin deriv.; (2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxyb |
Epigallocatechin 3-O-(3-O-Methyl)-Gallate | 83104-87-4 | C23H20O11 | 472.402 | Epigallocatechin 3-O-(3-O-methyl)gallate; [(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4-dihydroxy-5-methoxybenzoate |
Epi-Galantamine N-Oxide | 366485-18-9 | C17H21NO4 | 303.36 | (4aS,6S,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol 11-Oxide |
Epi-Galantamine | 1668-85-5 | C17H21NO3 | 287.36 | (4aS,6S,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol; 2-Epigalanthamine; (-)-Epigalanthamine; SPH 1068; 3-Epigalanthamine; Galantamine Impurity B |
Epifriedelanol acetate | 2259-07-6 | C32H54O2 | 470.8 | (3S,4R,4aS,6aS,6bR,8aR,12aR,12bS,14aS,14bS)-4,4a,6b,8a,11,11,12b, 14a-Octamethyldocosahydro-3-picenyl acetate |
Epifriedelanol | 16844-71-6 | C30H52O | 428.7 | (3S,4R,4aS,6aS,6aS,6bR,8aR,12aR,14aS,14bS)-4,4a,6a,6b,8a,11,11,14a-octamethyl-1,2,3,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-hexadecahydropicen-3-ol |
Epieriocalyxin A | 191545-24-1 | C20H24O5 | 344.4 | |
Epiequisetin | 255377-45-8 | C22H31NO4 | 373.5 | 5-Epiequisetin |
Epicriptine | 88660-47-3 | C32H43N5O5 | 577.722 | |
Epicorynoxidine | 58000-48-9 | C21H25NO5 | 371.433 | (7R,13aS)-2,3,9,10-tetramethoxy-7-oxido-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-7-ium |
Epicoccamide | 606139-26-8 | C29H51NO9 | 557.7 | |
EPICHLOROHYDRIN-2-D1 | 70735-27-2 | C3H4ClDO | 93.53 | EPICHLOROHYDRIN-2-D1; epichlorohydrin-2-D; EPICHLOROHYDRIN-2-D , 97 ATOM % D |
EP1-antanoist-1 | 851204-35-8 | C19H15BrCl2N2O3 | 470.14 | 1-[[5-Bromo-2-[[(2,4-dichlorophenyl)methyl]oxy]phenyl]methyl]-5-methyl-1H-pyrazole-3-carboxylic acid |
Epalrestat | 82159-09-9 | C15H13NO3S2 | 319.4 | Epalrestat; Kinedak; ONO-2235; ONO 2235; ONO2235; Sorbistat |
Epacadostat | 1204669-58-8 | C11H13BrFN7O4S | 438.23 | (Z)-N-(3-bromo-4-fluorophenyl)-N'-hydroxy-4-((2-(sulfamoylamino)ethyl)amino)-1,2,5-oxadiazole-3-carboximidamide; INCB024360; INCB 024360; INCB-024360; INCB24360; INCB-24360; INCB 24360; Epacadostat |
EP1013 | 223568-55-6 | C18H23FN2O6 | 382.38 | (3S)-5-fluoro-3-[[(2S)-3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]-4-oxopentanoic acid; benzyloxycarbonyl-valyl-aspartic acid fluoromethyl ketone; EP1013; F573 compound; MX1013; N-benzyloxycabonyl-Val Asp-fluoromethyl ketone; Z-VD-FMK; zVD-FMK |
Eosin-5-isothiocyanate | 60520-47-0 | C21H7Br4NO5S | 704.97 | 2',4',5',7'-Tetrabromofluorescein-5-isothiocyanate |
EO 1428 | 321351-00-2 | C20H16BrClN2O | 415.71 | EO-1428; (2-Methylphenyl)-[4-[(2-amino-4-bromophenyl)amino]-2-chlorophenyl]methanone |
Enzastaurin | 170364-57-5 | C32H29N5O2 | 515.617 | 3-(1-Methyl-1H-indol-3-yl)-4-(1-(1-(pyridin-2-ylmethyl)piperidin-4-yl)-1H-indol-3-yl)-1H-pyrrole-2,5-dione; LY-317615 |
Enzalutamide Impurity C | 179232-29-2 | C8H6BrFO2 | 233.04 | Methyl 4-broMo-2-fluorobenzoate |
Enzalutamide Impurity B | 749927-69-3 | C8H7BrFNO | 232.05 | 4-BroMo-2-fluoro-N-MethylbenzaMide |
Enzalutamide Impurity 2 | 143782-23-4 | C9H3F3N2S | 228.20 | 3-Fluoro-4-methylphenylisothiocyanate |
Enzalutamide D3 | 1443331-82-5 | C21H13D3F4N4O2S | 467.45 | 4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide- d3 |
Enviradene | 80883-55-2 | C19H21N3O2S | 355.45400 | |
Enzalutamide Carboxylic Acid | 1242137-15-0 | C20H13F4N3O3S | 451.4 | 4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-benzoic Acid |
Enzalutamide | 915087-33-1 | C21H16F4N4O2S | 464.44 | MDV3100; MDV 3100; MDV-3100; 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-methylbenzamide |
ent-Rotigotine | 92206-54-7 | C19H25NOS | 315.475 | 6-(Propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol; 6-[propyl(2-thiophen-2-ylethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol |
ent-Rosuvastatin tert-Butyl Ester | 615263-60-0 | C26H36FN3O6S | 537.66 | (3S,5R,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic Acid tert-Butyl Ester |
Entrectinib | 1108743-60-7 | C31H34F2N6O2 | 560.64 | RXDX-101; NMS-E628; N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(oxan-4-ylamino)benzamide |
ent-kauran-17,19-dioic acid | 60761-79-7 | C20H30O4 | ent-kauran-17,19-dioic acid; ent-kaurane-17,19-dioic acid | |
Entinostat | 209783-80-2 | C21H20N4O3 | 376.416 | MS-275; pyridin-3-ylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate |
Ent-Galantamine | 60384-53-4 | C17H21NO3 | 287.36 | Galantamine Impurity F; (4aR,6S,8aR)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofurol[3a,3,2,-ef][2]benzazepin-6-ol; (+)-Galanthamine |
ent-Ezetimibe | 1376614-99-1 | C24H21F2NO3 | 409.44 | (3S,4R)-1-(4-Fluorophenyl)-3-[(3R)-3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone; |
Enterotoxin STp (E. coli) | 115474-04-9 | C81H110N20O26S6 | 1978.3 | H-ASN-THR-PHE-TYR-CYS-CYS-GLU-LEU-CYS-CYS-ASN-PRO-ALA-CYS-ALA-GLY-CYS-TYR-OH; H-ASN-THR-PHE-TYR-CYS-CYS-GLU-LEU-CYS-CYS-ASN-PRO-ALA-CYS-ALA-GLY-CYS-TYR-OH, (DISULFIDE BONDS BETWEEN CYS5 AND CYS10/CYS6 AND CYS14/CYS9 AND CYS17); ENTEROTOXIN STP (E COLI); E |
Enterocin | 59678-46-5 | C22H20O10 | 444.4 | Vulgamycin, A 5294, WS 8096, |